Factor regulating component in plant, and use thereof

ABSTRACT

The present invention provides a polynucleotide having a function of regulating a content of a plant metabolite, a polypeptide having a function of regulating a content of a plant metabolite, a vector containing the polynucleotide or a part of the polynucleotide, and a transformed plant produced by using the vector, and a method for producing the transformed plant, and according to the above polynucleotide, polypeptide, vector, transformed plant and method, a novel gene regulating a content of a plant metabolite and use of the novel gene.

This application is a Continuation of PCT International Application No PCT/JP2011/053297 filed in Japan on Feb. 16, 2011, which claims the benefit of Patent Application No. 2010-032537 filed in Japan on Feb. 17, 2010, the entire contents of which are hereby incorporated by reference.

TECHNICAL FIELD

The present invention relates to a regulatory factor of a component in a plant, more specifically, to a base sequence and an amino acid sequence of a gene regulating a component in a plant, a genetically modified plant modified with the gene, and a preparation method of the genetically modified plant.

BACKGROUND ART

Generally, tobacco products are produced from a material obtained by blending various types of leaf tobacco. Blending is a process generally carried out not only for tobacco products but also for various food products such as products of coffee, tea, rice and wheat flour. Because leaf tobacco is an agricultural product, amounts of components in the leaf tobacco vary every year depending on weather conditions. However, blending a various types of leaf tobacco as appropriate makes it possible to reproduce a material having a target quality. This allows providing products having a stable quality. Further, if development of leaf tobacco can provide leaf tobacco having different components in terms of quantity and quality from those of conventional leaf tobacco, a range of taste and flavor created by blending will be able to extend. This makes it possible to further develop various new products. Presently, a diversity of leaf tobacco is created by combinations of varieties, cultivation methods, curing methods, storage/fermentation methods, production regions, stalk positions and the like. For further extending possibilities of such blending techniques, it is desired to develop new leaf tobacco having different components, for example, components relevant to flavor and smoking taste, in terms of quantity and quality from those of conventional leaf tobacco.

Examples of components relevant to flavor and smoking taste in leaf tobacco are sugars, amino acids, organic acids, phenolic compounds, terpenoids, and alkaloids (nicotine).

Among the above components, nicotine is one of main components of leaf tobacco. Leffingwell reports that respective nicotine contents of Nicotiana tabacum and Nicotiana rustica are in a range of 0.2% to 8% (Non-Patent Literature 1). The nicotine contents in leaf tobacco vary in a wide range due to great influences from not only genetic factors that each variety has but also environmental factors such as meteorological factors and edaphic factors, and cultivation factors such as fertilization methods, topping methods, and harvesting methods.

Among such factors, our understanding on genetic factors has greatly progressed in recent years, as a result of development of molecular biology and genetic recombination techniques. Such progress has lead to identification of many genes that influence nicotine contents of Nicotiana plants.

For example, Sato et al. report transgenic plants (Nicotiana sylvestris) whose leaf nicotine contents are decreased by suppression of expression of putrescine methyl transferase (PMT) gene or increased by overexpression of the PMT gene (Non-Patent Literature 2). Xie et al. report transgenic plants whose leaf nicotine contents are decreased by suppression of expression of quinolate phosphoribosyl transferase (QPT) gene (Non-Patent Literature 3). Hashimoto et al. report transformed tobacco hairy roots (variety K326) whose nicotine contents are increased by overexpression of one or both of A622 and NBB1 genes and transformed tobacco plants (variety K326) whose leaf nicotine contents are increased by overexpression of one or both of PMT and QPT genes (Patent Literature 1). Further, Hashimoto et al. report transformed tobacco hairy roots (variety SR-1) whose nicotine contents are decreased by suppressing expression of N-methyl putrescine oxidase (MPO) gene and transformed tobacco cells (BY-2) whose nicotine contents are increased by overexpression of the MPO gene (Patent Literature 2). Furthermore, Hashimoto et al. report transformed tobacco cells (BY-2) and transformed tobacco hairy roots (variety Petit Havana SR1) nicotine contents of which transformed tobacco cells and transformed hairy roots are decreased by suppressing expression of A622 gene or NBB1 gene and also reports transformed tobacco plants (variety Petit Havana SR1) whose leaf nicotine contents are decreased by suppressing expression of the NBB1 gene (Patent Literature 3). Chintapakorn and Hamill report transformed hairy roots (variety NC-95) whose nicotine content is decreased by suppressing expression of arginine decarboxylase (ADC) gene (Non-Patent Literature 4). Hakkinen et al. report transformed tobacco cells (BY-2) whose nicotine contents are increased by overexpression of MAP2, MC126 or MT401 gene and transformed tobacco hairy roots (variety BY-2) whose nicotine contents are increased by overexpression of C127 gene (Non-Patent Literature 5). Shoji et al. report transformed tobacco plants whose leaf nicotine contents are decreased by suppressing expression of COI1 gene (Non-Patent Literature 6). Wang et al. report transformed plants whose leaf nicotine contents are decreased by concurrently suppressing expression of JAR4 and JAR6 genes in Nicotiana attenuata (Non-Patent Literature 7). Bailey et al. report transformed tobacco plants whose nicotine contents are increased by overexpression of VHb gene (Patent Literature 4). Inze et al. report transformed tobacco cells (BY-2) whose nicotine contents are increased by overexpression of MAP3 gene (Patent Literature 5). Page and Todd report transformed plants (Nicotiana benthamiana) whose nicotine contents are decreased by suppressing expression of NbTF1, NbTF4, or NbTF5 gene encoding a transcription factor and transformed plants (Nicotiana benthamiana) whose nicotine contents are increased by overexpression of the NbTF1, NbTF4, or NbTF5 (Patent Literature 6).

Regarding biosynthesis and an accumulation mechanism of nicotine in Nicotiana plants, a lot of physiological studies have been made for ages. As a result, involvement of plant hormones such as auxin, jasmonic acid, salicylic acid, and ethylene has become evident. For example, Solt (Non-Patent Literature 8), Yasumatsu (Non-Patent Literature 9), Mizusaki et al. (Non-Patent Literature 10), and Takahashi and Yamada (Non-Patent Literature 11) report that auxin negatively regulates the biosynthesis or accumulation of nicotine. Further, Baldwin et al. (Non-Patent Literature 12) report that salicylic acid negatively regulates accumulation of nicotine. Furthermore, Baldwin et al. (Non-Patent Literature 13), Imanishi et al. (Non-Patent Literature 14), and Goossens et al. (Non-Patent Literature 15) report that jasmonic acid positively regulates biosynthesis and accumulation of nicotine. Shoji et al. (Non-Patent Literature 16) and Kahl et al. (Non-Patent Literature 17) report that ethylene negatively regulates biosynthesis or accumulation of nicotine.

Such involvement of various plant hormones indicates that biosynthesis and accumulation of nicotine is regulated by complex networks including a plurality of signaling systems and a plurality of transcriptional regulation systems. Such networks are reported by Kazan and Manners (Non-Patent Literature 18), for example. Among the above-described genes that influence nicotine contents of Nicotiana plants, for example, COI1, JAR4, JAR6, MAP3, NbTF1, NbTF4, and NbTF5 genes are considered to be not genes encoding nicotine biosynthetic enzymes but genes involved in signaling or transcriptional regulation.

Plant hormones act on various aspects of various life processes. For example, plant hormones act on growth and regulation of morphology of plants, regulation of a secondary metabolic system, and regulation of response to biological/non-biological stresses. Accordingly, genes affecting leaf nicotine contents via signaling or transcriptional regulation of the plant hormones may vary not only nicotine but also other components in plants. The genes having such functions are important in increasing a diversity of leaf tobacco as described above. Accordingly, studies have been continued for identification of not only known genes but also new genes.

CITATION LIST Patent Literatures

[Patent Literature]

-   [Patent Literature 1] International Publication No. WO2007/072224 A2     (Publication Date: Jun. 28, 2007) -   [Patent Literature 2] Specification of US Patent Application     Publication No. 2008/0292735 A1 (Publication date: Nov. 27, 2008) -   [Patent Literature 3] International Publication No. WO2006/109197 A2     (Publication Date: Sep. 29, 2006) -   [Patent Literature 4] International Publication No. WO1998/012913 A1     (Publication Date: Apr. 2, 1998) -   [Patent Literature 5] International Publication No. WO2003/097790 A2     (Publication Date: Nov. 27, 2003) -   [Patent Literature 6] International Publication No. WO2009/063312 A2     (Publication Date: May 22, 2009)

Non-Patent Literatures

-   [Non-Patent Literature 1] D. Layton Davis and Mark T. Nielsen., eds     Chapter 8, Leaf Chemistry, 8A -   Basic Chemical Constituents of Tobacco Leaf and Differences among     Tobacco Types, Tobacco Production, Chemistry and Technology,     Blackwell Science Ltd, 265-284 (1999). -   [Non-Patent Literature 2] Sato et al., Metabolic engineering of     plant alkaloid biosynthesis., Proc. Natl. Acad. Sci. USA. 98:     367-372 (2001). -   [Non-Patent Literature 3] Xie et al., BIOTECHNOLOGY: A TOOL FOR     REDUCED-RISK TOBACCO PRODUCTS-THE NICOTINEEXPREENCE FROM TEST TUBE     TO CIGARETTE PACK, In Recent Advances in Tobacco Science Vomule 30,     Synposium Proceedings 58th Meeting, TOBACCO SCIENCE RESEARCH     CONFERENCE (2004). -   [Non-Patent Literature 4] Chintapakorn and Hamill,     Antisense-mediated regulation in ADC activity causes minor     alterations in the alkaloid profile of cultured hairy roots and     regenerated transgenic plants of Nicotiana tabacum. Phytochemistry.     68: 2465-2479 (2007). -   [Non-Patent Literature 5] Hakkinen et al., Functional     characterization of genes involved in pyridine alkaloid biosynthesis     in tobacco. Phytochemistry. 68: 2773-2785 (2007). -   [Non-Patent Literature 6] Shoji et al., Jasmonate-Induced Nicotine     Formation in Tobacco is Mediated by Tobacco COI1 and JAZ Genes.     Plant and Cell Physiology. 49: 1003-1012 (2008). -   [Non-Patent Literature 7] Wang et al., Comparisons of LIPDXYGENASE3-     and JASMONATE-RESISTANT4/6—Silenced Plants Reveal That Jasmonic Acid     and Jasmonic Acid-Amino Acid Conjugates Play Different Roles in     Herbivore Resistance of Nicotiana attenuate. Plant Physiology. 146:     904-915 (2008). -   [Non-Patent Literature 8] Solt, Nicotine production and growth of     excised tobacco root cultures. Plant Physiology. 32: 480-484 (1957). -   [Non-Patent Literature 9] Yasumatsu, Studies on the chemical     regulation of alkaloid biosynthesis in t obacco plants. Part II.     Inhibition of alkaloid biosynth esis by exogenous auxins. Agr. Biol.     Chem. 31: 1441-1447 (1967). -   [Non-Patent Literature 10] Mizusaki et al., Changes in the     activities of ornithine decarboxylase, putorescine     N-methyltransferase and N-methylputorescine oxidase in tobacco roots     in relation to nicotine biosynthesis. Plant and Cell Physiology. 14:     103-110 (1973). -   [Non-Patent Literature 11] Takahashi and Yamada, Regulation of     nicotine production by auxins in tobacco cultured cells in vitro.     Agr. Biol. Chem. 37: 1755-1757 (1973). -   [Non-Patent Literature 12] Baldwin et al., Quantification,     correlations and manipulations of wound-induced changes in jasmonic     acid and nicotine in Nicotiana sylvestris. Planta. 201: 397-404     (1997). -   [Non-Patent Literature 13] Baldwin et al., Wound-induced changes in     root and shoot jasmonic acid pools correlate with induced nicotine     synthesis in Nicotiana sylvestris Spegazzini and Comes. J. Chem.     Ecol. 20: 1573-1561 (1994). -   [Non-Patent Literature 14] Imanishi et al., Differential induction     by methyl jasmonate of genes encoding ornithine decarboxylase and     other enzymes involved in nicotine biosynthesis in tobacco cell     cultures. Plant Mol. Biol. 38: 1101-1111 (1998). -   [Non-Patent Literature 15] Goossens et al., A functional genomics     approach toward the understanding of secondary metabolism in plant     cells. Proc. Natl. Acad. Sci. USA. 100: 8595-8600 (2003). -   [Non-Patent Literature 16] Shoji et al., Ethylene supresses     jasmonate-induced gene expression in nicotine biosynthesis. Plant     and Cell Physiology. 41: 1072-1076 (2000). -   [Non-Patent Literature 17] Kahl et al., Herbivore-induced ethylene     suppresses a direct defense but not a putative indirect defense     against an adapted herbivore. Planta. 210: 336-342 (2000). -   [Non-Patent Literature 18] Kazan and Manners, Jasmonate Signaling     Toward an Integrated View. Plant Physiology. 146: 1459-1468 (2008).

SUMMARY OF INVENTION Technical Problem

Accordingly, an object of the present invention is to provide a novel regulatory factor for regulating biosynthesis or accumulation of plant metabolites which new regulatory factor is usable for increasing a diversity of leaf tobacco.

Solution to Problem

As a result of diligent studies in light of the above-described object, the inventors of the present invention found a novel regulatory factor that regulates biosynthesis or accumulation of a plant metabolite. Such a new regulatory factor was found from among a group of genes whose expression varies in a plant body due to a treatment caused by external plant hormones or a treatment varying an amount of an endogenous plant hormone. As a result, the inventors of the present invention accomplished the present invention. Further, the inventors of the present invention successfully produced a plant whose content of a plant metabolite in leaves is regulated by using the novel regulatory factor, and thereby accomplished the present invention.

That is, in order to achieve the object above, a polynucleotide of the present invention is any one of the following (a), (b), and (c), the polynucleotide having a function of regulating a content of a plant metabolite: (a) a polynucleotide consisting of the base sequence of any of SEQ ID NO: 1 to 17; (b) a polynucleotide consisting of a base sequence in which one or several bases are deleted, inserted, substituted or added in the base sequence of any of SEQ ID NO: 1 to 17; and (c) a polynucleotide that hybridizes, under a stringent condition, to a polynucleotide consisting of a complementary sequence of the polynucleotide (a).

In order to achieve the object above, a polynucleotide of the present invention is a polynucleotide encoding a polypeptide set forth in any one of the following (d) and (e), the polypeptide having a function of regulating a content of a plant metabolite: (d) a polypeptide consisting of the amino acid sequence of any of SEQ ID NO: 18 to 32; and (e) a polypeptide consisting of an amino acid sequence in which one or several amino acids are deleted, inserted, substituted or added in the amino acid sequence of any of SEQ ID NO: 18 to 32.

In order to achieve the object above, a polypeptide of the present invention is any one of the following (d) and (e), the polypeptide having a function of regulating a content of a plant metabolite: (d) a polypeptide consisting of the amino acid sequence of any of SEQ ID NO: 18 to 32; and (e) a polypeptide consisting of an amino acid sequence in which one or several amino acids are deleted, inserted, substituted or added in the amino acid sequence of any of SEQ ID NO: 18 to 32.

A vector of the present invention is configured to include the polynucleotide described above.

A method for producing a transformed plant whose content of a plant metabolite is regulated, the method includes the step of transforming a plant cell by using the vector described above.

A transformed plant whose content of a plant metabolite is regulated, the transformed plant is produced by using the vector as described above.

A tobacco product of the present invention is being produced by using a plant body of the transformed plant described above, the transformed plant being Nicotiana tabacum or Nicotiana rustica whose content of the plant metabolite in a leaf is regulated.

Advantageous Effects of Invention

According to the present invention, an amount of a plant metabolite can be regulated in a plant. This makes it possible to obtain a plant whose amount of a plant metabolite is regulated.

BRIEF DESCRIPTION OF DRAWINGS

FIG. 1

FIG. 1 is a diagram showing changes in nicotine contents in cases where levels of endogenous gene expression are varied by use of genes of the present invention.

FIG. 2

FIG. 2 is a diagram showing a result of complementation tests using E. coli on genes of the present invention.

DESCRIPTION OF EMBODIMENTS Polynucleotide Having Function of Regulating Content of Plant Metabolite

In one aspect, the present invention provides an isolated polynucleotide having a function of regulating a content of a plant metabolite.

Specific examples of the polynucleotide of the present invention are: (a) a polynucleotide encoding the amino acid sequence of any of SEQ ID NO: 18 to 32 or a mutant of the amino acid sequence, or (b) a polynucleotide having the base sequence of any of SEQ ID NO: 1 to 17 or a mutant of the polynucleotide having the base sequence. Here, note that: the polynucleotide of SEQ ID NO: 1 is called TTF_(—)#20 gene; the polynucleotide of SEQ ID NO: 2 is called TTF_(—)#53 gene; the polynucleotide of SEQ ID NO: 3 is called TTF_(—)#54 gene; the polynucleotide of SEQ ID NO: 4 is called TTF_(—)#55 gene; the polynucleotide of SEQ ID NO: 5 is called TTF_(—)#56 gene; the polynucleotide of SEQ ID NO: 6 is called TTF_(—)#80 gene; the polynucleotide of SEQ ID NO: 7 is called TTF_(—)#84 gene; the polynucleotide of SEQ ID NO: 8 is called TTF_r20 gene; the polynucleotide of SEQ ID NO: 9 is called TTF_r25 gene; the polynucleotide of SEQ ID NO: 10 is called TTF_r33 gene; the polynucleotide of SEQ ID NO: 11 is called TTF_r35 gene; the polynucleotide of SEQ ID NO: 12 is called TTF_r40 gene; the polynucleotide of SEQ ID NO: 13 is called TTF_r48 gene; the polynucleotide of SEQ ID NO: 14 is called TTF_r49 gene; the polynucleotide of SEQ ID NO: 15 is called TTF_r66 gene; the polynucleotide of SEQ ID NO: 16 is called TTF_r84 gene; and the polynucleotide of SEQ ID NO: 17 is called TTF_r86 gene.

The term “polynucleotide having a function of regulating a content of a plant metabolite” as used in the present specification indicates (a) an endogenous polynucleotide that is naturally present in a plant cell and that is involved in regulation of a content of a metabolite, or (b) the endogenous polynucleotide isolated. Here, regarding the “function”, a polypeptide that is a translation product of the polynucleotide may have the “function”. Alternatively, like a functional RNA encoding no polypeptide, the polynucleotide itself may have the “function”. Known examples of such a functional RNA are Xist RNA involved in dosage compensation (Non-Patent Literature: Plath K et al., 2002. Annu Rev Genet. 36, 233-78), roX RNA (Non-Patent Literature: Meller and Rattner 2002. Embo J, 21, 1084-91), and SRA that is an activator of a steroid hormone receptor (Non-Patent Literature: Lanz R B et al. 1999. Cell, 97:17-27).

The term “polynucleotide” as used in the present specification is interchangeable with a term “gene”, “nucleic acid”, or “nucleic acid molecule”. This term “polynucleotide” is used to mean a polymer of nucleotides. The term “base sequence” is as used in the present specification is interchangeable with a term “nucleic acid sequence” or “nucleotide sequence”. This “base sequence” is shown as a sequence of deoxyribonucleotide (abbreviated by using letters A, G, C, and T).

The polynucleotide of the present invention may be present in a form of RNA (e.g., mRNA) or DNA (e.g., cDNA or genomic DNA). DNA may be present in a double stranded form or a single stranded form. A single-stranded DNA or RNA may correspond to a coding strand (also known as a sense strand) or a non-coding strand (also known as an anti-sense strand).

In the present specification, in a case where the term “mutant” is used in regard to a polynucleotide, the term “mutant” may be (a) a polynucleotide having a base sequence in which one or several bases are deleted, inserted, substituted or added in the base sequence of any of SEQ ID NO: 1 to 17 or (b) a polynucleotide that hybridizes, under stringent conditions, to a complementary sequence of the base sequence of any of SEQ ID NO: 1 to 17. The “several bases” here means, for example, 2 to 30 bases, more preferably 2 to 10 bases, and most preferably 2 to 6 bases.

The phrase “hybridize, under stringent conditions” means that hybridization occurs only in a case where sequences are at least 90% identical, more preferably 95% identical and most preferably 97% identical. A specific example of the “stringent conditions” is conditions where after overnight incubation at 42° C. in hybridization solution (containing 50% formamide, 5×SSC (150 mM NaCl and 15 mM trisodium citrate), 50 mM sodium phosphate (pH 7.6), 5×Denhardt's solution, 10% dextran sulfate, and 20 μg/ml denatured sheared salmon sperm DNA), a filter is washed in 0.1×SSC at approximately 65° C. Regarding the hybridization, a method is not specifically limited, but may be a conventionally known method such as a method as described in J. Sambrook et al. Molecular Cloning, A Laboratory Manual, 2d Ed., Cold Spring Harbor Laboratory (1989). In general, the higher a temperature is and the lower a salt concentration is, the higher the stringency becomes (that is, the more difficult the hybridization becomes).

Further, the polynucleotide of the present invention may be a polynucleotide encoding a polypeptide of the present invention. In other words, the polynucleotide of the present invention may be (a) a polynucleotide having a base sequence encoding the amino acid sequence of any of SEQ ID NO: 18 to 32 or (b) a polynucleotide having a base sequence encoding an amino acid sequence in which one or several amino acids are deleted, inserted, substituted or added in the amino acid sequence of any of SEQ ID NO: 18 to 32. The term “several amino acids” here means, for example, 2 to 30 amino acids, more preferably 2 to 10 amino acids, and most preferably 2 to 5 amino acids. As described later, the polypeptide of the present invention has a function of regulating a content of a metabolite in plants.

The term “polypeptide” as used in the present specification is interchangeable with a term “peptide” or “protein”. The polypeptide of the present invention may be isolated from a natural source or may be chemically synthesized.

The term “plant metabolite” as used in the present specification is interchangeable with a term “metabolite” or “component”. The “plant metabolite” can be classified into a primary metabolite or a secondary metabolite. The primary metabolites are substances essential for maintaining a living body. Examples of such substances are sugars, organic acids, amino acids, and fats. The secondary metabolites are metabolites other than the primary metabolites. The secondary metabolite of plants is derived from a primary metabolic system and considered to be involved in, for example, protection against foreign enemies, resistance to stress, and attraction of insects. Specific examples of the secondary metabolism of plants are terpenoids, alkaloids, phenolic compounds, and derivatives of these substances.

The terpenoids basically mean compounds produced as a result of biosynthesis of a plurality of bound isoprene units. The alkaloids mean nitrogen-containing basic organic compounds derived from plants. The phenolic compounds mean phenol-ring-containing organic compounds such as phenylpropanoid and flavonoid.

Examples of the alkaloids are tropane alkaloids, pyrrolidine alkaloids, pyrrolizidine alkaloids, piperidine alkaloids, phenylethylamines, isoquinoline alkaloids, quinoline alkaloids, pyridine alkaloids, indole alkaloids, imidazole alkaloids, purine alkaloids, and benzylisoquinoline alkaloids. The tropane alkaloids are alkaloids each containing in a structure thereof a tropane skeleton. An example of such tropane alkaloids is atropine. The pyridine alkaloids are alkaloids each containing in a structure thereof a pyridine ring. An example of the pyridine alkaloids is nicotine. Note that nicotine as well as nornicotine is a main alkaloid in Nicotiana plants. Examples of nicotine-related alkaloids contained in Nicotiana plants are nornicotine, anatabine, anabasine, myosmine, N-methylmiosmine, cotinine, nicotyrine, nornicotyrine, nicotine N-oxide, and 2,3′-bipyridyl-metanicotine.

The term “content of plant metabolite” as used in the present specification means an amount of a specific plant metabolite in a plant body. Similarly, the term “alkaloid content” means an amount of specific alkaloid in a plant body. Note that an analysis of the content of the plant metabolite may be carried out by conventionally known methods such as gas chromatography. The content of the plant metabolite can be expressed by weight with respect to dry weight of the plant or weight with respect to fresh weight of the plant.

The phrase “having a function of regulating a content of a plant metabolite” as used in the present specification broadly means involvement in a content of a plant metabolite. That is, the phrase means not only (a) having a function of directly regulating biosynthesis of a plant metabolite but also (b) having a function of indirectly varying a content of a plant metabolite, that is, having a function of changing a content of the plant metabolite consequently even though the change occurs outside a biosynthesis pathway of the plant metabolite. Here, “regulating” means decreasing or increasing a content of a specific plant metabolite.

The term “isolated” as used in regard to the polynucleotide in the present specification indicates to obtain, by “a method for obtaining a polynucleotide” described later, only a specific polynucleotide from a condition where the polynucleotide is naturally present in plant cells. In addition, the term “isolated” also indicates that the polynucleotide may be obtained by chemically synthesizing a full length polynucleotide or the polynucleotide may be synthesized by joining a plurality of polynucleotides that are chemically synthesized.

The method for obtaining the polynucleotide of the present invention is not specifically limited, but may be a general method. For example, the polynucleotide of the present invention may be obtained by cutting out, with use of an appropriate restriction enzyme, and purifying a polynucleotide from a genomic DNA or cDNA library of an organism having a gene of the present invention. The genomic DNA of the gene of the present invention can be obtained, for example, by (i) extracting a genomic DNA from a plant cell or tissue, (ii) preparing a genomic library, and (iii) carrying out colony hybridization or plaque hybridization by using a probe or primer designed based on the base sequence of SEQ ID NO: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, or 17 from the library prepared above. Alternatively, the polynucleotide of the present invention can be obtained by PCR employing cDNA or genomic DNA of the gene of the present invention as a template.

The gene of the present invention is found as a gene influencing a nicotine content in leaves of Nicotiana plants, through analysis by use of a VIGS (Virus-induced gene silencing) system. The gene is found from among selected 149 types of tobacco genes that have responsiveness to plant hormones or some relevance to a transcription factor.

The VIGS system is a method for clarifying a function of a gene by using a mechanism of PTGS (post-transcriptional gene silencing). In the present invention, a TRV (Tobacco Rattle Virus) vector (Ratcliff F. et al., 2001, Plant Journal, 25, 237-245, and U.S. Pat. No. 7,229,829) is used as the VIGS system. Moreover, as a polynucleotide to be inserted into the vector, a partial length cDNA of tobacco (Nicotiana tabacum cv. Burley 21, or Tsukuba No. 1) is used. As a plant to which the vector is introduced, Nicotiana benthamiana is used.

A new function of the gene of the present invention thus obtained may be further found by use of an accurate mass spectrometer such as a liquid chromatography—time-of-flight mass spectrometry (LC-TOF/MS).

More specifically, influence of the gene of the present invention on a plant metabolite can be clarified in a wide range by analyzing the plant metabolite of (i) plants that are transformed so that the gene of the present invention is overexpressed or progenies of such plants or (ii) plants that are transformed so that expression of the gene of the present invention is suppressed or progenies of such plants. Such analysis is carried out by using an accurate mass spectrometer such as an LC-TOF/MS.

The LC-TOF/MS is an apparatus in which a time-of-flight mass spectrometry (TOF/MS) as a detector is combined with a liquid chromatography (LC) that is a separation/analysis method of refractory or thermolabile compounds. Components separated by the LC are ionized by an ionization section (e.g. ESI; ElectroSpray Ionization). In the TOF/MS, thus obtained ions are flied by electromagnetic force and detected according to difference in flight time caused by mass difference. According to the LC-TOF/MS, various metabolites can be analyzed all at once by using extract from plant leaves. The analysis of the plant metabolites by use of the LC-TOF/MS can be performed specifically as follows.

First, a sample taken from a plant that is transformed or a progeny of the transformed plant, or a wild-type plant is dried and then ground. To the sample ground, 50% acetonitrile is added and extraction is performed. Then, extract is subjected to centrifugation. Further, supernatant obtained as a result of the centrifugation is ultrafiltered and then provided for the LC-TOF/MS analysis. In the analysis using the LC-TOF/MS, 100 or more metabolites can be analyzed all at once in a case where, for example, a tobacco leaf is used as a sample.

Alternatively, the influence of the gene of the present invention on the plant metabolites can also be clarified in a wide range by using a gene expression analysis method such as microarray analysis. For example, by clarifying a gene whose expression level in an above mentioned transformed plant or its progeny is different from that in a wild type plant, it is possible to clarify other genes' expression and a metabolic pathway on both of which the gene of present invention gives effects.

The term “transcription factor” as used in the present specification indicates a protein that has a function of increasing or decreasing transcription of a specific gene. Such a protein works by (a) binding to DNA, in particular, a promoter region of the DNA by interacting with a general transcription factor or (b) binding to another transcription factor that binds to DNA. As a result of studies on Arabidopsis thaliana, it is clarified that, as compared to animals and yeasts, higher plants have a remarkably wide variety of transcription factor genes. This suggests that regulation at a transcription level has an important part in biological activities of plants. Though a large part of functions of transcription factors of these plants have not been clarified yet, some functions have been known so far. Examples of such functions are functions relevant to the occurrence and regulation of differentiation of individuals, functions relevant to response to environmental stresses such as heat and drought, and functions relevant to response to disease and insect damages and injuries.

The genes whose functions are clarified as described above are the polynucleotides of the present invention respectively having the base sequences of SEQ ID NO: 1 to 17. For example, in Nicotiana plants, by silencing TTF_(—)#20 gene, TTF_(—)#53 gene, TTF_(—)#54 gene, TTF_(—)#55 gene, TTF_(—)#56 gene, TTF_(—)#80 gene, TTF_(—)#84 gene, TTF_r20 gene, TTF_r25 gene, TTF_r33 gene, TTF_r35 gene, TTF_r40 gene, TTF_r48 gene, TTF_r49 gene, TTF_r66 gene, TTF_r84 gene, or TTF_r86 gene, a nicotine content can be decreased or increased as compared to a nicotine content in a plant where the above gene is not silenced.

From the function as described above, it can be said that the genes shown by the base sequences of SEQ ID NO: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16 and 17 are regulatory factors each regulating a “leaf nicotine content” in Nicotiana plants.

Some of the genes of the present invention have a domain specific to a transcription factor and therefore considered to be a transcription factor. As the domain specific to the transcription factor that some of the genes of the present invention have, TTF_(—)#20 gene and TTF_(—)#55 gene have WRKY domain. Moreover, TTF_r20 gene, TTF_r25 gene, and TTF_r33 gene have AP2 domain, and TTF_r40 gene and TTF_r48 gene have tify domain. Further, TTF_r49 gene has AUX/IAA domain, and TTF_(—)#53 gene has bHLH domain. In addition, TTF_(—)#54 gene has SANT domain. Note that no domain specific to a transcription factor is found in other genes of the present invention. The genes of the present invention may be involved in any one step of generation, translocation, accumulation and the like of nicotine in Nicotiana plants. As a result, it is considered that each of the genes of the present invention affect the “leaf nicotine content”.

The functions of the above 17 types of genes of the present invention have not conventionally been clarified. The inventors of the present invention first clarified that each of these 17 types of genes of the present invention has a function of regulating a content of a metabolite.

As possible effects of the above 17 types of genes of the present invention, resistance to environmental stresses such as heat and drought and resistance to disease and insect damages can be provided by (i) increasing/decreasing a content of a plant metabolite or (ii) regulating various signal transduction and transcription.

The vector of the present invention may be prepared by a known genetic recombination technique. In this preparation, the polynucleotide of the present invention or a part thereof is inserted into a predetermined vector. This predetermined vector is not specifically limited, but it is possible to use a cloning vector as well as a gene expression vector described later.

[2. Polypeptide Having Function of Regulating Content of Plant Metabolite]

In one aspect, the present invention provides a polypeptide having a function of regulating a content of a plant metabolite.

The polypeptide of the present invention is preferably a polypeptide having the amino acid sequence of any of SEQ ID NO: 18 to 32 or a mutant of the polypeptide.

The term “mutant” as used in regard to a protein or a polypeptide in the present specification indicates a polypeptide retaining a specific activity that a target polypeptide has. The “mutant of the polypeptide having the amino acid sequence of any of SEQ ID NO: 18 to 32” indicates a polypeptide having a function of regulating a content of a plant metabolite.

It has been known in the field to which the present invention pertains that some amino acids in an amino acid sequence constituting a polypeptide can be easily modified without significantly affecting a structure or function of the polypeptide. Further, it is also conventionally known that, other than the mutant obtained by artificial modification, there is a mutant that is present as a natural protein which mutant has a structure or function not significantly changed from that of the natural protein. Further, the present invention encompasses a polypeptide of an allele of the gene encoding the polypeptide described above.

It is possible for a person skilled in the art to easily cause mutation of one or several amino acids in an amino acid sequence of a polypeptide, by using a conventionally known technique. For example, according to a method of conventional induced point mutation, it is possible to cause mutation of any base of a polynucleotide encoding a polypeptide. Further, it is also possible to prepare a deletion mutant or an additional mutant by designing a primer for any part of the polynucleotide encoding the polypeptide.

The polypeptide of the present invention includes a natural purified product, a product synthesized by chemical synthesis, and a product produced by a recombination technique from a prokaryotic host or a eukaryotic host (including, for example, a bacterial cell, a yeast cell, a higher plant cell, an insect cell, and a mammal cell). Depending on the host used in recombination production procedures, the polypeptide of the present invention can be glycosylated or non-glycosylated. Further, the polypeptide of the present invention may include a modified initiating methionine residue as a result of a host-mediated process.

The polypeptide of the present invention may be a polypeptide that forms a peptide bond with an amino acid, but not limited to this polypeptide. The polypeptide of the present invention may be a complex polypeptide having a structure other than that of polypeptide. The term “structure other than that of polypeptide” as used in the present specification may be a sugar chain, an isoprenoid group, or the like, but not limited to these.

Further, the polypeptide of the present invention may include an additional polypeptide. Examples of such an additional polypeptide are an epitope indicator polypeptide such as His tag, Myc tag, and FLAG (Registered Trademark) peptide.

[3. Vectors]

The vector of the present invention can be prepared by a known genetic recombination technique. In this preparation, the polynucleotide of the present invention or a part thereof is inserted into a predetermined vector. This predetermined vector is not specifically limited, but encompasses a cloning vector as well as a plant transformation vector for transformation of plants described later. Further, the plant transformation vector encompasses a gene expression vector and a gene suppression vector. The gene expression vector and the gene suppression vector may be used according to need for regulating a content of a plant metabolite. The plant transformation vector to be used may be vectors intended for (i) homologous recombination, (ii) expression of dominant negative gene products (Patent Literature: Japanese Patent Application Publication, Tokukai, No. 2005-027654), and (iii) introduction of decoy molecules (Patent Literatures: Publications of Japanese Translations of PCT International Applications, Tokuhyo, No. 2001-510987 and Tokuhyo, No. 2004-507250; and Non-Patent Literature: Sullenger et al., 1991, J. Vitrol., 65, 6811-6816.).

(Gene Expression Vector)

Among recombinant vectors used for genetic transformation of a plant, the gene expression vector is a vector for overexpressing the gene of the present invention within a plant cell. The gene expression vector is constructed by inserting, into an appropriate vector, a polynucleotide encoding the amino acid sequence of any of SEQ ID NO: 18 to 32 or a mutant of the amino acid sequence or a polynucleotide having the base sequence of any of SEQ ID NO: 1 to 17 or a mutant of the polynucleotide having the base sequence. Here, the phrase “overexpressing the gene of the present invention” is used to mean both increase in an amount of mRNA that is a transcription product of the gene of the presnet invention and increase in an amount of protein that is a translation product of the gene of the present invention. Further, it is desirable that one polynucleotide selected from the polynucleotides described above is inserted into the vector. However, a plurality of polynucleotides may also be selected here.

The appropriate vector above is not specifically limited as long as the vector is capable of causing expression of the polynucleotide inserted into the vector within a plant cell. Suitable examples of such a vector are pBI, pPZP, and pSMA vectors each of which allows introduction of a target gene into a plat cell via Agrobacterium. Particularly, plasmids of binary vectors (e.g., pBIG, pBIN19, pBI101, pBI121, pBI221, and pPZP202) are preferable. In a case where the gene is directly introduced into a plant cell, it is possible to use, for example, pUC vectors (e.g., pUC18, and pUC19). It is also possible to use plant virus vectors such as Cauliflower mosaic virus (CaMV), Bean golden mosaic virus (BGMV), and Tobacco mosaic viruses (TMV). Here, the phrase “inserting a polynucleotide into a vector” means inserting the polynucleotide into a vector in a manner such that a promotor is connected to a 5′ upstream region of the polynucleotide and a terminator is connected to a 3′ downstream region of the polynucleotide. Further, in a case where the polynucleotide is derived from a genomic DNA and the polynucleotide includes a promoter or a terminator, it is possible to insert the polynucleotide into a vector that does not have a promoter or a terminator.

The term “introducing” as used in the present invention in relation to a gene or a vector is interchangeable with the term “transforming” or “transfecting”. Similarly, the term “introduction” is used so as to be interchangeable with “transformation” or “transfection”. Further, the term “introduction” as used in the present specification in relation to plants includes a case of a transient plant transformation in which DNA introduced into a plant is not integrated into a host genomic DNA as well as a case where the DNA is integrated into a host genomic DNA.

In a case where the gene has an ORF, the gene expression vector only needs to include at least an ORF region of the gene. That is, for example, the gene expression vector only needs to include a polynucleotide encoding the amino acid sequence of SEQ ID NO: 18 to or a mutant of the amino acid sequence. Alternatively, the gene expression vector may include an UTR (untranslated region) of each gene. As a further alternative, in a case where the gene has no ORF, the gene expression vector may be a part of the gene as long as the part of the gene has a function of regulating a content of a plant metabolite. For example, the gene expression vector may include a polynucleotide having the base sequence of any of SEQ ID NO: 1 to 17 or a mutant of the polynucleotide or a part of such a polynucleotide. Further, in the recombinant vector, it is possible to provide a promoter sequence, an enhancer sequence, a terminator sequence, a poly A additional signal, a 5′-UTR sequence, a selection marker gene, a reporter gene, and a replication origin for amplification in Agrobacterium.

The promoter is not specifically limited as long as the promoter is capable of functioning in a plant cell. In particular, suitable examples of the promoter are a promoter constitutively expressing a polynucleotide in a plant cell and a promoter whose activity is induced by an external stimulus. Examples of the promoter constitutively expressing a polynucleotide are a Cauliflower mosaic virus (CaMV) 35S promoter, a promoter of Agrobacterium nopaline synthase gene, a maize ubiquitin gene promoter, and a rice actin gene promoter. An example of a promoter whose activation is inducible is a heat shock gene promoter. Alternatively, it is also possible to use a promoter activating gene expression specifically in a tissue. Examples of such a promoter that can be used are a promoter of root-specific extensin-like protein gene in tomato (Patent Literature: Publication of Japanese Translation of PCT International Application, Tokuhyo, No. 2002-530075), a TobRB7 promoter of Tobacco (Patent Literature: U.S. Pat. No. 5,459,252) and the like, and a root cortex specific TobRD2 gene promoter (Patent Literature: Publication of Japanese Translation of PCT International Application, Tokuhyohei, No. 11-510056), a promoter of Arabidopsis thaliana phosphate transporter gene PHT1 (Patent Literature: Patent Application Publication, Tokukai, No. 2005-046036) and the like.

An example of the enhancer sequence is an enhancer region having an upstream sequence of the CaMV 35S promoter which enhancer region is used for enhancing an expression efficiency of a target gene.

The terminator sequence only needs to be a sequence capable of terminating mRNA synthesis of a gene transcribed by a promoter sequence. Examples of such a terminator sequence are a terminator of nopaline synthase (NOS) gene and a terminator of CaMV 35S RNA gene.

Examples of the selection marker gene are ampicillin resistance gene (Amp, bla), neomycin resistance gene (NPTII), kanamycin resistance gene (NPTIII), hygromycin resistance gene (htp), glufosinate resistance gene (Bar), and chloramphenicol acetyltransferase (CAT). By using these selection marker genes, for example, it becomes possible to easily select a recombinant into which a target gene is introduced on a culture medium containing a selection agent such as ampicillin, neomycin, kanamycin, hygromycin, glufosinate, and chloramphenicol. The reporter gene may be any reporter gene that makes it possible to check whether or not a plant cell is transformed by expression of genes. Examples of such a reporter gene are β-glucuronidase (GUS), luciferase (LUC), fluorescent proteins such as green fluorescent protein (GFP) and cyan fluorescent protein (CFP), and β-galactosidase (LacZ).

Note that it is also possible to provide a target gene and an expression cassette including the reporter gene on separate recombinant vectors. In this case, both the vectors should be cotransfected into a host.

(Gene Suppression Vector)

Among the recombinant vectors used in transformation of a plant, the gene suppression vector is a vector for suppressing endogenous gene expression within a plant cell. This gene suppression vectors allows producing a transformed plant whose content of a plant metabolite is regulated. The gene suppression vector is constructed by inserting, into an appropriate vector, (a) a part of a polynucleotide encoding the amino acid sequence of any of SEQ ID NO: 18 to 32 or a mutant of the amino acid sequence, or (b) a part of a polynucleotide encoding the base sequence of any of SEQ ID NO: 1 to 17 or a mutant of the polynucleotide. The term “part” as used in the present specification is explained later in detail in a section of various gene suppression vectors, but the “part” is a polynucleotide having a base sequence including 21 or more consecutive bases in the gene of the present invention. This “part” may include a full length gene of the present invention. Further, the “part” may be selected from any part of the gene of the present invention. Therefore, the part may be selected from a UTR. Further, the “base sequence having 21 or more consecutive bases” may be selected from a plurality of parts of the gene of the present invention. For example, it is possible to connect and use these parts of the gene of the present invention. For example, siRNAs used for gene silencing may be used as a cocktail of a plurality of siRNAs mixed, for ensuring an effect of silencing. Further, the “part” may be selected from a polynucleotide derived from a genomic DNA fragment containing the gene of the present invention. For example, the “part” may be selected from an intron, a promoter and the like. Further, though it is desirable that, as in the case of the gene expression vector, one of the polynucleotides described above is selected as the polynucleotide, several polynucleotides may also be selected.

The phrase “Suppression of gene expression” as used in the present specification is intended to mean both decrease in an amount of mRNA that is a transcription product of an endogenous gene and decrease in an amount of protein that is a translation product of the endogenous gene. The gene suppression vector has basically the same components as those of the gene expression vector except the polynucleotide inserted. Therefore, an explanation of the components of the gene suppression vector is omitted.

As a method for causing suppression of gene expression, a conventionally known method can be used. Examples of the method are methods employing antisense, co-suppression, RNA interference (RNAi), microRNA, VIGS, ribozyme, homologous recombination, expression of dominant negative gene products, and standard mutagenesis technology.

In other words, the gene suppression vector indicates an RNAi vector, an antisense vector, a VIGS vector, and the like.

For example, the RNAi vector is a vector expressing a double-stranded RNA (dsRNA) that causes RNAi. Thus expressed dsRNA is digested by a double-stranded-RNA-specific RNase (Dicer) and becomes an RNA having 21 to 25 bases. This RNA is called siRNA. The siRNA forms a complex called RNA-induced silencing complex (RISC). The RISC ultimately recognizes a target mRNA by base sequence homology and degrades the target mRNA. The RNAi vector is preferably a vector that expresses, as a hairpin dsRNA, dsRNA that causes RNAi. The RNAi vector that expresses dsRNA may be a hairpin RNAi vector. This hairpin RNAi vector is constructed, by positioning, at each end of a spacer sequence having at least several bases such as an intron, DNA corresponding to a part in which the dsRNA is formed, and thereby forming IR (inverted repeat). The spacer is not specifically limited, but, an example of the spacer that can be suitably used is a pdk intron (Non-Patent Literature: Wesley S V et al., 2001., Plant J., 27, 581-90.). Further, the RNAi vector may be a tandem-type RNAi. In the tandem RNAi, the sense RNA and the antisense RNA are transcribed by separate promoters and hybridized within a cell and as a result, dsRNA is produced. Alternatively, it is possible to cause RNAi by constructing a plurality of expression vectors from which a sense RNA and an antisense RNA are transcribed, respectively.

Examples of the polynucleotide to be inserted into the RNAi vector is (i) a polynucleotide having the base sequence of 21 or more consecutive bases, more preferably 50 or more consecutive bases, and most preferably 100 or more consecutive bases of (a) a part of a polynucleotide encoding the amino acid sequence of any of SEQ ID NO: 18 to 32 or a mutant of the amino acid sequence, or (b) a part of a polynucleotide encoding the base sequence of any of SEQ ID NO: 1 to 17 or a mutant of the polynucleotide and (ii) a polynucleotide having a complementary sequence of the above base sequence.

Further, for example, the VIGS vector is a vector used for simply checking a function of a gene. Into this vector, a polynucleotide for causing VIGS of a target gene is integrated. The VIGS is a mechanism included in a mechanism of PTGS and considered as a defense mechanism of a plant against viruses. Into the VIGS vector, a part of a base sequence of the target gene is contained. In a plant into which the VIGS vector is introduced, VIGS is induced against amplification of recombinant virus RNA to be produced and an endogenous target gene is silenced.

A usable example of the VIGS vector is a TRV vector. Regarding a VIGS system using the TRV vector, it is possible to refer to Non-Patent Literature: Ratcliff F. et al., 2001, Plant Journal, 25, 237-245 and U.S. Pat. No. 7,229,829.

A possible examples of the polynucleotide inserted into the VIGS vector is a polynucleotide having a base sequence of 100 or more consecutive bases, more preferably 150 or more consecutive bases, and most preferably 200 or more consecutive bases of (a) a part of a polynucleotide encoding the amino acid sequence of any of SEQ ID NO: 18 to 32 or a mutant of the amino acid sequence, or (b) a part of a polynucleotide encoding the base sequence of any of SEQ ID NO: 1 to 17 or a mutant of the base sequence. The polynucleotide may be inserted into the vector either in a sense direction or in an antisense direction.

Further, for example, the antisense vector is a vector into which a polynucleotide for expressing an antisense RNA bound to mRNA of a target gene is integrated. The “antisense” RNA is a polynucleotide having a base sequence that is complementary to endogenous mRNA having a “sense” sequence. The antisense vector used here is, for example, a polynucleotide having, at a downstream of a promoter, a base sequence of 50 or more consecutive bases, more preferably 100 or more consecutive bases, and most preferably 500 or more consecutive bases of (a) a part of a polynucleotide encoding the amino acid sequence of any of SEQ ID NO: 18 to 32 or a mutant of the amino acid sequence or (b) a part of a polynucleotide encoding the base sequence of any of SEQ ID NO: 1 to 17 or a mutant of the base sequence of any of SEQ ID NO: 1 to 17.

Further, regarding the ribozyme vector, it is possible to use a vector in which a ribozyme is connected to a downstream of a promoter such as CaMV 35S promoter in a recombinant vector in a manner such that the ribozyme can be transcribed within a plant cell. The ribozyme here is designed so as to be able to digest a target mRNA.

Further, for example, the co-suppression vector is a vector into which DNA having a sequence identical or similar to a base sequence of a target gene is integrated. The term “co-suppression” is a phenomenon in which expression of both an exogenous gene introduced and a target endogenous gene is suppressed as a result of introduction of a gene having a sequence identical or similar to that of the target endogenous gene into a plant. The gene used in the co-suppression does not need to be completely identical to the target gene. However, it is preferable that the sequence of the gene used in the co-suppression is at least 70% identical, preferably 80% or more identical, and more preferably 90% or more (e.g., 95% or more) identical to that of the target gene. A conventional method can be used to determine the identity of sequence.

Note that results of gene suppression methods may be different due to difference in mechanisms of the methods (e.g., whether the mechanism is transient or constitutive) or difference in experimental systems. Therefore, it is preferable to select a gene suppression method in accordance with a purpose. For example, as compared to VIGS that is a transient assay system under virus infection, RNAi gene silencing in a stably transformed plant provides an embodiment that is closer to cultivation by farmers.

[4. Method for Producing Transformed Plant Whose Content of Plant Metabolite is Regulated]

The transformed plant of the present invention whose content of a plant metabolite is regulated can be produced by transforming a target plant by use of the vector of the present invention described above.

The term “transformed plant of the present invention whose content of a plant metabolite is regulated” means a transformed plant whose content of a specific plant metabolite is decreased or increased as compared to a control plant. Here, the “control plant” is a plant satisfying the following conditions: (i) the plant is a wild-type plant whose content of a plant metabolite is not regulated; (ii) the plant is of the same species or the same variety as the plant whose content of a plant metabolite is regulated; and (iii) the plant is cultivated or cultured under the same conditions as the plant whose content of a plant metabolite is regulated. Alternatively, the “control plant” also encompasses a plant satisfying the following conditions: (i) the plant is a transformed plant into which a gene used as a control or a part of the gene is introduced, and the gene here is not involved in regulation of a content of a plant metabolite; (ii) the plant is of the same species or the same variety as the plant whose content of a plant metabolite is regulated; and (iii) the plant is cultivated or cultured under the same conditions as the plant whose content of a plant metabolite is regulated.

For example, the phrase “content of plant metabolite is regulated” preferably means that a content of a specific plant metabolite is decreased or increased by 10% or more. The “10% or more” of decrease or increase above is preferably 20% or more, more preferably 30% or more, much more preferably 40% or more, and the most preferably 50% or more of decrease or increase. The “increase or decrease” here is accomplished preferably in a plant on which topping for removing an apical bud and an axillary bud has been carried out. However, the “increase or decrease” may be accomplished in a plant on which topping has not been carried out. The content is “regulated” preferably in a specific tissue such as a leaf or a root, though not limited to this. Note that the topping is carried out on various crops and is an important process that has a large effect on quality and yield of crops.

The term “transformed plant” as used in the present specification indicates a genetically modified plant (also called a transgenic plant) in which DNA introduced into a plant is integrated into a host genomic DNA. In addition to such a genetically modified plant, the “transformed plant” here encompasses a transiently transformed plant in which DNA introduced into a plant is not integrated into a host genomic DNA. Further, the term “transformed plant” indicates a transformed plant cell prepared by using the vector of the present invention, a plant body originating from the transformed plant cell or a part of the plant body. Further, as described below, the “transformed plant” may also be a progeny that receives, through the transgenic plant cell, a genome into which a desired polynucleotide of the present invention is integrated. The “transformed plant” may also be a plant cell, a plant body, a part of the plant body, or a seed.

In the present invention, a plant material to be a target of transformation indicates any of whole plant bodies, plant organs (e.g., root, stalk, leaf, seed, embryo, ovule, shoot apex, anther, and pollen), plant tissues (e.g., epidermis, phloem, parenchyma, xylem, vascular bundle, palisade tissue, and spongy tissue), plant cells including cultured plant cells (e.g., suspension cultured cell) and protoplasts, segments of leaves, and calluses.

The plant used for transformation is not specifically limited, but preferably a dicotyledonous plant. In particular, a solanaceous plant or an asteraceae plant is preferable. Examples of the solanaceous plant are Duboisia, Anthocericis, Salpiglessis, Nicotiana, and the like. Examples of the asteraceae plant are Eclipta, Zinnia, and the like. Among the plants above, solanaceous plants are more preferable and among the solanaceous plants, a Nicotiana plant is particularly preferable. The Nicotiana plant is not specifically limited as long as the plant belongs to Nicotiana. Examples of such Nicotiana plant are Nicotiana acaulis, Nicotiana acuminata, Nicotiana acuminata var. multzjlora, Nicotiana africana, Nicotiana alata, Nicotiana amplexicaulis, Nicotiana arentsii, Nicotiana attenuata, Nicotiana benavidesii, Nicotiana benthamiana, Nicotiana bigelovii, Nicotiana bonariensis, Nicotiana cavicola, Nicotiana clevelandii, Nicotiana cordifolia, Nicotiana corymbosa, Nicotiana debneyi, Nicotiana excelsior, Nicotiana forgetiana, Nicotiana fragrans, Nicotiana glauca, Nicotiana glutinosa, Nicotiana goodspeedii, Nicotiana gossei, Nicotiana ingulba, Nicotiana kawakamii, Nicotiana knightiana, Nicotiana langsdorfi, Nicotiana linearis, Nicotiana longiflora, Nicotiana maritima, Nicotiana megalosiphon, Nicotiana miersii, Nicotiana noctiflora, Nicotiana nudicaulis, Nicotiana obtusifolia, Nicotiana occidentalis, Nicotiana occidentalis subsp. Hesperis, Nicotiana otophora, Nicotiana paniculata, Nicotiana pauczjlora, Nicotiana petunioides, Nicotiana plumbaginifolia, Nicotiana quadrivalvis, Nicotiana raimondii, Nicotiana repanda, Nicotiana rosulata, Nicotiana rosulata subsp. Ingulba, Nicotiana rotundifolia, Nicotiana rustica, Nicotiana setchellii, Nicotiana simulans, Nicotiana solanifolia, Nicotiana spegauinii, Nicotiana stocktonii, Nicotiana suaveolens, Nicotiana sylvestris, Nicotiana tabacum, Nicotiana thyrsiflora, Nicotiana tomentosa, Nicotiana tomentosifomis, Nicotiana trigonophylla, Nicotiana umbratica, Nicotiana undulata, Nicotiana velutina, Nicotiana wigandioides, and a hybrid of Nicotiana plants. Among the above Nicotiana plants, Nicotiana benthamiana, Nicotiana rustica, and Nicotiana tabacum are more preferable. Particularly preferable examples are Nicotiana rustica, and Nicotiana tabacum that are used as materials of leaf tobacco.

Once a desired polynucleotide contained in the vector of the present invention is integrated into a genome of a plant and the plant having such a genome is obtained, it is possible to obtain a progeny of this plant by sexual reproduction or asexual reproduction of such a plant. Further, for example, a seed, a leaf, a stalk, a root, a stamen, a pollen, a callus or a protoplast obtained from the plant or its progeny can be used to proliferate the plants in each of which a desired polynucleotide is introduced into the genome. Therefore, the present invention includes a plant into which a desired polynucleotide in the vector of the present invention is introduced or a plant that is a progeny of this plant or a tissue derived from the above plant or the progeny that has the same nature as the plant.

As a method of transformation, a method conventionally known to a person skilled in the art can be used. Preferable examples of such a method are an Agrobacterium method, a particle gun method, a PEG-calcium phosphate method, and an electroporation method. These methods are broadly divided into a method using Agrobacterium and a method in which introduction is carried out directly into a plant cell. In particular, employing the Agrobacterium method is preferable. Examples of Agrobacterium preferably used in transformation are bacterial strains GV2260, LBA 4404 and C58 of Rhizobium radiobacter (old name: Agrobacterium tumefaciens). In a case where transformation is carried out by the Agrobacterium method, pBI binary vectors can be preferably used. Note that for preparation of Agrobacterium for transformation having a target vector, a conventionally known method can be used.

The transformed plant cell into which the gene is introduced is first selected according to resistance to an agent using the above-described selection marker gene. Then, the transformed plant cell is reproduced in the form of a plant body by a conventional method. The reproduction of the plant body from the transformed cell can be performed by a method conventionally known to a skilled person, in accordance with a type of the plant cell.

Whether or not a gene is introduced into a plant can be checked by, for example, PCR, Southern hybridization and Northern hybridization. For example, DNA is prepared from a transformed plant and primers specific to a polynucleotide introduced is designed. Then, PCR is carried out by using thus prepared DNA as a template. After the PCR, for example, agarose gel electrophresis, polyacrylamidogel electrophresis, capillary electrophoresis, and the like are carried out on an amplified product. Further, the amplified product is stained by ethidium bromide, SYBR Green solution, and the like, and detected. Thereby, whether or not transformation has occurred can be checked. Alternatively, it is also possible to perform PCR by use of primers labeled in advance by fluorescent dye or the like and then to detect an amplified product. As a further alternative, it is possible to employ a method in which the amplified product is bound to a solid phase such as a microplate or the like and the amplified product is checked by fluorescence or enzyme reaction. Alternatively, it is possible to check, by expression of the reporter gene, whether or not a plant cell is transformed. Whether or not the VIGS vector is introduced into a plant can be checked by checking infection and amplification of a recombinant plant virus integrated into the VIGS vector in each tissue of the plant. The infection and amplification of the recombinant plant virus can be checked by RT-PCR or RT-QPCR each of which uses total RNA extracted from each tissue and a PCR primer for virus genome.

As a result of the above procedures, it is possible to obtain a transformed plant whose expression of the following genes in the plant is modified: TTF_(—)#20 gene, TTF_(—)#53 gene, TTF_(—)#54 gene, TTF_(—)#55 gene, TTF_(—)#56 gene, TTF_(—)#80 gene, TTF_(—)#84 gene, TTF_r20 gene, TTF_r25 gene, TTF_r33 gene, TTF_r35 gene, TTF_r40 gene, TTF_r48 gene, TTF_r49 gene, TTF_r66 gene, TTF_r84 gene or TTF_r86 gene.

In the “transformed plant whose content of a plant metabolite is regulated”, an amount of a specific plant metabolite is decreased or increased. Accordingly, for example, a “tobacco whose content of a plant metabolite is regulated” can be used for production of leaf tobacco whose component is different in terms of quantity or quality from that of conventional leaf tobacco. By using such “leaf tobacco whose content of a plant metabolite is regulated”, it is possible to further widen a range of taste and flavor of tobacco products created by blending. Here, the “leaf tobacco” indicate materials of tobacco products. Such materials are obtained by drying leaves (including stalks) of Nicotiana plants harvested. The Nicotiana plants that can be used for “leaf tobacco” are Nicotiana tabacum and Nicotiana rustica. Further, the tobacco products typically encompass cigarette, cigar, pipe, snuff, and chewing tobacco, but the tobacco products are not limited to the tobacco.

Note that the present invention can be restated as follows.

That is, a polynucleotide set forth in any one of the following (f), (g), and (h), the polynucleotide having a function of increasing or decreasing a content of a plant metabolite:

(f) a polynucleotide consisting of the base sequence of any of SEQ ID NO: 1 to 17;

(g) a polynucleotide consisting of a base sequence in which one or several bases are deleted, inserted, substituted or added in the base sequence of any of SEQ ID NO: 1 to 17; and

(h) a polynucleotide that hybridizes, under a stringent condition, to a polynucleotide consisting of a complementary sequence of the polynucleotide (f).

A polynucleotide encoding a polypeptide set forth in any one of the following (i) and (j), the polypeptide having a function of increasing or decreasing a content of a plant metabolite:

(i) a polypeptide consisting of the amino acid sequence of any of SEQ ID NO: 18 to 32; and

(j) a polypeptide consisting of an amino acid sequence in which one or several amino acids are deleted, inserted, substituted or added in the amino acid sequence of any of SEQ ID NO: 18 to 32.

A vector including: a promoter functioning in a plant cell; and at lest one of the polynucleotides above, wherein the promoter and the polynucleotide are connected so as to make expression of the at least one polynucleotide possible in the plant cell.

A vector including: a promoter functioning in a plant cell; and a polynucleotide consisting of a consecutive base sequence that is a part of the polynucleotides above, wherein the promoter and the at least one polynucleotide are connected so that RNA is transcribed as RNA of a sense strand or an antisense strand of the at least one polynucleotide in the plant cell.

A vector of one of the following (k) and (l), the vector including: a promoter functioning in a plant cell; and a polynucleotide consisting of a base sequence having 21 or more consecutive bases that is a part of at least one of the polynucleotides above, wherein the promoter and the polynucleotide are connected so that RNA is transcribed so as to form a double-stranded RNA of the polynucleotide within the plant cell:

(k) a vector including both a sense strand and an antisense strand each as the polynucleotide; and

(l) a vector to which the promoter is connected so that each of the sense strand and the antisense strand of the polynucleotide is transcribed, the promoter being connected to each of 5′ end and 3′ end of the polynucleotide.

A method for preparing a transformed plant cell whose content of a plant metabolite is decreased or increased, the method including the step of transforming a plant by using the vector above.

The above method for preparing a transformed plant cell whose content of a plant metabolite is decreased or increased, wherein the vector used for transforming the plant cell includes a promoter of any one of the following (m), (n), and (o):

(m) a promoter being active in constitutively expressing a target gene in a plant;

(n) a promoter being active in selectively expressing the target gene in a root tissue cell of a plant; and

(o) a promoter being active in selectively expressing the target gene in a root cortex cell of the plant.

A method for preparing a transformed plant cell whose content of a plant metabolite is decreased or increased, the method employing a plant cell transformation method of any one of the following (p) and (q):

(p) a method performed through mediation of Agrobacterium having the vector; and

(q) a method performed by bombardment of fine particles to which the vector is adhered.

A method for preparing the above transformed plant cell, the method including the step of reproducing a plant body from the transformed plant cell.

In the method for preparing the transformed plant cell, the transformed plant cell is more preferably a cell of a dicotyledonous plant. Much more preferably, the dicotyledonous plant is a solanaceous plant. Particularly preferably, the solanaceous plant is Nicotiana plant. Most preferably, the Nicotiana plant is Nicotiana tabacum.

Further, in the method for preparing the transformed plant cell, the transformed plant is preferably a plant cell or a plant body.

Further, the present invention encompasses (i) a transformed plant prepared by any of the methods above for preparing the transformed plant and (ii) a progeny of the transformed plant.

The present invention encompasses (i) a tobacco material (leaf tobacco) obtained from the plant whose content of a plant metabolite is decreased or increased, the plant being Nicotiana tabacum, and (ii) a tobacco product produced by using the tobacco material.

The vector of the present invention is a vector allowing production of a transformed plant whose content of a plant metabolite is regulated, the vector including a part of the above polynucleotide.

The following provides Examples and the embodiments of the present invention are explained in more detail. Certainly, the present invention is not limited to the following Examples and various embodiments are possible in regard to details. Further, the present invention is not limited to the description of the embodiments above, but may be altered by a skilled person within the scope of the claims. An embodiment based on a proper combination of technical means disclosed in different embodiments is encompassed in the technical scope of the present invention. All documents described in the present specification are incorporated herein as references.

EXAMPLES Example 1 Plant Hormone Treatment of Root Segments

An apical bud (1-2 cm) cut from a seedling plant of sterilely cultivated tobacco (Nicotiana tabacum, varieties: Burley21 and LA Burley21) was cultured for approximately a month on a ½ MS agar medium (culture vessel: plant box, volume: 50 ml, containing 0.65% agar and 1.5% sucrose). A root of thus grown seedling plant was picked. Then, a root segment whose length was approximately 1 cm was tested. The root segment was a center portion of the root from which a tip portion including a root apex and a base portion having a lot of lateral roots were removed. Note that LA Burley21 is an isogenic line of Burley21. The LA Burley21 is a strain mutated at both of two regulatory loci (Nic 1 and Nic2) involved in biosynthesis of nicotine, so that nicotine-related alkaloids such as nicotine are scarcely accumulated (Non-Patent Literature: Legg et al., 1970, Crop Sci, 10., 212.). Further, as compared to expression of nicotine biosynthesis enzyme gene in Burley21, the expression of nicotine biosynthesis enzyme gene is severely suppressed in the LA Burley21 (Non-Patent Literature: Hibi et al., 1994, Plant Cell., 6, 723-35.).

(Jasmonate Treatment)

The following procedures were used for obtaining a total RNA sample for clarifying genes inducible by jasmonate.

The root segments were precultured (80 rpm) in the dark at 25° C. in a HF modified liquid medium containing 1% sucrose and 5 μM indole acetate (IAA) (pH5.8, Non-Patent Literature: Mano et al., 1989, Plant Sci, 59, 191-201.). After 24 hour culturing, the root segments were washed with sterile water. Then, the root segments were cultured on 40 ml of HF liquid medium (culture vessel: 100 ml conical flask) containing 1% sucrose and 0.5 μM methyl jasmonate (MeJA). Part of the root segments washed with the sterile water after the preculture were cultured as a control on a HF modified liquid culture containing 1% sucrose and 5 μM IAA. Approximately 10 root segments were collected at each time point of 0, 30, 60, and 120 minutes after the start of the culturing. At each time point above, the root segments collected were immersed in 0.4 ml of RNAlater (product name, Ambion Ltd.) and stored at −30° C. until RNA extraction. For replication of this experiment, the root segments were collected into 3 tubes at each time point in each experimental lot. Then, by using RNeasy Plant Mini Kit (product name, QIAGEN), the total RNA was extracted from the root segments.

From thus obtained samples, cDNA was synthesized. Thus synthesized cDNA was used to check, by quantitative PCR, a change in amount of transcription products including 4 types of nicotine synthase genes (PMT1, ODC1, MPO1, and QPT). These 4 types of nicotine synthase genes are known to be inducible by jasmonate. As a result, a large increase in the amount of the transcription products was observed in the time period from 60 to 120 minutes after the start of the culturing. Therefore, the total RNA obtained was considered to be useful for screening of genes inducible by jasmonate.

(Auxin Removing Treatment)

The following procedures were taken for obtaining total RNA samples for clarifying genes inducible by removal of auxin from liquid culture medium.

The root segments were precultured for 24 hours on a HF modified medium containing 1% sucrose and 5 μM IAA and then washed with sterile water. Further, the root segments were cultured on a HF modified medium containing 1% sucrose. Part of the root segments were cultured as a control on a HF modified medium containing 1% sucrose and 5 μM IAA. At each time point of 0, 1, 2, and 4 hours after the start of the culturing, approximately 10 root segments were collected. Then, as in the case of the jasmonate treatment, total RNA samples were extracted from the root segments.

In regard to these samples, there was a change in amount of a transcription product of known nicotine synthase gene whose transcription was regulated by presence of auxin. Therefore, the total RNA obtained was considered to be useful for screening of genes to be inducible by removal of auxin.

(Auxin Treatment, Ethylene Treatment)

Similar experiments were performed for clarifying genes whose expression was inducible by addition of auxin or ethylene.

The root segments were precultured for 24 hours on a HF modified medium containing 1% sucrose and then washed with sterile water. Further, the root segments were cultured on a HF modified medium containing (i) 1% sucrose and (ii) 1 μM IAA or 5 μM 1-aminocyclopropane-1-carboxylic acid (ACC) that was a precursor of ethylene in a plant body. Part of thus precultured root segments were cultured as a control on a HF modified medium containing 1% sucrose. At each time point of 0, 30, and 60 minutes after the start of the culturing, approximately 10 root segments were collected. Then, as in the case of the jasmonate treatment, total RNA samples were extracted from the root segments.

Example 2 Topping of Tobacco Plant Individual

For clarifying genes expressed in roots in response to topping (also called decapitation) in which apical bud sections of a plant individual is removed, the following experiment was carried out and total RNA was extracted. First, a tobacco plant (variety: Tsukuba No. 1) was grown in a phytotron (Koitotron, manufactured by Koito Industry Ltd.) whose conditions were set as follows: 12 hours/26° C./humidity of 60% (light period) and 12 hours/18° C./humidity of 60% (dark period). Then, after one month from seeding, the Tobacco plant was transplanted into a 12 cm terracotta pot in which vermiculite was filled. Then, 60 to 75 ml of 2000-fold diluted Hyponex (HYPONEX JAPAN Corp. Ltd.) was provided every day. This was intended to also serve as watering. Topping was carried out 18 days after the Tobacco plant was transplanted. In the topping, lower 12 leaves were left on the Tobacco plant. At a time before the topping and each time point of 1, 3, 9, 24, and 48 hours after the topping, roots were taken from the plant individual and provided for total RNA extraction. As a control, roots were taken from an individual on which the topping was not performed. Samples were taken from 4 individuals at each one time point and the samples were used for replication of the experiment. The roots taken was immediately frozen by using liquid nitrogen and stored at −80° C. Thus frozen roots were ground by using a pestle and a mortar in liquid nitrogen. Then, total RNA was extracted. The extraction of the total RNA was carried out as in Example 1.

Example 3 Selection of Genes By Microarray Analysis

The total RNA obtained in Examples 1 and 2 were provided for microarray analysis.

A microarray is a 44K custom array manufactured on contract by Agilent Technologies Inc. The microarray has probes for assembled base sequences obtained by clustering base sequences from terminal sequence information of a full-length cDNA library (Nicotiana tabacum cv. Tsukuba No. 1) that the applicant has and from sequence information of Nicotiana tabacum gene registered in GenBank.

Hybridization and labeling were carried out by a method according one-color protocol (file name: One-Color Microarray-Based Gene Expression Analysis, ver 5.5, February 2007) recommended by Agilent Technologies Inc.

Proceeding to microarray data analysis, BLASTX homology search was performed by using KOG database (ftp://ftp.ncbi.nih.gov/pub/COG/KOG/kyva, version 2003/03/02). As a result of this search, a list of genes was produced. Here, each of the genes in the list was considered to encode a transcription factor from among the assembled base sequences. Based on this list, microarray data was analyzed by using GeneSpring GX (Agilent Technologies Inc.).

(Selection of Genes Inducible By Jasmonate)

The genes inducible by jasmonate were selected as follows. First, in an experiment in which the MeJA treatment was performed on root segments of the variety Burlay21, microarray signals of genes at a time point of 30 minutes or 60 minutes after the MeJA treatment were compared with microarray signals of genes before the MeJA treatment. Then, each gene whose microarray signal ratio in the comparison was 2 or higher was selected. Further, at a time point of 30 minutes or 60 minutes after the MeJA treatment, microarray signals of genes were compared with genes of the control. Then, each gene whose microarray signal ratio was 2 or higher was selected. Consequently, a union of the genes selected in the above two cases were determined to be the genes inducible by jasmonate.

(Selection of Genes Influenced By Nic 1 and Nic2 Loci)

Under a condition where the MeJA treatment has not been carried out or at the time point 30 minutes after MeJA induction treatment, microarray signals of genes of wild-type Burley21 was compared with microarray signals of genes of low-nicotine-type LA

Burley21. Then, each gene of wild-type Burley21 whose signal ratio was 2 or higher in the above comparison was selected. The genes from wild-type Burley21 here were selected as genes influenced by Nic1 and Nic2 loci.

(Selection of Genes Inducible by Auxin or Ethylene)

The following procedures were taken for selection of genes inducible by addition of auxin or ACC. First, microarray signals of genes at a time point 1 hour or 2 hours after the addition of auxin or ACC were compared with microarray signals of genes before the addition of auxin or ACC. Then, each gene whose microarray signal ratio was 2 or higher was selected. Then, at a time point 1 hour or 2 hours after the addition of auxin or ACC, the microarray signals of the genes were compared with microarray signals of genes of the control. Then, each gene whose microarray signal ratio was 2 or higher was selected. Consequently, a union of the genes of the above two cases were determined to be genes inducible by auxin or ethylene.

(Selection of Genes Inducible by Removal of Auxin)

At a time point 1 hour or 2 hours after the removal of auxin, microarray signals of genes were compared with microarray signals of genes of the control. Then, each gene whose microarray signal ratio was 2 or higher was selected. The genes here were selected as genes inducible by removal of auxin.

(Selection of Genes Induced By Topping)

Microarray signals of genes 9 hours after the topping were compared with microarray signals of genes before the topping. Then, each gene whose microarray signal ratio was 2 or higher was selected as a gene induced by topping.

Example 4 Selection of Genes According to Known Information

There are genes whose expression is induced in response to treatment that induces synthesis of nicotine in tobacco. Such treatment includes jasmonate treatment and wounding. Such genes were extracted according to known information disclosed in the following Non-Patent Literatures: Proc. Natl. Acad. Sci. (2003) 100(14) p8595-8600: Supplement Data Table2, Plant Sci. (2000) 158 p19-32, Plant J. (2005) 44 p1065-1076, Plant Physiol (2005) 139 p. 949-959: Supplement Data, Nature (2007) 448 p661-665, Nature (2007) 448 p666-6′73, Plant Physiol (2002) 129 p. 661-677: Table1, Plant Cell (2007) 19 p2225-2245: Supplement Data (Table 1), Plant Cell (2004) 16 p1938-1950, Gene Dev. (2004) 18 p1577-1591, Plant Molecular Biology (2005) 58 p585-595, J. of Biochemistry (2004) 279(53) p55355-55361, Plant Molecular Biology (2004) 55 p183-192, Plant Cell Physiol (1998) 39(10) p993-1002, Plant Molecular Biology (2004) 55 p′743-'761, Plant Molecular Biology (2006) 60 p699-'716, Plant Molecular Biology (2001) 45 p4′7′7-488, EMBO J. (1991) 10(7) p1793-1802, EMBO J. (1999) 18(16) p4455-4463, Plant J. (2001) 25(1) p43-53,J. of Biochemistry (2004) 279(51) p52940-52948, Plant Physiol (2007) 144 p1680-1689, and Plant Physiol (1997) 115 p397-407. In regard to these gene sequences, BLAST search was carried out on the assembled base sequences. As a result, corresponding 250 genes were selected. From among these 250 genes, 45 genes respectively having high gene expression levels in roots were extracted. Further, 13 types of genes were selected. Each of these 13 types of genes selected were either a gene that was not on the 44K custom array described in Example 3 or a gene in which no unique probe sequence was designed.

Meanwhile, by using the assembled base sequences as a query, Blastx search was carried out on Non-redundant protein sequence(nr) database of National Center for Biotechnology (NCBI). In the Blastx search, assembled base sequences that hit on the following amino acid sequence were selected. That is, the amino acid sequence of thus selected assembled base sequences had IAA, auxin, bHLH, MYC, C2H2, zinc finger, ZAT, WZF, ZPT, or ethylene as a keyword. Further, by using EAR motif (SEQ ID NO: 94 to 113) shown in Table 1 as a query, tblastn search was carried out on the assembled base sequences. Thereby, assembled base sequences having the EAR motif were extracted. The assembled base sequences selected above were 178 genes in total. From these 178 genes, 27 genes respectively having a high gene expression levels in roots were selected.

TABLE 1 GENE NAME MOTIF NAME SPECIES IAA1 TELRLGLPG ARABIDOPSIS THALIANA IAA20 TDLRLGLSF ARABIDOPSIS THALIANA IAA12 ELELGLGL ARABIDOPSIS THALIANA IAA11 ELGLTLSL ARABIDOPSIS THALIANA IAA29 ELDLGLSL ARABIDOPSIS THALIANA IAA34 DLGLSLRT ARABIDOPSIS THALIANA IAA31 NLSLSLTF ARABIDOPSIS THALIANA IAA26 KKLELRL ARABIDOPSIS THALIANA NtERF3 IDLDLNLAP TOBACCO AtERF4 LDLDLNLPP ARABIDOPSIS THALIANA AtERF8 LDLDLNLAP ARABIDOPSIS THALIANA OsERF3 FDLDLNRP RICE AtERF3 FQFDLNFPP ARABIDOPSIS THALIANA AtERF10 LDLNASP ARABIDOPSIS THALIANA AtERF11 LDLDLNFPP ARABIDOPSIS THALIANA ZAT10 FDLNIPP ARABIDOPSIS THALIANA ZAT11 LDLNLTP ARABIDOPSIS THALIANA ZAT1 IDLNLP ARABIDOPSIS THALIANA ZCT1 LDLNLTP CATHARANTHUS ROSEUS ZCT3 FDLNLPA CATHARANTHUS ROSEUS

Example 5 Yeast One-Hybrid Screening

In addition to the selection in the microarray analysis in Example 3 and the selection according to known information in Example 4, selection of genes was carried out by Yeast One-Hybrid Method described below. For the Yeast One-Hybrid selection, Matchmaker™ One-Hybrid Library Construction 86 Screening Kit (Takara Bio Inc.) was used. The Yeast One-Hybrid selection here was carried out by following a manual attached to the above kit. Note that as to yeast transformation method, High efficiency method found at the following homepage address (http://www.umanitoba.ca/faculties/medicine/biochem/gietz/method.html) was partially improved and used.

(1. Yeast Transformation)

The following procedures were used to prepare a yeast competent cell for transformation. First, Y187 yeast strain was cultured on a YPDA plate at 30° C. for 3 days. Then, a single colony (2 to 3 mm) of the Y187 yeast strain was picked. Further, this single colony of the Y187 yeast strain was put in 6 ml of 2×YPDA liquid medium and shaken for approximately 24 hours at 200 rpm. Thereby, preculture was prepared. Then, 2 ml of this preculture was added to 100 ml of 2×YPDA liquid medium. Further, the culture (for 2 to 4 hours) was shaken at 30° C. until OD600 becomes approximately 0.5. Then, thus cultured yeast was harvested by low-speed centrifugation for 5 minutes and washed with sterile water. Ultimately, the yeast was suspended in 1 ml of sterile water and every 300 μl of thus obtained yeast suspension was poured into a separate 1.5 ml tube.

The following procedures were taken for yeast transformation. First, the yeast suspension was subjected to centrifugation for 30 seconds at 10000 rpm and supernatant was removed. Then, to a yeast pellet thus prepared, 360 μl of Transformation Mix (50% PEG3500: 240 μl, 1M lithium acetate: 36 μl, dH₂O: 64 μl, 10 mg/ml denatured carrier DNA: 10 μl, plasmid DNA: 10 μl) prepared in advance was added and fully suspended by vortex. Further, a heat shock was given by keeping thus obtained suspension at 42° C. for 20 minutes. Subsequently, the suspension was subjected to centrifugation for 30 seconds at 10000 rpm, and a supernatant was removed. The pellet of the centrifugation was then gently suspended in 1 ml of sterile water. Further, 200 μl of thus obtained suspension was plated onto an SD plate and cultured at 30° C. for 2 to 7 days.

(2. Preparation of cDNA for Screening)

The following procedures were taken for preparing cDNA for screening. First, 24-hour preculture of root segments was carried out on a HF modified medium, described in Example 1, that does not contain a plant hormone. Then, IAA or ACC was added and the root segments were further cultured. Subsequently, by using, as a template, total RNA extracted from the root segments, the cDNA for screening was prepared according to a manual attached to the kit.

(3. Preparation of Bait Vector)

With reference to information on presence of known cis-elements and promoter activity, the following two types of Bait sequences were selected from promoter sequences of nicotine biosynthesis enzyme genes. As one of the two types of Bait sequence, a polynucleotide consisting of 90 bases including ARE motif (GAGCAC: Non-Patent Literature: Guilfoyle et al., 2002, Plant Molecular Biology, 49, 373-385.) was selected as a QPT1 Bait sequence (SEQ ID NO: 33). This polynucleotide was selected from a quinolinate phosphoribosyltransferase gene (QPT1, GenBank Accession Number AJ748262) of tobacco. The quinolinate phosphoribosyltransferase gene has conventionally known expression specificity in roots and wound inducibility. As another type of the Bait sequences, a sequence in which actaataattgcaccgagacaaac (24mer: SEQ ID NO: 93) of TAA-Box/ARE motif from a putrecine N-methyltransferase gene (PMT1, GenBank Accession Number AF126810) was repeated three times and connected was selected as PMT1 Bait sequence (SEQ ID NO: 34). These sequences were cloned into pHis2.1 Vector according to a manual attached to the kit.

(4. Screening)

For screening, for each 360 μl of Transformation Mix, 250 ng of Bait Vector, 150 ng of pGADRec Vector, 100 ng of cDNA were used as plasmid DNA. In this screening, a colony grown on an PD plate of TDO (-His/-Leu/-Trp) containing 10 mM 3-Amino-1,2,4-Triazole (3-AT, Sigma-Aldrich Corporation) was selected as a positive clone. Note that for PMT1 Bait, an SD plate of TDO containing 20 mM 3-AT was used. The positive colony was re-streaked onto an SD plate of TDO containing 3-AT and clones thus grown were selected. Further, base sequences that the clones have respectively were analyzed. By using these base sequences as a query, blastx search and blastn search were carried out. Thereby, the following genes were selected: (i) genes whose possibility of encoding a transcriptional factor was suggested; or (ii) genes encoding a protein whose function was unknown. By transforming the yeast again with use of thus selected genes, genes whose bindability to Bait was reproducible were selected.

Example 6 VIGS Assay

Regarding each of the 149 types of genes selected in total in Examples 3, 4, and 5, a relation with nicotine content in leaf of Nicotiana plant was examined by VIGS assay using a TRV vector.

(Construction of TRV Vector)

The following documents can be used as references for details of the TRV vector: Ratcliff F. et al., 2001, Plant Journal, 25, 237-245, Liu Y. et al., 2002, Plant Journal, 31, 777-786, Liu Y. et al., 2002, Plant Journal, 30, 415-429, Burch-Smith T. M. et al., 2004, Plant Journal, 39, 734-746, and Baulcombe D., 2004, Nature, 431, 356-363; and U.S. Pat. No. 6,369,296 and U.S. Pat. No. 7,229,829.

For preparation of a construct of VIGS, pSP221 was used. This pSP221 is TRV-RNA2 vector that employs Gateway (Registered Trademark) system. This pSP 221 was prepared, by inserting a TRV-RNA2 expression cassette of pTRV2-attR2-attR1 (Non-Patent Literature: Liu Y. et al, 2002, Plant Journal, 31, 777-786) into a multiple cloning site of pSP 202 originating from a binary vector pBI 121. Note that pSP 202 was modified by inserting Amp gene of pUC18 into pBI121 so that pSP 202 could be used in selection by carbenicillin.

By using primers specific to the base sequences of the 149 types of genes selected in total in Examples 3, 4, and 5, DNA fragments to be inserted into pSP 221 were amplified by PCR. Among the primers, Table 2 shows primers used for preparing the DNA fragments each having a partial base sequence of TTF_(—)#20 gene, TTF_(—)#53 gene, TTF_(—)#54 gene, TTF_(—)#55 gene, TTF_(—)#56 gene, TTF_(—)#80 gene, TTF_(—)#84 gene, TTF_r20 gene, TTF_r25 gene, TTF_r33 gene, TTF_r35 gene, TTF_r40 gene, TTF_r48 gene, TTF_r49 gene, TTF_r66 gene, TTF_r84 gene or TTF_r86 gene. Note that PCR amplification was carried out by using PfuUltra High-Fidelity DNA Polymerase (product name, Stratagene Corporation) and GeneAmp PCR System 9700 (product name, Applied Biosystems Inc.). PCR amplification was carried out by (a) heating at 95° C. for 2 minutes, (b) carrying out 35 cycles of heating at 95° C. for 30 seconds and heating at 65° C. for 2 minutes, and then (c) heating at 72° C. for 10 minutes. Further, PCR amplification was carried out by using a reverse transcription reaction product as a template. This reverse transcription reaction product was prepared from the total RNA described in Example 1 by using Omniscript RT Kit (product name, QIAGEN). Moreover, cloning of a PCR product was carried out by using pENTR/D-TOPO cloning kit (product name, Invitrogen Corporation).

TABLE 2 PRIMER NAME SEQUENCE (SEQ ID NO) TTF_#20_TRV_F CACCACAAGATACAATTGCAGCTGCTAC (SEQ ID NO: 35) TTF_#20_TRV_R GGCTAAAGCAATGACTTCAGTAAGCG (SEQ ID NO: 36) TTF_#53_TRV_F CACCATTGCTTACATAACTGAGATGC (SEQ ID NO: 37) TTF_#53_TRV_R ACGATATGATTCTTCACTACACTTTATGCC (SEQ ID NO: 38) TTF_#54_TRV_F CACCGCATCAAGTGCTGAAAACATAGCC (SEQ ID NO: 39) TTF_#54_TRV_R CACTAATGTTAAAACAGTCATACCTGGCC (SEQ ID NO: 40) TTF_#55_TRV_F CACCATTATTACCATCCTTATAATTTTCCC (SEQ ID NO: 41) TTF_#55_TRV_R GAACTTATCCTGAATCTACCTATACTCCC (SEQ ID NO: 42) TTF_#56_TRV_F CACCGAGCAATGATTCAAGTATGGGG (SEQ ID NO: 43) TTF_#56_TRV_R CGATGTCTACTACACAGAGAATTGCC (SEQ ID NO: 44) TTF_#80_TRV_F CACCATCGTCGGAATTTCAATTTGCTACC (SEQ ID NO: 45) TTF_#80_TRV_R ATTGTTGAGAAGGGAAGGAAGTCACAGC (SEQ ID NO: 46) TTF_#84_TRV_F CACCATCTTGCCTACCGCCATTTTCC (SEQ ID NO: 47) TTF_#84_TRV_R TGTATGCATTTAACGAGGGGTCTAAAGG (SEQ ID NO: 48) TTF_r20_TRV_F CACCAAGAATTTAATAATGAGATTCGGC (SEQ ID NO: 49) TTF_r20_TRV_R ATCGAACAAATTGTTAAACTCACTGCG (SEQ ID NO: 50) TTF_r25_TRV_F CACCAAGTTCGCAGCAGAAATTCGTGACC (SEQ ID NO: 51) TTF_r25_TRV_R TACACATCTTCTATTGAGTCCTAATCCC (SEQ ID NO: 52) TTF_r33_TRV_F TATAATAATGAGATTCCACAGTCGGC (SEQ ID NO: 53) TTF_r33_TRV_R AATAAATACGTAGGTTTTAGTAGGTATATGC (SEQ ID NO: 54) TTF_r35_TRV_F CACCGATGATAGTTTATCTTTGAGAAAGGC (SEQ ID NO: 55) TTF_r35_TRV_R AACTTCAATTGAATTACATGAAAGAATGGC (SEQ ID NO: 56) TTF_r40_TRV_F CACCGAAGATGAGAAGAAACTGTAACTTGG (SEQ ID NO: 57) TTF_r40_TRV_R CTGGAGATTGTAAAAATGGTGATGAAGGC (SEQ ID NO: 58) TTF_r48_TRV_F CACCCATAACACAACACCTACTCTCCC (SEQ ID NO: 59) TTF_r48_TRV_R TATTGAAGTCAAAACGACCACCAATTTAGC (SEQ ID NO: 60) TTF_r49_TRV_F CACCAAAGGTTGATATCAAAACTTACAGCG (SEQ ID NO: 61) TTF_r49_TRV_R CTTCTTAAACCAGTGCTTTTCCTTTCAGG (SEQ ID NO: 62) TTF_r66_TRV_F CACCGCTATAGTTTATAAAATTACCAAGAACGTCG (SEQ ID NO: 63) TTF_r66_TRV_R TACATCATCATATACATGTGACATACGGG (SEQ ID NO: 64) TTF_r84_TRV_F CACCAGAAGCTGAAGGAGAAGAGAATATCGG (SEQ ID NO: 65) TTF_r84_TRV_R AAACAGGAGATGACCAGTTCCCAACC (SEQ ID NO: 66) TTF_r86_TRV_F CACCAAGAGAAATCCCTAAATGGCGACG (SEQ ID NO: 67) TTF_r86_TRV_R AGCACATTGTAAGTATACAGCAAAAGATGG (SEQ ID NO: 68) GUS_TRV_F CACCTACGGCAAAGTGTGGGTCAA (SEQ ID NO: 69) GUS_TRV_R TGTCTGGCTTTTGGCTGTGA (SEQ ID NO: 70)

Base sequences of the DNA fragments amplified by PCR are shown, respectively, in SEQ ID NO: 71 (T TF_(—)#20), 72 (TTF_(—)#53), 73 (TTF_(—)#54), 74 (TTF_(—)#55), 7 5 (TTF_(—)#56), 76 (TTF_(—)#80), 77 (TTF_(—)#84), 78 (TTF_r20), 79 (TTF_r25), 80 (TTF_r33), 81 (TTF_r35), 82 (TTF_r40), 83 (TTF_r48), 84 (TTF_r49), 85 (TTF_r66), 86 (T TF_r84), and 87 (TTF_r86).

In this way, each of the DNA fragments having the base sequences of any one of SEQ ID NO: 71 to 87 was cloned into a pENTR/D-TOPO vector. As a result, an entry clone for Gateway (Registered Trademark) system was attained. Further, for use as a control in VIGS assay, DNA of a partial base sequence of GUS gene was amplified by PCR by using primers shown in Table 2. In this PCR amplification, the binary vector pBI121 was used as a template. Then, thus amplified DNA was cloned into pENTR/D-TOPO vector (entry clone). A base sequence of this DNA obtained by PCR is shown in SEQ ID NO: 88.

Each DNA fragment having the base sequence of any one of SEQ ID NO: 71 to 88 had been cloned into pENTR/D-TOPO vector. Thus obtained DNA fragment was integrated into pSP221 that was TRV-RNA2 vector. This integration was carried out by attL×attR recombination reaction by use of Gateway (Registered Trademark) LR Clonase II. Note that E. coli containing a target recombinant construct was selected in the presence of μg/mL carbenicillin. As a result of the above procedures, the following TRV/RNA2 constructs were obtained: pTRV2-TTF_(—)#20, pTRV2-TTF_(—)#53, pTRV2-TTF_(—)#54, pTRV2-TTF_(—)#55, pTRV2-TTF_(—)#56, pTRV2-TTF_(—)#80, pTRV2-TTF_(—)#84, pTRV2-TTF_r20, pTRV2-TTF_r25, pTRV2-TTF_r33, pTRV2-TTF_r35, pTRV2-TTF_r40, pTRV2-TTF_r48, pTRV2-TTF_r49, pTRV2-TTF_r66, pTRV2-TTF_r84, pTRV2-TTF_r86, and pTRV2-GUS. These TRV-RNA2 constructs were introduced by the electroporation method, into Agrobacterium strain GV2260 (See Non-Patent Literature: Deblaere R., 1985, Nucleic Acids Res., 13, 4777-88.).

Further, in addition to the above TRV-RNA2 constructs, a TRV-RNA1 construct (GenBank Accession No. AF406990) was similarly introduced into Agrobacterium strain GV2260. The TRV-RNA1 construct encodes RNA-dependent RNA replication enzyme of Tobacco Rattle Virus.

(Virus Infection)

Each of Agrobacterium containing the TRV-RNA2 construct and Agrobacterium containing the TRV-RNA1 construct was cultured overnight at 28° C. in 10 ml of LB liquid medium (containing 50 mg/L kanamycin). On the following day, a part of this preculture was added to 50 ml of LB liquid medium (containing 50 mg/L kanamycin) and cultured overnight at 28° C. Each Agrobacterium collected by centrifugation at 3000×g for 15 min was suspended in 10 mM MES buffer (pH 5.7) so that a value of OD600 became 1.0. The MES buffer here contains 10 mM MgCl₂ and 150 μM Acetosyringone. Thus obtained suspension was gently shaken for 3 hours at a room temperature. Then, inoculum was prepared by mixing (i) Agrobacterium suspension containing the TRV-RNA1 construct and (ii) Agrobacterium suspension containing the TRV-RNA2 at a proportion of 1:1. Nicotiana benthamiana was cultivated in soil in a phytotron whose conditions were set as follows: 12 hours/25° C./humidity of 60% (light period) and 12 hours/18° C./humidity of 60% (dark period).

Approximately 18 days after seeding, the inoculum was injected into leaves of plants. Then, the conditions for cultivation was changed to 12 hours/22° C./humidity of 60% (light period) and 12 hours/18° C./humidity of 60% (dark period) and the plants were cultivated for additional 17 days. In this period, the plants were transplanted into 9 cm terracotta pots. The injection of Agrobacterium was carried out onto fully expanded leaves by infilteration (Non-Patent Literature: Kapila et al, 1997, Plant Sci., 122, 101-108., Rossi et al., 1993, Plant Mol. Biol. Rep., 11, 220-229., and Van der Hoorn et al, 2000, Mol. Plant-Microbe Interact., 13, 439-446.) with use of 1 ml syringe having no needle.

On the 18th day from the injection, topping was carried out on half the number of the plants having received the injection. In the topping, an apical bud section was removed while 13 leaves were left. From the 18th day after the injection, all the plants having received the injection were cultivated under the following conditions: 12 hours/26° C./humidity of 60% (light period) and 12 hours/18° C./humidity of 60% (dark period). Then, on 24th day from the injection, all leaves and roots were collected. The leaves thus collected were ground after dried overnight by hot air at 70° C. (humidity 10%). Then, the leaves were used as samples for nicotine analysis. Further, after 18th day from the injection, all auxiliary buds having started developing were removed from all plants having received the injection.

(Measurement of Nicotine Content)

The following procedures were taken for analysis of nicotine contents. First, 5 ml of water, 10 ml of 0.5 g/L n-heptadecane-containing hexane and 2.5 ml of 8M NaOH were added to 0.3 g of dried leaf powder. Then, shaking was carried out for 60 minutes. Subsequently, a hexane layer (upper layer) was taken and used as a sample for the analysis. The analysis of nicotine contents was carried out by using a gas chromatograph (Agilent 6890N, Agilent Technologies Inc.) and DB-17 column (Agilent Technologies Inc.).

As a result of the VIGS assay described above, it was found that, among the 149 types of genes selected in total in Examples 3, 4, and 5, the following gene affects nicotine content per dry weight of a leaf of Nicotiana plant (FIG. 1, Table 3): TTF_(—)#20 gene, TTF_(—)#53 gene, TTF_(—)#54 gene, TTF_(—)#55 gene, TTF_(—)#56 gene, TTF_(—)#80 gene, TTF_(—)#84 gene, TTF_r20 gene, TTF_r25 gene, TTF_r33 gene, TTF_r35 gene, TTF_r40 gene, TTF_r48 gene, TTF_r49 gene, TTF_r66 gene, TTF_r84 gene or TTF_r86 gene. Note that FIG. 1 shows each nicotine content in leaves of (i) a control plant to which Agrobacteirum containing pTRV2-GUS was injected and (ii) a plant to which Agrobacterium containing TRV-RNA2 construct was injected. Into this TRV-RNA2 construct, a part of the gene of the present invention had been inserted. Moreover, Table 3 shows each ratio of nicotine contents in leaves of (i) a plant obtained by silencing the gene of the present invention and (ii) a control plant. As shown in FIG. 1 and Table 3, as compared to the control plant, silencing of the following genes increased, by 17% to 69%, the nicotine content of the leaves in Nicotiana benthamiana subjected to the topping: TTF_(—)#20 gene, TTF_(—)#53 gene, TTF_(—)#54 gene, TTF_(—)#55 gene, TTF_(—)#56 gene, TTF_r20 gene, TTF_r25 gene, TTF_r33 gene, TTF_r35 gene, TTF_r40 gene, TTF_r48 gene and TTF_r66 gene. Further, as compared to the control, silencing of the following genes decreased, by 15% to 74%, the nicotine content of the leaves in Nicotiana benthamiana subjected to the topping: TTF_(—)#80 gene, TTF_(—)#84 gene, TTF_r49 gene, TTF_r84 gene, and TTF_r86 gene. As compared to the control, silencing of TTF_r66 gene increased, by approximately 40%, the nicotine content of the leaves in Nicotiana benthamiana under a condition where the topping had not been performed. The term “untreated” in FIG. 1 means that the topping had not been performed, whereas the term “topping” means that the topping had been performed.

TABLE 3 AFTER VIRUS INFECTION CASE WHERE CASE WHERE TOPPING WAS TOPPING WAS GENE CARRIED OUT NOT CARRIED OUT TTF_#20 GENE 138%** 110%  TTF_#53 GENE 167%** 128%* TTF_#54 GENE 133%*  108%  TTF_#55 GENE 169%** 109%  TTF_#56 GENE 138%** 124%* TTF_#80 GENE 85%*  76%* TTF_#84 GENE  26%**  55%* TTF_r20 GENE 117%*  121%  TTF_r25 GENE 131%*  126%  TTF_r33 GENE 146%** 127%* TTF_r35 GENE 120%*  92% TTF_r40 GENE 135%*  91% TTF_r48 GENE 128%** 143%* TTF_r49 GENE 80%* 104%  TTF_r66 GENE 105%  146%* TTF_r84 GENE 72%* 79% TTF_r86 GENE  69%** 94% **SIGNIFICANTLY DIFFERENT VALUE AT SIGNIFICANCE LEVEL OF 1% *SIGNIFICANTLY DIFFERENT VALUE AT SIGNIFICANCE LEVEL OF 5%

Example 7 Cloning of cDNA Having Full-Length ORF

(TTF_(—)#20 gene)

A full-length cDNA of TTF_(—)#20 gene was obtained from a cDNA clone library that the applicant has. TTF_(—)#20 gene was selected as a gene whose expression was inducible by addition of jasmonate and removal of auxin in the microarray analysis as described in Example 3. TTF_(—)#20 gene has the base sequence of SEQ ID NO: 1. It is inferred that TTF_(—)#20 gene encodes the amino acid sequence of SEQ ID NO: 18. This amino acid sequence has WRKY domain and accordingly TTF_(—)#20 gene is predicted to be a transcription factor.

(TTF_(—)#53 Gene)

A full-length cDNA of TTF_(—)#53 gene was obtained from a cDNA clone library that the applicant has. TTF_(—)#53 gene was selected as a gene whose expression was inducible by addition of jasmonate in the microarray analysis as described in Example 3. A base sequence of the full-length cDNA is shown in SEQ ID NO: 2. It is inferred that TTF_(—)#53 gene encodes the amino acid sequence of SEQ ID NO: 19. This amino acid sequence has bHLH domain and accordingly TTF_(—)#53 gene is predicted to be a transcription factor.

(TTF_(—)#54 gene)

A full-length cDNA of TTF_(—)#54 gene was obtained from a cDNA clone library that the applicant has. TTF_(—)#54 gene was selected as a gene whose expression was inducible by addition of jasmonate in the microarray analysis as described in Example 3. TTF_(—)#54 gene was also selected as a gene whose expression was suppressed in LA Burley21. A base sequence of the full-length cDNA is shown in SEQ ID NO: 3. It is inferred that TTF_(—)#54 gene encodes the amino acid sequence of SEQ ID NO: 20. This amino acid sequence has SANT domain, and accordingly TTF_(—)#54 gene is predicted to be a transcription factor.

(TTF_(—)#55 Gene)

A full-length cDNA of TTF_(—)#55 gene was obtained from a cDNA clone library that the applicant has. TTF_(—)#55 gene was selected as a gene whose expression was inducible by addition of jasmonate in the microarray analysis as described in Example 3. A base sequence of the full-length cDNA is shown in SEQ ID NO: 4. It is inferred that TTF_(—)#55 gene encodes the amino acid sequence of SEQ ID NO: 21. This amino acid sequence has WRKY domain and accordingly TTF_(—)#55 is predicted to be a transcription factor.

(TTF_(—)#56 Gene)

A full-length cDNA of TTF_(—)#56 gene was obtained from a cDNA clone library that the applicant has. TTF_(—)#56 gene was selected as a gene whose expression was inducible by addition of jasmonate and removal of auxin in the microarray analysis as described in Example 3. A base sequence of the full-length cDNA is shown in SEQ ID NO: 5. In regard to TTF_(—)#56 gene, no clear ORF was found in the base sequence.

(TTF_(—)#80 Gene)

A full-length cDNA of TTF_(—)#80 gene was obtained from a cDNA clone library that the applicant has. TTF_(—)#80 gene was selected as a gene that responded to jasmonate and injury in Example 4. A base sequence of the full-length cDNA is shown in SEQ ID NO: 6. It is inferred that TTF_(—)#80 gene encodes the amino acid sequence of SEQ ID NO: 22. This amino acid sequence has NadA domain and SufE domain and shows 64% homology with quinolinate synthetase of Arabidopsis thaliana.

(TTF_(—)#84 Gene)

A full-length cDNA of TTF_(—)#84 gene was obtained from a cDNA clone library that the applicant has. TTF_(—)#84 gene was selected as a gene that responded to jasmonate and injury in Example 4. A base sequence of the full-length cDNA is shown in SEQ ID NO: 7. It is inferred that TTF_(—)#84 gene encodes the amino acid sequence of SEQ ID NO: 23. Like the amino acid sequence of TTF_(—)#84 gene, this amino acid sequence shows homology (66%) with quinolinate synthetase of Arabidopsis thaliana. TTF_(—)#84 gene is a homolog of TTF_(—)#80 gene.

(TTF_r20 Gene)

A full-length cDNA of TTF_r20 gene was not in a cDNA clone library that the applicant has. Accordingly, by using Primer 1 (5′-GGATTCCCGGGATTTTGAATTCTTG-3′: SEQ ID NO: 89) and Primer 2 (5′-ATCGAACAAATTGTTAAACTCACTGCGTA-3′: SEQ ID NO: 90), PCR was performed. In this PCR, the reverse transcription reaction product described in Example 1 was used as a template. This provided a cDNA having a full-length ORF. TTF_r20 gene is selected as a gene inducible by auxin and ethylene in the microarray analysis as described in Example 3. A base sequence of this cDNA having the full-length ORF is shown in SEQ ID NO: 8. It is inferred that TTF_r20 gene encodes the amino acid sequence of SEQ ID NO: 24. This amino acid sequence has AP2 domain and accordingly TTF_r20 gene is predicted to be a transcription factor.

(TTF_r25 Gene)

A full-length cDNA of TTF_r25 gene was not in a cDNA clone library that the applicant has. Accordingly, by using Primer 3 (5′-CTTTCCCTCGTTTTATTAGCAGATCA-3′: SEQ ID NO: 91) and Primer 4 (5′-CTATTTACAAGAATTAACGCTTAATCAATG-3′: SEQ ID NO: 92), cDNA having a full-length ORF was obtained as in the case of TTF_r20 gene described above. TTF_r25 gene was selected as a gene inducible by auxin and ethylene in the microarray analysis as described in Example 3. A base sequence of this cDNA having the full-length ORF is shown in SEQ ID NO: 9. It is inferred that TTF_r25 gene encodes the amino acid sequence of SEQ ID NO: 25. This amino acid sequence has AP2 domain and accordingly TTF_r25 gene is predicted to be a transcription factor.

(TTF_r33 Gene)

A full-length cDNA of TTF_r33 gene was obtained from a cDNA clone library that the applicant has. TTF_r33 gene was selected as a gene inducible by auxin and ethylene in the microarray analysis as described in Example 3. A base sequence of this cDNA having the full-length ORF is shown in SEQ ID NO: 10. It is inferred that TTF_r33 gene encodes the amino acid sequence of SEQ ID NO: 26. This amino acid sequence has AP2 domain and accordingly TTF_r33 gene is predicted to be a transcription factor.

(TTF_r35 Gene)

A full-length cDNA of TTF_r35 gene was not in a cDNA clone library that the applicant has. Further, 5′ upstream region and 3′ downstream region of a transcription product could not be clarified even by RACE. In regard to TTF_r35 gene, only a polynucleotide (SEQ ID NO: 11) used in the VIGS assay could be isolated. Note that TTF_r35 gene was selected as a gene whose expression was suppressed by addition of jasmonate and removal of auxin in the microarray analysis as described in Example 3. A partial amino acid sequence that TTF_r35 gene is predicted to have is shown in SEQ ID NO: 27.

(TTF_r40 Gene)

A full-length cDNA of TTF_r40 gene was obtained from a cDNA clone library that the applicant has. TTF_r40 gene was selected as a gene inducible by jasmonate treatment and topping in the microarray analysis as described in Example 3. A base sequence of this full-length cDNA of TTF_r40 gene is shown in SEQ ID NO: 12. It is inferred that TTF_r40 gene encodes the amino acid sequence of SEQ ID NO: 28. This amino acid sequence has tify domain and accordingly TTF_r40 gene is predicted to be a transcription factor.

(TTF_r48 Gene)

A full-length cDNA of TTF_r48 gene was obtained from a cDNA clone library that the applicant has. TTF_r48 gene was selected as a gene inducible by jasmonate treatment and topping in the microarray analysis as described in Example 3. A base sequence of the full-length cDNA of TTF_r48 gene is shown in SEQ ID NO: 13. It is inferred that TTF_r48 gene encodes the amino acid sequence of SEQ ID NO: 29. This amino acid sequence has tify domain and accordingly TTF_r48 gene is predicted to be a transcription factor.

(TTF_r49 Gene)

A full-length cDNA of TTF_r49 gene was obtained from a cDNA clone library that the applicant has. TTF_r49 gene was selected as a gene whose expression was suppressed by jasmonate treatment in the microarray analysis as described in Example 3. A base sequence of this full-length cDNA of TTF_r49 gene is shown in SEQ ID NO: 14. It is inferred that TTF_r49 gene encodes the amino acid sequence of SEQ ID NO: 30. This amino acid sequence has AUX/IAA domain and accordingly TTF_r49 gene is predicted to be a transcription factor.

(TTF_r66 Gene)

A full-length cDNA of TTF_r66 gene was obtained from a cDNA clone library that the applicant has. TTF_r66 gene was selected in Example 4 as a gene related to an amino acid sequence having ethylene as a keyword. A base sequence of this full-length cDNA of TTF_r66 gene is shown in SEQ ID NO: 15. No clear ORF is found in the base sequence of TTF_r66 gene.

(TTF_r84 Gene)

A full-length cDNA of TTF_r84 gene was obtained from a cDNA clone library that the applicant has. TTF_r84 gene was selected by using QPT1 Bait sequence in Example 5. A base sequence of the full-length cDNA of TTF_r84 gene is shown in SEQ ID NO: 16. It is inferred that TTF_r84 gene encodes the amino acid sequence of SEQ ID NO: 31. In this amino acid sequence, no conserved domain structure is found.

(TTF_r86 Gene)

A full-length cDNA of TTF_r86 gene was obtained from a cDNA clone library that the applicant has. TTF_r86 gene was selected by using PMT1 Bait sequence in Example 5. A base sequence of the full-length cDNA of TTF_r86 gene is shown in SEQ ID NO: 17. It is inferred that TTF_r86 gene encodes the amino acid sequence of SEQ ID NO: 32. This amino acid sequence has a conserved domain structure of Cytochrome c oxidase subunit VIa.

Note that names of the domains of the amino acid sequences are described in Conserved Domain Database (CDD) of NCBI.

Example 8 Modification of Component in Transformed Plant

A transformed plant was prepared by introducing an RNAi construct or an overexpression construct. Then, a change in components in thus prepared transformed plant was checked as below.

(Construction of Constructs)

A vector used for RNAi was pSP231 into which GFP expression cassette was inserted into SacI site of pHellsgatel2 (Non-Patent Literature: Wesley et al., 2001, Plant J., 27, 581-590) that was a Gateway (Registered Trademark) vector.

The entry clone of Example 6 was used for RNAi construct of TTF_(—)#53 gene, TTF_(—)#54 gene, TTF_(—)#55 gene, TTF_(—)#56 gene, TTF_(—)#80 gene, TTF_(—)#84 gene, TTF_r33 gene, TTF_r35 gene, TTF_r40 gene, TTF_r48 gene, TTF_r49 gene, TTF_r66 gene, TTF_r84 gene, and TTF_r86 gene. For preparing RNAi construct of TTF_(—)#20 gene, TTF_r20 gene, TTF_r25 gene, or NtPMT1 gene, a DNA fragment (SEQ ID NO: 122 (TTF_(—)#20), SEQ ID NO: 123 (TTF_r20), SEQ ID NO: 124 (TTF_r25), or SEQ ID NO: 125 (PMT1)) was obtained by PCR amplification with use of primers shown in Table 4. Then, this DNA fragment was inserted into pENTR/D-TOPO vector and thereby an entry clone was obtained. By using this entry clone, the RNAi construct above was prepared. Note that the PCR amplification and cloning of the DNA fragment were carried out by the procedures described in Example 6. Further, note that a plasmid obtained form a full-length cDNA clone library that the applicant has was used as a template in the PCR amplification.

TABLE 4 PRIMER NAME SEQUENCE (SEQ ID NO) TTF_#20_triger_F2 CACCTACGACATGGAAGTGGCTTTCAGA (SEQ ID NO: 114) TTF_#20_triger_R2 GCCTTATCTTTGCTCAAGATTTTGG (SEQ ID NO: 115) TTF_r20_triger_F2 CACCTGACTATGAAGAAAGTCTGAG (SEQ ID NO: 116) TTF_r20_triger_R2 GGCTTTAATTGAATAACTTCATAAAATGAATCG (SEQ ID NO: 117) TTF_r25_triger_F2 CACCATTGTCTCCACATTTGCCTTA (SEQ ID NO: 118) TTF_r25_triger_R2 GAAAAGAATTCAAGACTCAAAGACACCC (SEQ ID NO: 119) NtPMT1_D_TOPO_F CACCTCAACGGCTACCAGAATGGC (SEQ ID NO: 120) NtPMT1_D_TOPO_R CCACCATTCTCTGTATGTTGAATTGCTCC (SEQ ID NO: 121)

The DNA fragment contained in the entry clone was inserted into pSP231 that was a Gateway (Registered Trademark) RNAi vector by using LR clonase (Invitrogen Corporation). Thus constructed RNAi construct was purified from E. coli by using QIAprep Spin MiniprepKit (QIAGEN) and further introduced into Agrobacterium strain LBA4404 (Non-Patent Literature Hoekema et al., 1983, Nature, 303, 179-180) by the electroporation method. Note that for use as a positive control of decrease in nicotine content, an RNAi construct of NtPMT1 was prepared. Further, for producing a transformed plant that was to be a positive control of increase in nicotine content, an overexpression construct of NtPMT1 gene was prepared. As a transformation vector for overexpression, pRI201-AN (Takarabio Inc.) was used. The DNA fragment to be inserted into the transformation vector was obtained by (i) obtaining a DNA fragment (SEQ ID NO: 128) amplified by PCR by use of a forward primer having PshBI restriction enzyme recognition site and a reverse primer having SalI restriction enzyme recognition site which are shown in Table 5 and (ii) performing double digestion of thus obtained DNA fragment at NdeI and SalI. Thus obtained product of the double digestion was inserted at the NdeI/SalI site in a multiple cloning site of pRI201-AN. Thereby, the overexpression construct of NtPMT1 gene was obtained.

TABLE 5 PRIMER NAME SEQUENCE (SEQ ID NO) pmt_oe_f GCGATTAATGGAAGTCATATCTACCAACACAAATGGC (SEQ ID NO: 126) pmt_oe_r CGTGGTCGACTTAAGACTCGATCATACTTCTGGCG (SEQ ID NO: 127)

(Preparation of Transformed Plant)

From a tobacco variety SR-1 cultivated for approximately 1.5 month in a greenhouse, an expanded top leaf was picked. Then, a surface of this leaf was disinfected for approximately 5 minutes with sodium hypochlorite solution (which contains available chlorine by 1% and to which several drops of Tween 20 were added per liter) and washed three times with sterile water. Further, by using a surgical knife, an approximately 5 mm square leaf segment was prepared from the leaf whose surface was disinfected. The leaf segment and Agrobacterium (approximately 10⁸ cells) containing a transformation construct were co-cultured for 48 hours on Murashige and Skoog medium (MS medium, Non-Patent Literature Physiol. Plant, 1962, 18, 100-127) containing 30 g/L sucrose. Subsequently, the leaf segment was washed three times with sterile water containing 250 mg/L cefotaxime so that bacteria was washed off. Then, the leaf segment was placed on an MS medium (pH 5.8) containing 30 g/L sucrose, 0.3 mg/L indole acetate, 10 mg/L 6-(γ,γ-dimethylallyl-amino)purine, 100 mg/L kanamycin, 250 mg/L cefotaxime, and 0.3% gellan gum. Approximately 2 weeks after the start of culturing on the MS medium, a callus-like cellular mass showing resistance to kanamycin was obtained. This callus-like cellular mass was placed on a ½ MS medium (pH 5.8) containing 15 g/L sucrose, 100 mg/L kanamycin, 250 mg/L cefotaxime and 0.3% gellan gum. Consequently, a redifferentiated individual was obtained.

Then, a transformed plant (TO generation) into which a target construct was introduced was selected by GFP fluorescence. Approximately three months after the co-culture, thus selected transformed plant was transplanted into a 12 cm terracotta pot having a diameter of 124 mm, and cultivated in a closed system greenhouse whose temperature was regulated at approximately 23° C. Further, approximately 2.5 months after potting, pollen was collected from the transformed plant (TO generation) and used for pollination with wild-type SR-1. Thereby, a seed of F1 hybrid was obtained.

(Cultivation of Transformed Plant)

Cultivation of F1 plants was carried out by using a phytotron (day length of 8 hours, illuminance: approximately 300001x, temperature: 26° C. (light period)/18° C. (dark period), and relative humidity: 60% (light period)/80% (dark period)).

Seeds of the F1 plants and SR-1 were sowed in rich soil for seeding (Supermix A, Sakata Seed Co.) and germinated by bottom irrigation. Then, 18 days after the seeding, seedlings germinated were temporarily planted. Further, 13 days after the temporary planting, the seedlings were transplanted into 12 cm terracotta pots. Note that approximately 4 weeks after the seeding, a leaf disc was taken from a leaf of each of the F1 plants and GFP fluorescence was observed. Thereby, transformed plants F1 each having a transgene were selected. Ultimately, 3 or 4 individuals for each line of the transformed plants F1 were selected and provided for the following experiment. Similarly, 5 or 6 individuals of SR-1 that was a control plant were provided for the experiment.

Thirteen days after the transplant, first to fourth leaves from the bottom were removed from the transformed plants F1 and the wild-type plants. On some of individuals, topping was carried out by leaving up to 7th leaves from the bottom. From the individuals subjected to topping, an auxiliary bud extending from each leaf axil was removed as appropriate. On individuals having not been subjected to topping, auxiliary buds were left as they were.

Twenty days after the transplant (7 days after the topping), all leaves of the individuals having been subjected to topping were picked. Further, from the individuals having not been subjected to topping, leaves (5th to 7th leaves) at the same stalk positions as the leaves picked from the individuals having been subjected to topping were picked. From thus picked leaves, mid-rib was removed. Then, the picked leaves were immediately frozen by using liquid nitrogen and stored at −80° C. Subsequently, the leaves frozen were freeze-dried, and then ground by using Multi Beads Shocker (Yasui Kiki Corporation).

(Measurement of Nicotine Content)

Analysis of nicotine contents in the transformed plants was carried out in the same manner as in Example 6. Table 6 shows, as a nicotine content ratio of each transformed plants F1 to the control, an influence of the transformation onto the nicotine content. As compared to the control plant, increase in leaf nicotine content was observed in the transformed plants F1 into which the RNAi constructs of the following genes had been introduced: TTF_(—)#20 gene, TTF_(—)#53 gene, TTF_(—)#54 gene, TTF_(—)#55 gene, TTF_r33 gene, TTF_r40 gene, TTF_r48 gene, and TTF_r66 gene. That is, RNA interference of these genes increased the nicotine contents of tobacco plants as in a case of the TRV assay of Example 6. Further, in each transformed plant F1 into which RNAi construct of TTF_(—)#80 gene, TTF_(—)#84 gene, or TTF_r86 gene was introduced, the leaf nicotine content was decreased as compared to the control plant. That is, the RNA interference of these genes decreased the nicotine contents of tobacco plants as in the case of the TRV assy.

TABLE 6 NICOTINE CONTENT (RATIO TO CONTROL) CASE WHERE CASE WHERE TOPPING TOPPING WAS WAS NOT RNAi TRANSFORMATION CARRIED CARRIED CONSTRUCT LINE OUT OUT TTF_#20 1 134% 105% 2 124% 105% 3 110% 104% TTF_#53 1  155%*  96% 2 123% 108% 3  132%* 115% TTF_#54 1 121%  99% 2  129%** 106% 3 110%  98% TTF_#55 1 121%  93% 2  139%* 103% 3  123%* 120% TTF_#56 1 109%   81%** 2 102%  92% 3 113%   72%** TTF_#80 1   62%**   69%** 2   16%**   10%** TTF_#84 1   2%**   6%** 2   5%**   1%** 3   1%**   4%** TTF_r20 1 100% 100% 2  89%  90% 3 101%  99% TTF_r25 1  99% 124% 2 105% 110% 3 101% 104% TTF_r33 1 101%  86% 2  134%**  123%** 3  123%** 109% TTF_r35 1   75%** 101% 2   76%**  77% 3   71%** 108% TTF_r40 1  139%**  114%* 2 117%  111%* TTF_r48 1  136%**  143%** 2  156%**  117%** 3  196%**  129%** TTF_r49 1  124%*  133%** 2  122%* 111% TTF_r66 1  94%  131%* 2  99% 134% TTF_r84 1  98% 105% 2 106% 102% 3 113% 101% TTF_r86 1  85%* 115% 2   85%**  121%* **SIGNIFICANTLY DIFFERENT VALUE AT SIGNIFICANCE LEVEL OF 1% *SIGNIFICANTLY DIFFERENT VALUE AT SIGNIFICANCE LEVEL OF 5%

TABLE 7 NICOTINE CONTENT (RATIO TO CONTROL) CASE CASE WHERE WHERE TOPPING TOPPING WAS WAS NOT CONTROL TRANSFORMATION CARRIED CARRIED CONSTRUCT LINE OUT OUT NtPMT1_RNAi 1   3%**  7%** 2   3%**  7%** NtPMT 1 96% 140%** OVEREXPRESSION 2 95% 148%** 3 104%  107% 

Meanwhile, influence of RNA interference of TTF_(—)#56 gene, TTF_r35 gene, and TTF_r49 gene was different from that in the case of TRV assay. That is, the RNA interference of TTF_(—)#56 gene decreased leaf nicotine content of tobacco having not been subjected to the topping. The RNA interference of TTF_r35 gene decreased leaf nicotine content of tobacco having been subjected to the topping. The RNA interference of TTF_r49 gene increased leaf nicotine content of tobacco regardless of whether or not the topping had been carried out.

The RNAi constructs of TTF_(—)#80 and TTF_(—)#84 significantly decreased leaf nicotine content in the same manner as the RNAi construct of NtPMT1 gene that was used as a positive control of decrease in nicotine content. Meanwhile, the RNAi constructs of TTF_r35 gene and TTF_r86 gene significantly decreased leaf nicotine content by 15% to 29%. Further, the overexpression construct of NtPMT1 gene that was used as a positive control of increase in nicotine content increased leaf nicotine content of tobacco that had not been subjected to the topping. However, this overexpression construct did not affect leaf nicotine content of tobacco having been subjected to topping in accordance with an actual tobacco cultivation method.

As described above, some of the RNAi constructs of the genes of the present invention decreased or increased leaf nicotine content of tobacco plants. Conventionally, an example in which nicotine content is drastically decreased has been known. However, an example in which nicotine content is moderately decreased has not been known. Such an example of moderate decrease was realized by the cases of the RNAi constructs of TTF_r35 gene and TTF_r86 gene of the present invention. Further, there has been no known example of a stably transformed plant, like some of the transformed plants of the present invention, having leaf nicotine content increased by introduction of a construct suppressing gene expression. Furthermore, there has been no known example in which increase in nicotine content is checked in comparison of stably transformed tobacco and a control, by using individuals having been subjected to topping in a manner that is generally performed in actual tobacco cultivation.

Note that Shoji et al. found that there are at least 7 types of ERF genes present at NIC2 locus that had been considered as one of a master switch for alkaloid synthesis. Further, Shoji et al. report a transformed tobacco hairy roots (variety: Petit Havana SR 1) whose alkaloid content is significantly decreased by overexpression of ERF189 and ERF179 caused by connecting EAR motif to ERF189 and ERF179 (Non-Patent Literature: Shoji et al, 2010, Plant Cell., 22, 3390-409). ERF189 and ERF179 are among the 7 types of ERF genes described above. Furthermore, Shoji et al. successfully improves the alkaloid content in roots of a nic (niclnic2) mutant line having a genetic background of a variety NC 95, by overexpression of ERF189 and ERF115.

(LC-TOF/MS Analysis)

As described in the section of Cultivation of Transformed Plant, freeze-dried powders of leaves was prepared. The leaves were picked from individuals of the control plant and the transformed plants F1 to each of which the topping had been carried out. The transformed plants F1 here had been obtained by introduction of RNAi construct of TTF_(—)#53 gene, TTF_(—)#56 gene, TTF_r20 gene, TTF_r25 gene, TTF_r84 gene, or TTF_r86 gene. Then, thus prepared freeze-dried powders were provided for LC-TOF/MS analysis. This LC-TOF/MS analysis was entrusted to Genaris, Inc. (Kanagawa, Japan).

The freeze-dried powders of 3 or 4 individuals (regarding the control, 5 or 6 individuals) of one line were mixed to give a sample to be provided for the analysis. An amount of each of the freeze-dried powders mixed was equal. Here, for the analysis, samples of two lines per construct were prepared. Further, from each of the freeze-dried powder samples, an extract to be provided for LC-TOF/MS analysis was obtained as follows. First, to 100 mg of the freeze-dried powders, 1 ml of 50% acetonitrile and 0.5 g of glass beads having Φ1.0 mm were added. Then, disruption was carried out at 4° C. for 5 minutes. Thus obtained disrupted sample solution was subjected to centrifugation (4° C.) for 1 min at 15000 rpm. Then, supernatant was 10-fold diluted. This diluted supernatant solution was subjected to ultrafiltration (molecular weight cut-off: 10,000, 10° C.) and provided as an extract for the LC-TOF/MS analysis. According to need, a sample diluted by 5% acetonitrile solution (water/acetonitrile=95/5) was used for the analysis.

In the analysis, LCT Premier XE/ACQUITY UPLC (Waters Corporation) was used. For separation in UPLC, ACQUITY UPLC T3 column (2.1×50 mm, Waters Corporation) was used and linear gradient elution (for 10 minutes) was carried out by using water/acetonitrile containing 0.1% formic acid. In a mass analysis section, two types of ionization modes of ESI Positive and ESI Negative were used and all peaks in a range of 50 to 1000 m/z were measured.

The following procedures were applied for extraction of peaks at which signal intensity increased or decreased in the transformed plants F1 as compared with the control. First, in the analysis by comparison between the transformed plants F1 and the control, each peak whose signal intensity is greater than 50 in regard to at least one sample was selected a target for analysis, among peaks whose retention time in LC is in a range of 0.3 min to 9.9 min. Though the target for analysis depends on each construct, there were approximately 1700 peaks.

Next, signal intensities of the two lines of the transformed plants F1 were compared with signal intensities of the control. As a result of the comparison, peaks at which the signal intensities of the two lines of the transformed plants F1 were ½ or less or twice or more of the signal intensities of the control were extracted. Table 8 shows the number of peaks extracted. Compounds responsible for the respective peaks are inferred by comparing information such as m/z value and retention time of each peak extracted, with those shown in known compound database or data obtained by analyzing standard compounds. Then, according to thus inferred compounds mapped on KEGG metabolic pathway and the compounds inferred from the data obtained by analyzing standard compounds, the following compounds were inferred as metabolites at the peaks which metabolites were found to increase or decrease in each transformed plant F1.

TABLE 8 NUMBER OF PEAKS EXTRACTED NUMBER OF PEAKS NUMBER OF PEAKS THAT DECREASED INCREASED TWICE RNAi CONSTRUCT BY HALF OR MORE OR MORE TTF_#53 21 14 TTF_#56 37 81 TTF_r20 31 11 TTF_r25 14 45 TTF_r84 78 6 TTF_r86 52 132

In the transformed plant F1 into which the RNAi construct of TTF_(—)#53 gene was introduced, anatalline (Pyridinealkaloid biosynthesis) increased. In the transformed plant F1 into which the RNAi construct of TTF_(—)#56 gene was introduced, glutamine, arginine (arginine, proline metabolism), and phenylalanine (phenylalanine metabolism) increased. In the transformed plant F1 into which the RNAi construct of TTF_r20 gene was introduced, no inferred compound that allows inference of a metabolic pathway could be found. In the transformed plant F1 into which the RNAi construct of TTF_r25 gene was introduced, a compound in a naphthalene and anthracene degradation pathway, and a compound in fluorene degradation pathway decreased. In the transformed plant F1 into which the RNAi construct of TTF_r84 gene was introduced, erythronolide B (12-, 14-,16-macrolide biosynthesis) decreased. In the transformed plant F1 into which the RNAi construct of TTF_r86 gene was introduced, succinic acid, 2-oxoglutaric acid (TCA cycle), and anatalline (Pyridinealkaloid biosynthesis) decreased. As described above, the RNA interference of each gene caused a change in plant leaf component. Therefore, any of TTF_(—)#53 gene, TTF_(—)#56 gene, TTF_r20 gene, TTF_r25 gene, TTF_r84 gene, and TTF_r86 gene has a function of regulating contents of various metabolites.

Example 9 Check Functions of TFF_(—)#80 Gene and TFF_(—)#84 Gene

By performing complementation tests using E. coli, respective functions of TFF_(—)#80 gene and TFF_(—)#84 gene were checked.

(Construction of E. Coli Expression Construct)

PCR was carried out by (i) using, as primers, #80_F_(—)5-Bam (5′-GGATCCGTGATGGATGCCGCAAAT-3′: SEQ ID NO: 129) and #80_F_(—)3-Kpn (5′-GGTACCTTAAGCAGAGCTTGATCGTCC-3′: SEQ ID NO: 130) and (ii) using, as a template, plasmid containing a full-length cDNA of TFF_(—)#80 gene obtained from a cDNA clone library that the applicant has. In the PCR, a DNA fragment containing a full-length ORF of TFF_(—)#80 was amplified. Similarly, PCR was carried out by (i) using, as primers, #84_F_(—)5-Bam (5′-GGATCCGTTATGGACGCCGCAAAT-3′: SEQ ID NO: 131) and #84_F_(—)3-Kpn (5′-GGTACCTTAAGCGGAGCTTGATCGTTG-3′: SEQ ID NO: 132) and (ii) using, as a template, plasmid containing a full-length cDNA of TFF_(—)#84 gene obtained from a cDNA clone library that the applicant has. In the PCR, a DNA fragment containing a full-length ORF of TFF_(—)#84 was amplified. By using 10 μM of each primer and PrimeStarMax (Takarabio Inc.) as enzyme, reaction was carried out according to an attached manual. By introducing an amplified fragment which was digested with both BamHI and KpnI into a BamHI/KpnI site in a multiple cloning site of pQE30 vector (Qiagen), IPTG inducible expression construct was prepared.

Competent cells of Nad deficient E. coli: JD26148 transferred from National Institute of Genetics were prepared by a general method, and transformation was carried out by using each of the constructs. Into thus obtained transformed E. coli, the expression constructs of TFF_(—)#80 gene and TFF_(—)#84 gene were introduced. These E. coli were called #80_pQE3O_JD and #84_pQE3O_JD, respectively.

(Complementation Tests Using E. Coli)

JD26148 (control that had not been transformed), #80_pQE3O_JD and #84_pQE3O_JD were streaked on M9 medium that is a minimum medium, M9+IPTG (1 mM) medium, M9+NA (nicotinic acid: 10 μg/ml) medium, and M9+NA+IPTG medium, and then cultured at 37° C. for 4 days. JD26148 was resistant to kanamycin, and accordingly, 25 μg/ml kanamycin was added to the medium. FIG. 2 shows a result of this culture. (1) of FIG. 2 shows a result of the culture using the M9+IPTG medium; (2) of FIG. 2 shows a result of the culture using the M9 medium; (3) of FIG. 2 shows a result of the culture using the M9+NA+IPTG; and (4) of FIG. 2 shows a result of the culture using the M9+NA medium. In addition, (5) of FIG. 2 shows strains of E. coli streaked onto each division on the medium shown in (1) to (4) of FIG. 2. JD26148 was streaked in the division corresponding to “A”; #80_pQE3O_JD was streaked in the division corresponding to “B”; and #84_pQE3O_JD was streaked in the division corresponding to “C”. As shown in FIG. 2, JD26148 did not grow on the M9 medium, but grew only on the medium containing NA. On the other hand, #80_pQE3O_JD and #84_pQE3O_JD did not grow on the M9 medium, but grew on the M9+IPTG (1 mM) medium that did not contain NA. All of JD26148, #80_pQE3O_JD and #84_pQE3O_JD grew in the presence of NA regardless of the presence of IPTG. Table 9 shows these results. JD26148 became capable of growing by expression of the full-length ORF of TFF_(—)#80 gene or TFF_(—)#84 gene. Therefore, it was inferred that TFF_(—)#80 gene and TFF_(—)#84 gene encodes Quinolinate Synthase (QS).

TABLE 9 RESULTS OF COMPLEMENTATION TESTS M9 + IPTG M9 M9 + NA M9 + NA + IPTG JD26148 − − + + #80_pQE30_JD + − + + #84_pQE30_JD + − + +

INDUSTRIAL APPLICABILITY

According to the present invention, a specific metabolite content can be regulated. Therefore, it is possible, for example, to develop leaf tobacco having component that is different in terms of quantity and quality from that in conventional leaf tobacco. This makes it possible to further widen a range of taste and flavor of tobacco products created by blending.

<160> NUMBER OF SEQ ID NOS: 132 <210> SEQ ID NO 1 <211> LENGTH: 1946 <212> TYPE: DNA <213> ORGANISM: Nicotiana tabacum <400> SEQUENCE: 1 gaagaggtga aaattcacaa agaaagagag agagaataga ggagataagg tctacgacat     60 ggaagtggct ttcagaaaat ctattaatgg aggcttagtc aaagaggaga agaggaacaa    120 attagcttat caatccagtt ctgatgagga gggttttgtt gaagacagta atgttcttaa    180 ggtcgggaag gaaagagaag tccatgagga cgataattcg aagtatcctc agcaagagga    240 tatcgacagt gacaaggagg acgatcagct acaatcagtc aaagctgata tgaaagaggt    300 aatgaaagaa aatcagaggc tgaagatgca cttggatcga attatgaagg attatcggaa    360 ccttcagctg caatttcacg acattgttca aagaaatgct gaaaaatcca atagtattat    420 tgatactgat cggcataatg aatgtaacga agctgaattt gtctccctta gcttaggaag    480 atcttcaagc gacactaaaa aagaagagta cttatccaaa atcttgagca aagataaggc    540 agaggaagag aataaaggag gcctaaccct aggactggat tgcaagtttg atttgtgtgt    600 gaaaacaaca ccgacagaat tttcaactgc aaatctcagt gaagagaata ggtcagagga    660 agttaaggac gaaaatggag aaacattgcc accccataaa attctcaaga caatgagaaa    720 tggagaagat gatacacaac caaacccttc taaaagagca aaggtttctg ttagagtcag    780 atgtgatgcc ccgacgatga atgatggatg ccaatggaga aaatatggac aaaaaattgc    840 aaaaggaaat ccgtgtcctc gagcttacta ccgttgcaca gtagcaccct cctgcccagt    900 gagaaagcag gttcagagat gcattgagga tatgtcaatc ttgatcacta catatgaggg    960 aacacacaat catccacttt ctctttcagc aacatcaatg gcttccacaa cttcagcagc   1020 tgcttctatg ctattatctg gttcatcgtc cagctctgaa tcaggcccca atccaccagc   1080 aactgacgcc acgaatatca atggactcaa cttctatctc tccgatagct caaaaccaaa   1140 accattttac cttcaaaatt cgtccatctc ttcttcatcc tcgcccccta caatcactct   1200 tgatttaacc tcaagctcgt tcacttcctt atttccccat cataacagaa tgagtagtaa   1260 ttatctcccc agatataatt cttccacaaa tattctcaac ttcagttcct tggaatctaa   1320 tcctcttctt cccatgtctt ggagtaatgg ggcctataac aagaaccaag aaattagttc   1380 tctcaacttt gcaaggcggc cacaagatat tcttttccaa tcttatctac aaaataatat   1440 tagtgcaaag cctacacaat ctttattacc acaagataca attgcagctg ctacaaaagc   1500 aataacatcc gacccaaatt ttcaatctgc attggctgtt gctcttgcat ctatcattgg   1560 ctcaggcagc ggaaatcatg caggtggtat tgaagaaaaa tctggtctaa atttgaaggt   1620 taccgaacca tttccagttc tttgcagctt cccatctacc tcaaagaaat aatatatcca   1680 attaactgtt cttcaaattt ttctgaataa atcgacttct acggcaaata gacaggctgc   1740 tagtaacttt cgcttgctga agtaagaaac taattgcggc gttaattaat cagatgtaat   1800 atttttttta tgatttggag gtacgatgtc caaagtgtag atattttagt ttgataaaac   1860 taattgacac ttcgcttact gaagtcattg ctttagcctt tacattgttt tttcgttaag   1920 tgttagttaa atgtgatttt aacaaa                                        1946 <210> SEQ ID NO 2 <211> LENGTH: 2598 <212> TYPE: DNA <213> ORGANISM: Nicotiana tabacum <400> SEQUENCE: 2 ggactttgca agaaaataga gaaaacagct tctctcattt cgtttcccaa aaaactacca     60 atatttcttt attggggcaa aactatagta ttttcccagt tgaattctag ttctattaca    120 gaacctcagt ttcttccaga gctcaaaagt ttgcttggtc accttcttga ctgcaaagat    180 accggtgtgt atttttcatg cttttttacc aatcttcttt gtttgtccat ttatgcattt    240 ttatgtccaa gtttgtatcc tttctgggta tttttttata gttacttata ccctctagtt    300 tccaagcttt tgagatctga aaagtagagg tatggacaat tgggtgttca ataagaagaa    360 gaagatcaat tgtttttctt gaagttacga tgagtttgct ttagattggt taattggtgt    420 tctagaatgt gttaaaggtt caagctttgg aggagaaaaa aaaagaattg tctttttcag    480 ttcttgtttc atctaggaat ataaatttgg aatctctttt gggtcctagg ggtgttttgt    540 agttcaaggg atttttttta ctaggtagag atgggtacgg tgaatatgtc gtggagtgat    600 gaggataagg caacagtggc ggctgtactg ggaaaagaag cttttgaata tttgatatct    660 agctcggttt cagcagaatg ttctttaatg gcaataggga atgatcagaa tttgcagaat    720 aagctttcag atctcgtgga acgcccgaac gccactaatt ttagctggaa ttatgccatc    780 ttttggcaaa tttcacggtc taaatcgggg gaattggtgc tagggtgggg cgatgggtgt    840 tgcagagaac ctagggaagg agaggagcgt gaagttaaaa gtatatttaa tctacgcctt    900 gaggatgagg ctccacaaag gatgaggaaa agggtccttc agaagttgca tatgttattt    960 ggtggaacag atgaagataa ctatgctatt ggattggata gggtcactga tactgaaata   1020 ttcttccttg cctcgatgta cttttcgttc cctcgaggag agggaggtcc agggaagtgt   1080 tttggttcgg gtaagcattt gtggttatca gatgcattga agtcccctct agattattgt   1140 gctagatctt tcctagctaa gtcagctggt atgcaaacta ttgttttgat cccaactgat   1200 gttggagttg tggaattggg atcagtgaga tcgataccgg aaagtttgga gctattgcat   1260 tctataaaat cttgcttctc ttcgtttctt gttagggcta agcaagcagc aggtttagca   1320 gttgtaactg agaaaaaaga tggaaataat tccccttttt cgagctcagc ttttagtgag   1380 cgaccagatg gaattcctaa gatttttggg cacgatttaa attccggtac ccactttagg   1440 gaaaaacttg ctgttaggaa agcggaggag agaccatggg atatttacca aaacggtacc   1500 aggatgccat tcatgaacgg gcgtactggt ttacatgctg cttcttgggc gcaattcagt   1560 aatgtgaagc cggtaaagcc agtggagctc tatagtcctc agacgccccc agcacacaac   1620 ctacaagagc ttgtcaatgg tggaagggaa gaattccgtt tgaacaactt tcagcatcaa   1680 aagcctgcta gaatgcaaat tgatttcact ggagcaacct cgagacccat tatttcgcca   1740 gcacacactg ttgagtctga gcattcagat gttgaagctt cgtgtaagga agactgtgca   1800 ggcccggttg atgaaaagag gcctagaaaa cgtggaagaa agccagccaa cggaagggaa   1860 gagcccctca atcatgtaga ggcggagagg cagcggcggg aaaagctgaa ccagcgattc   1920 tatgcattac gagctgttgt tccgaatatc tccaaaatgg acaaagcttc cctcttagga   1980 gatgccattg cttacataac tgagatgcag aaaaaactaa gagacatgga atccgagagg   2040 gagctgagat taggaagcac ttcaagggat gcaatggctg cagaagacag cccgaattca   2100 gagattcaaa tccgtggacc cgacatcaac gtagaagctg ccaatgatga agtcattgta   2160 agggtgagtt gtcctctgga aacccatcca atatcaagag tcatccaaac attcaaagat   2220 gcacagatca atgttgttga atcaaaactt tctgccggga atggaactgt atttcacaca   2280 tttgtactca agtctagtgg atctgaacag ctgacaaagg aaaagttgct ggctgcattt   2340 tccagcgaat cagactcgct gaggcaattt tcaccggtag ggcaataaca gttttatgtt   2400 ttatgtagtt gctaggcata aagtgtagtg aagaatcata tcgtagtttc tgcagagttt   2460 ttcgtataca tcagttcaag ataggtggaa ataactagct attgacaaag tagcagcaaa   2520 ttttctgtgt ttgtctatag tatacatgtt ttatcatgag gcatgatgga tcaattgcaa   2580 gcttaactat cttttgca                                                 2598 <210> SEQ ID NO 3 <211> LENGTH: 1235 <212> TYPE: DNA <213> ORGANISM: Nicotiana tabacum <400> SEQUENCE: 3 acgaggaata ttacaaaaag agttgaaaac agaggggaga gatgggtaga ccaccttgtt     60 gtgataaaat aggggtgaag aaaggaccat ggactcctga agaagatatt atgttggtct    120 cttatgttca agaacatggt cctgggaatt ggagagcagt tcccactaat acagggttgc    180 gcagatgtag caagagctgc aggctaaggt ggactaatta cctcagaccg ggaattaaga    240 gaggcagttt cactgatcaa gaggagaaaa tgattatcca gcttcaggct ctcttaggca    300 acaaatgggc tgccatagct tcatatctcc cggagagaac agacaacgat gtcaaaaact    360 attggaatac tcatttaaag aaaaagttga aaaagctcga atcaagtgat ttatactcta    420 aagatggatc ttgtttatca ccatcaaact caacctcgag aggccagtgg gaaaggacac    480 ttcaaactga tataaacaca gccaaacaag ctttacaaaa tgccctgtca ctggataagt    540 caagcccaat tcctgaatat acgaccactg atgtgaagcc tataaatctt ggctgttact    600 catacataaa acaagaagga aaagtgtcta cttctactta cgcatcaagt gctgaaaaca    660 tagccaaatt gcttaaacaa tggaccagaa gtgattcaac aaacatttct gagcaatcga    720 aagcttcatc aagtactcaa ctctcaagta ataacaatgc caccaccgag gaatttgagt    780 cactttccag tttcgattca tttgaacagt caaattcaga tcaattttca cagagtttga    840 cacttgaggc tggtaaatta cactgtgaaa ttagtaaaag agaagtggat gatcaagtac    900 ccttgtcagt aatgctggag agttggcttt ttgatgaaaa tgacgatttg ctaatttaga    960 aggaattttt ttgcttttcc atttggggat tctatttgtt gcattatgtt tttgtttctt   1020 accccaagta ctagaatttt acctaggtat ggatgtgaca tccacattct tttttttttt   1080 tgggccaggt atgactgttt taacattagt gtatatttag cttattctta gaggaatttc   1140 gttcttttct aatatgataa gtgtctatca tttaacctcg tgtttcctaa gaatcgaaat   1200 atttattata ctaagattag tatgttgaat ccaaa                              1235 <210> SEQ ID NO 4 <211> LENGTH: 1185 <212> TYPE: DNA <213> ORGANISM: Nicotiana tabacum <400> SEQUENCE: 4 gaaagttgat agaattaata tcactcatca tatatatgga gtcccaatgg caagaaaact     60 cattgtctga tctgaaaatg ttaatcaaag agttgaattg cggccaagaa ttcacacaca    120 agctaagaga tgtgataaaa caatctctag taaatggaga catgaatatg ttggctgaga    180 atttggtagg gcaaattatg ggttcatttt gtaagacttt gtcaatacta aacactagca    240 actccaatga agattctcag attccgatgg tggccgtttt tccttgtccg aaagacggac    300 ggacgtcgcc ggaagactca acgggcagtt gcaagaaatc atcagcaaaa gatcgaatag    360 gatgcaataa gaaaaggaaa atttcagcga aaaccgttaa agaaacctca actttggcgg    420 atgacggaca tgtttggaga aaatatggcc aaaaacaaat tcttgatgcc ccttatccaa    480 ggcattatta tagatgtacc aacaaatttg atcaaggatg tgaagcaatt aaacaagtgc    540 aaagaattca agacaatcca ccacagtttc ggacaatata ccaaggtcat cacacatgta    600 caacttaccc cacagcttcc caaatactct tagattcttc aacagattat gaaaattctt    660 caatcctact cagttttaat accaaggata atcattatta ccatccttat aattttccca    720 catttttttc aacaaaaaaa gaaactaaag aggaaaactc cccaagtttc ttctacccta    780 ataacaacca aaaccaaata tcaacttccg actatattct tccggccaat gattattgga    840 ctccggcaac tgaaacctcc ggcaatgtta tggcgacggc gttatcgtcg gcgtctgata    900 atgtggatta catctcatct gaatcagtta ctagcactca caatttggag atggagatgg    960 agatggagat ggagatgatg gcgggaattg actttgacga tttgcctttt gaattttaag   1020 ggtagatttt tctctcatat ttttttggga gtataggtag attcaggata agttcttgtg   1080 agttcaacta aattaattac tttcggggtt ctaactatgt atacataagt ataagttaaa   1140 ataatatata gtgtatacat gtaataaaat tagacttatt ttaga                   1185 <210> SEQ ID NO 5 <211> LENGTH: 3592 <212> TYPE: DNA <213> ORGANISM: Nicotiana tabacum <400> SEQUENCE: 5 gtggaacaag aaatacatag agagagaaat agggagagag atacgaaaaa aaatacacac     60 acagatagag agaaaaattc cgaaaaatat ttaagctttc aaaataaaaa taaaactaaa    120 aaaaatctac tgctttcttt ctttgtttga aattagtatt aatggttgtt gtttcattta    180 aagcttaaag cttttgtttt tgggattact actccaccgg tctgttactg ggttgttact    240 gttgctgggc agttgttgct attgtactgt cattattgct gctgattctc atcatcattt    300 tcttttgctt ccaatatcag gtacatatct gaaaattcat gtcatgaaaa gcttcaacat    360 ggcaagtaaa tgaagtttga ttataaggtt gttttctact catttaaatt ttattagttt    420 aaatttcatt tttgttttag ttggttaata tagtattaaa tcaattggta gattagttct    480 ctttcttaat aacaaatggc ttagttattt taggaacgcg atcaactcat ttcttttaat    540 atacgaaata atgtcaatga ttttttacaa aatatagagt tagtgtttgc agatattcgc    600 ataggtagaa tataagaatt ggtttattta tctcaaaccc aatcttcgta agcaaaatta    660 accaaacaat tataacctcg gactaaaaac aagtggtgta aaagaaggat gagatttata    720 gattgtaact ttttaagtca aaaaatgtgt aaatagtgtt tgctccaaat ataacaatga    780 aaattcttca aaaaatatta cttcatttat taaatcaatt gttttcctaa gttttatacg    840 caattcgctt tttgggtaga taaatattgt atttaccata aaaacggtag tattaatcac    900 acgttgttta tttttatttt atttttattt tactctttaa actcatggtt tttgaggaat    960 ataattcaca cgtaaaaaaa tataatttgc ggtcacttaa tgaattgtga attcttttca   1020 aggaatttag aggcatctca aatagtgatt tctcatgact cttacattta aaatagatgg   1080 atgcaataaa catttgtaga gaatttatat tactgtcaag aatatttgca taattaagga   1140 tgcgttcgcg tgacttgatt atacttctaa aggcgattcg gattatgcgt tcgcgcaact   1200 tcgagcaaat ttttaataaa aaggggttat tcggagatca tcaatattaa tttcatataa   1260 cctgagatgt gcagttcact atttaatcat acaagagcga cagacgttct taattttatt   1320 taagcacaat ttcgaactta agtctatttt tataataata aaaaaaattc gaaaataata   1380 ataattatat tatcaatatc attgtgtaca cgtgcgcgtg acacaactcc gcatgtttta   1440 aaaaatataa tttataacac gaatatacgt acgcgtgatt cgattcaaag aagggtcttt   1500 aaatctaaat agaagcggta acaataaaat catgcaataa aaatgtattt aacaaatcaa   1560 aataatcaag ccgaatataa cagttgagcg accgtgctag aaccacggaa ctcgggaatg   1620 cctaacacct tctcccgggt taacagaatt ccttatctgg atttctggtg cacagactgt   1680 taaatagaca gagtcatatt cttttcctcg attcgggatt aaaataggtg acttgggaca   1740 ccctaaatct cccaagtggc gactctgaaa taaagaaata aatcccgttt cgactgtact   1800 ttatttggaa aaaactccct tgcaccctcg cgggggcgga aaaaggaggt gtgacaatta   1860 gtatttggta ttagcatgct ggttataaaa cttacccttg gtaatacaaa taaactcatc   1920 ttttatttta ttcttaattg ttgttcttgt atagtattaa agttttcaaa taattattcg   1980 catgatttca aacatatttt tttcatttat gccatataac ttcaaagttt gaatttgtgc   2040 ttttgtgatg gcaataatga atctcctaat ccgagaaata gttgaaattg agaaacatta   2100 tgatctcaac aggtagaatc aataaagctt tgctagaact ttccccaaat gtttatcaag   2160 gcgaaattat agacaatatt gagttttaaa tgaaattagg cttttcttga ttcacttttt   2220 agcctctctg ttttaccact acactcacac acacacacac acacacacac acacacacac   2280 acatatatat atatatatat atatatattc ctttagcacc caactttgag acttattaaa   2340 aaaacaagaa aggataaacc aactcttctt gatacaccat attggtttaa ccaaagagaa   2400 aaaaaattct tccagctata attgagcaga aatggctatt taatcaaggg atgaaggaat   2460 acttttggag taaagtttgt attcagagga aggtggattg gtttgtatat aaatttaaaa   2520 aaaatgatat gaatatcctt ctcaaaaaat gatgtgaata tacttatgga ataaattctt   2580 ggtgtaagaa gttagaactt atggagaata tttctgttga aaggaatgct gacttaattg   2640 gtgttaatca tggaactgaa gacatctcta gagtttatgt tctttgtatt aagttgtact   2700 agttcctttg gtaaaataat tggctcacat tataaagctg gaaggaatac agtcactata   2760 aatatttcat ttacccttac cgcactaagc ctaacaataa aagcctgaaa aagtcataaa   2820 aagatcttaa aaatcaatgt tgattctata ttagtggaga ctgacatgaa gggcaagctt   2880 atgaacaaag tttgagaaac tcaaagattg tgatcataat gttatcaatc tcaaaaaaat   2940 tcatcaaaag gaggagaaaa agtttttgtc aaacaaaagc agagaaacac ggtaaagatt   3000 tggtgacttg aaaaacttat aggttttgaa tgttacgtga atttttattt tattactttt   3060 ctagtctaca agaaaaaata attactaata aaataattct cctcgaggac gagcaatgat   3120 tcaagtatgg gggagtttga tgaatataaa atattcatat attatatact taaaaatata   3180 ctattttaaa taaagtattt atataatatt tcgattctct gtattttcta acaatatttt   3240 gcaggagata agaatgctat taattaagca agaaaatgaa agaatcaaga agctcgtaac   3300 ggattcactc cataatgcaa gaagatcacg acgcatcttc ttcatgacgt atcttcctcg   3360 agatacatct tcctcaagac atattctcct caagatgcat cttcctcact tgagatcaca   3420 acacttcaag aagaaatgca cgtctataaa tagaaggcaa ttctctgtgt agtagacatc   3480 gaggaaaaag aaacaaaaga gccactttat tttctaaagc tttggtcact tattatttct   3540 tgttcttctt tcattactta taattttcag atttcctaga agtattggca aa           3592 <210> SEQ ID NO 6 <211> LENGTH: 2913 <212> TYPE: DNA <213> ORGANISM: Nicotiana tabacum <400> SEQUENCE: 6 ggagagctga gagatagcag cagaaaaggt cttcgattcc agcacttttc taaagtttct     60 ttggagcttc taatattact gaagagcttt tttctactaa aggtggccat cgtcggaatt    120 tcaatttgct accattaatt tgcaaggccc tcctcctccc gttccctttg tcctctcctc    180 tctcttctgc acatccaaat ccaacttccc taccgccatt ttccgcactt cgataactcg    240 ttaacccctc agtctctaat ttcttcctca ccccaaaaaa aaaaaaactt tcatttctct    300 gtcttctttc caaacttttt tcttcctccc ctgcttacac acaagaatct gtgatggatg    360 ccgcaaattt agtcatgaaa tcttccttgt tttcgaaatc cccatgtccc ctttttagtt    420 ctaaactcat tcctagagca ccaccctctg tctttactct gccttctacc tttagacccc    480 tcgttaaatg catacaagct tcattcccac caaaccctga ttccaaaaaa ccctcaaaca    540 attcaacctt tacgtgttca gctgtgactt ccttcccttc tcaacaatct cagcctcacg    600 cgccttccga tgccaagctc caactcctga tctctgaatt ccagtccctc gtcgaaccaa    660 tggaccgcgt gaaacgcctc ttgcactact ccacactcct ccctccaatg gacgcgtcct    720 tcaaaacccc tgagaatcgc gtaccgggtt gcactacaca ggtatggctg aacgtgagtt    780 tcgatgaggc tgagaacagg atgaaatttt tggcggacag tgactcggaa ataactaaag    840 ggttttgcgc gtgtttggtt tcgctgctgg acggggctac tcccgatgag gtgctggcgt    900 tgaaaacgga ggacttgaat gctttgaatg ttgcggggtt gaacgggaaa ggatcggcat    960 ctagggcgaa tacgtggcat aatgtgttgg tcagcatgca gaaaaggaca agggccttag   1020 ttgcggagcg tgaaggcagg ccgcgcggcg agctctttcc atctctagta atcacagctg   1080 atggtatcca accccaaggc agctacgctg aagcccaggc aaggttcctg tttcctgatg   1140 aatcaagggt ccaaaaactt gccaatttgc taaaggagaa gaaaatagga gttgttgctc   1200 atttctacat ggaccctgag gtgcaaggtg ttctaactgc agcgcagaag ctttggcccc   1260 atatacatat atctgattct ttagtcatgg ctgataaagc tgtcagtatg gcaaaagctg   1320 gatgtgaata tatatctgta ttgggtgtag atttcatgtc agagaatgtg cgagccattc   1380 ttgatctagc tggattccca gaggttggag tttatcggat gtcggacgaa cgcattggtt   1440 gttctttggc tgatgctgca gccagcccag catacttgga ttatcttaaa acagcttcaa   1500 cttcttctcc atctctgcat gttgtgtaca taaatacttc actggagaca aaagcatatt   1560 ctcatgagct tgttccgact ataacatgta cttcctctaa tgttgtgcaa actattctgc   1620 aggcatttgc tgaagtacct gacttggaag tgttgtatgg tcctgatacc tacatgggtt   1680 caaacattgc ggaattgttc acccagatgt ccacgatgac tgatgaagaa atttctgcga   1740 tacatccttt gcacaacaga atctccatta aatctttgct tcctcgactg cattattttc   1800 aggatgggac atgtattgtt catcacctct ttggtcatga agttgtggag aagataaatg   1860 aaatgtatgg ggatgcattc cttactgcac actttgaagt tcctggtgaa atgttttccc   1920 tggcaatgga agcgaagaaa aggggcatgg gagtagtagg ttctacctcg aacatactcg   1980 actttatcaa agaaagggta gaagagtcct tgaatagaaa cgtagatgaa catcttcagt   2040 ttgttttggg aacggaatca ggaatgatta cggcaatagt tgcagcagtc ggtaaattac   2100 taggttctgc tgactcctct tccggtggag caaaagtaag tgttgagatt gtctttcctg   2160 tctcgtcaga atcagtgaca agaacatcta cgggttcgcc tctggaccaa aataaggtca   2220 atattatacc tggagttgca agtggagagg ggtgttctct acatggtgga tgtgcctcct   2280 gtccatatat gaagatgaac tctcttagct cgttgctaaa agtttgccag agcttgcccc   2340 atggcaaagc cgaactttca gcttatgagg caggacgatt cagtttgcga acccccaagg   2400 gaaaacaaat tgcggatgtt ggttgtgagc cggttctgca catgagacac tttcaggcaa   2460 caaagagatt accagagcag ctaatcaatc aaatacttca acctcgtgat aatggacgat   2520 caagctctgc ttaaacaaga cgaaagctag acagacagtg gtatttactc gagacaaata   2580 aaagtttact tcccttcacc atacttggca agggaaggcc tagaggagca ttatgccagc   2640 ctcatttttt ctgcatagga catggattat acaggaattt tatgctgtgc acatgctttg   2700 gttgttccgt ttcttacctt tctttttatt tttacctggt ttaagtgtga ttgtaataga   2760 tggaggaaaa taatggttgt acttttgttt cccctacaaa atattgaagg tgtttgtatt   2820 cgttatgctt aaataagctt taaagctctt ttagttttgt tcttttttag tgtttggcaa   2880 tattgtcaaa tttattttgg ttgaccaatc aaa                                2913 <210> SEQ ID NO 7 <211> LENGTH: 2822 <212> TYPE: DNA <213> ORGANISM: Nicotiana tabacum <400> SEQUENCE: 7 gaagagctga gagattagca gcagataagg tcttcgattc cagttctaat attactgtag     60 agctttcttc tacaaaaggt ggccatcgtc ggaatttcaa tttgctacca ttaatttact    120 aggtcctcct cctccctttc cctctgtcct ctcctctctc ttctgcacat ccaaatccat    180 cttgcctacc gccattttcc gcacttcgag aactcgttaa cccctcactc tccaatttcg    240 tcctcaccca aaaaaaaaaa aaaaaaaacc ttgtcagttc tctgtcttct tttcaaactc    300 ttttcttctt tctcctctgc ttaaacacaa gaatctgtta tggacgccgc aaatttagtc    360 atgaaatctt ccatgttttc gaaatcccca tgtcccgttt ttggttctaa actcattcct    420 agagcaccac cctctgtctt tactctgcct tctaccttta gacccctcgt taaatgcata    480 caagcttcct tcccacaaaa ccctgattcc aaaataccct caaacaattc aacctttacg    540 tgttcagccg tgacttcttt cccttctcaa cagtctcagc ctcacgcgac ttccgatgcc    600 aagctccaac tcctgatctc ggaattccag tccctcgtcg aaccaatgga ccgcgtgaaa    660 cgcctcttgc actactccac actcatccct tcaatggatg cgtccctcaa aaccccagag    720 aatcgcgtgc tgggttgcac tacacaggta tggctgcacg tgagtttcga tgaggccgag    780 aacaggatga aatttgtggc ggacagtgac tcggatataa ctaaagggtt ttgcgcgtgt    840 ttggtttcgc tgctggacgg agctactcct gatgaggtgc tggcgttgaa aacggaggac    900 ttgaatgctt tgaatgttgc gggtttgaac gggaaaggat ctgcatctag ggcgaatacg    960 tggcataacg tgttggtcag catgcagaaa aggacaaggg ccttggtggc ggagcgtgaa   1020 ggcagaccgc gcaacgagct cttcccatct ctagtaatca ctgctgatgg tatccaaccc   1080 caaggcagct acgctgaagc ccaggcaagg ttcctgtttc ctgatgaatc aagagtccaa   1140 gaacttgcca gtttgctaaa ggagaagaaa ataggagttg ttgctcattt ctacatggac   1200 cctgaggtgc aaggtgttct aactgcagcg cagaagcttt ggccccatat acatatatct   1260 gattctttag tcatggctga taaagctgtc agtatggcaa aagctggatg tgaatatata   1320 tctgtattgg gtgtagattt catgtcagag aatgtgcgag ccattcttga tctagctgga   1380 ttcccagagg ttggagttta tcggatgtcg gatgaacgca tcggttgctc tttggctgat   1440 gctgcagcca gcccagcata cttggattat cttaaaacag cttcaacttc ttctccatct   1500 ctgcatgttg tgtacataaa tacttctctg gagacaaaag catattctca tgagcttgtt   1560 ccgactataa catgtacttc ctctaatgtt gtgcaaacta ttctgcaggc atttgctgaa   1620 gtacctgact tggaagtgtt gtatggtcct gatacctaca tgggttcaaa cattgcagaa   1680 ttgttcaccc agatgtccac gatgactgat gaagaaattt ctgagataca tcctttacac   1740 aacagaagct ccattaaatc tttgcttcct cgactccatt attttcagga tgggacatgt   1800 attgttcatc acctctttgg tcatgaagtt gtggagaaca taaatgaaat gtatggtgat   1860 gcattcctta ctgcacactt tgaagttcct ggtgaaatgt tttccctggc aatggaagcg   1920 aagaaaaggg gcatgggagt agtaggttct acctcgaaca tactcgattt tatcaaagaa   1980 agggtggaag aggccttgaa tagaaacgta gatgaacatc ttcagtttgt tttaggaacg   2040 gaatcaggaa tgattacggc aatagttgca gcagtcggta aattactagg ttctgctgac   2100 acctcttccg gtggagcaaa agtaagtgtt gagattgtct ttcctgtctc gtcggaatca   2160 gtgacaagaa catctaccgg ttcgtctctg gaccaaaata aggtcaatat tatacctgga   2220 gttgcaagtg gagagggatg ttctctacat ggtggctgtg cctcctgtcc atatatgaag   2280 atgaactctc ttagctcgtt gctaagagtt tgccagagct tgccccatgg caaagccgaa   2340 ctttcagctt atgaggcagg acgattcagt ttgcaaaccc ccaatggaaa acaaattgcg   2400 gatgttggtt gtgagccggt tctgcacatg agacactttc aggcaacaaa gagattacca   2460 gagcagctaa tcaatcaaat acttcaacga tcaagctccg cttaactaag acgaaagcta   2520 gatggaaagt ggtatttact tgagacaaat aaaagtttac ttcccttcac catacttggc   2580 cagggaaggc ctggaggagc attatgccag cctcattttt tctgcatagg acatggatta   2640 tacaggaatt ttatgctgtg cacatgcttt gattgttccg tttcttacct tttctttttc   2700 tttttacttt ggtttaagtg tgattgtaat agatggtgga aaataatgat tgtacttttg   2760 ttttccctac aaaatattga aggtgtttgt attggttctg gtcaaaaaaa aaaaaaaaat   2820 ag                                                                    2822 <210> SEQ ID NO 8 <211> LENGTH: 1232 <212> TYPE: DNA <213> ORGANISM: Nicotiana tabacum <400> SEQUENCE: 8 ggattcccgg gattttgaat tcttgaaata tttgaaatta aattcccttc cgcccgtctt     60 tacaaataat tatattacag tatatatctt gtttcactaa attaaatatc aaaaaatggc    120 cttaccacaa gagaattgca ctacacttga tttaattagg caacatcttc ttgatgataa    180 tgttttcatg gaacattatt gtccccaacc aattctttat tctcaaagct cctcctcttc    240 tgaatcttta aactccattg cttctgagct caataacgac actttctcct ttgaaccaac    300 tctcaactat gccgacacag cccaaagttc caatcttgat atctcaacct tctttaacaa    360 ttcaaaaaca gagtttgact gctttgagtt tgagacaaaa ccaaacgtgt tagctgctcg    420 tattagtcca aattctccga agcaaacaag cttcaaagaa cgcaagcctt ctctaaatat    480 tgctataccc ctgaagcatc aagaggttgt tcagaaagtg gaaaaatcca atgagagcga    540 gaagaagcat tacagaggag ttaggcaaag gccgtggggc aagttcgcgg cagagattcg    600 tgacccgaac cgaaagggga ctcgggtttg gttaggaacc tttgacactg ccttagaggc    660 ggctaaggca tatgacaggg cggcgtttga gcttagaggc agcaaagcta tagtgaattt    720 ccctctcgaa gttgcaaact ttaagcaaga atttaataat gagattcggc cattggtgaa    780 ctcaagcagg aaaagggtga gagaaacagt gaatgaggag caactagtta tcaataagga    840 aatgaaaata gaagaagaaa gagtcccgac ggctccatta acgccgtcaa tttggtcggc    900 aatttgggac agtggagatg ggaagggtat ttttgaagtg ccgccattat ctccacatat    960 ggcctattct cagcttgtca tgatataatc aataatggat aaggagtata taatttggga   1020 tgttagtatt tggaagatga tgaatatata aatatgcacc tgactatgaa gaaagtctga   1080 ggtgaaatca agaattaaga tgagattcaa taggaagatg tagaacaata aaatagtcca   1140 tggatgtgtc tttgggtctt taatcttttc tgattttatt gatttagcgt tatttcatgt   1200 aaatacgcag tgagtttaac aatttgttcg at                                 1232 <210> SEQ ID NO 9 <211> LENGTH: 1026 <212> TYPE: DNA <213> ORGANISM: Nicotiana tabacum <400> SEQUENCE: 9 ctttccctcg ttttattagc agatcaaaaa tggcctcacc acaagagaat tgcactacac     60 ttgatttgat aaggcagcat ctttttgatg atgctgcttt tatggaatat tactgctctg    120 aacctaccac cctttattcc caaaactcct cctcttctga atctctggac cagagtttct    180 cttttgaacc aactctcaac tatgccgaca cagcacaaag ttccagtttt gaaatctcta    240 gcttctttga caattcaaaa acagagtttg actgctctga gttggagaca attcaaaaac    300 agagtttgaa ttctcggaag caaacaagct tcaaagaacg caagccttct ctgaacattg    360 cgataccagt gaagcagcag aaagtggaag tagttccaag agggaagaag cattacagag    420 gagttaggca aaggccgtgg ggcaagttcg cagcagaaat tcgtgacccg aaccgaaagg    480 ggactcgggt ttggttagga acctttgaca ctgccttaga ggcggccaag gcatatgaca    540 gggcagcgtt taaacttaga ggaaacaaag caatagtgaa tttccctctc gaagttgcaa    600 actttaagca agaatataat aatgagattc cacagtcagc taactcaggc cggaaaaggg    660 tgagagaaac agagaatgag gagcaactcg ttatcaataa ggaaatgaaa atagaagaag    720 aaagagtccc tacgactcca ttaacgccgt caagttggtc ggcgatttgg gacagtggag    780 atgggaaggg tatatttgag atgccgctgc tttccccatt gtctccacat ttgccttatt    840 ctcagcttgt cattatataa tcaaaaggac accggtatat atacatatgc acctgaccgt    900 aaagaaagtc tgaggtgatt ccctgaattg ggattaggac tcaatagaag atgtgtagaa    960 gaggggtgtc tttgagtctt gaattctttt caatttcatt gattaagcgt taattcttgt   1020 aaatag                                                              1026 <210> SEQ ID NO 10 <211> LENGTH: 1355 <212> TYPE: DNA <213> ORGANISM: Nicotiana tabacum <400> SEQUENCE: 10 gatttctcca acccagaagg ctcctatgaa acctcttctc atctcaaaat tctgaccttt     60 ataactatcc tccccacact ctctttttcc actcaactca atactctccc cactttgaat    120 tctttcaaga atttaaatat atatagctga aattagattc ttcaactctc tttccctcgt    180 tttattagca gatcaaaaat ggcctcacca caagagaatt gcacacttga tttgataagg    240 cagcatcttt ttgatgatga tgcttttatg gaatgttact gctctgaacc taccaccctt    300 gattcccaaa actcctcctc ttctgaatct ctggaccaga gtttctcttt tgaaccaact    360 ctcaactatg ccgacacagc ccaaagttcc agttttgaaa tctctagctt ctttgacaat    420 tcaaaaacag agtttgactg ctttgagttg gagacaattc aaaaacagag tttgaattct    480 cggaagcaaa caagcttcaa agaacgcaag ccttctctga acattgcaat acctgtgaag    540 ctgcagaaag tggaagtagt tccaagcgag aagaagcatt acagaggagt taggcaaagg    600 ccgtggggca agttcgcagc agaaattcgt gacccgaacc gaaaggggac tcgggtttgg    660 ttaggaacgt ttgacactgc cattgaggcg gccaaggcat atgacagggc ggcgtttaag    720 cttagaggaa gcaaagcaat agtgaatttc cctctcgaag ttgcaaactt taagcaagaa    780 tataataatg agattccaca gtcggctaac tcaggccgga aaagggtgag aggaacagag    840 aatgaggagc aattagttat caataaggaa atgaaaagag aagaagaaag agtccctact    900 gcggcggctc cattaacgcc gtcaagttgg tcggcgattt gggacagcgg agacggaaaa    960 ggaatttttg aggtgccgcc tctttcccca ttgtctccac atatagggta ttctcaggtt   1020 gtgatgatat gatcagataa ggaacggcaa cgtatataga ttgtggtgtt agtatttagt   1080 agatgaagga taaatattgc acctgactgt aaaaagtctg tggtgattaa tttctcagcc   1140 aaaaaaagaa atatggggga aggtgggggt agctacggga attagtatgg tgataataaa   1200 gattggtgtc tggtctcctc cttaagtctt ttgattaaat tttattgttt atgtaaaaac   1260 gtcagtcaga gatctgtttg attgttttat atattcatat ctatgaaact atgaaagcat   1320 atacctacta aaacctacgt atttatttaa accca                              1355 <210> SEQ ID NO 11 <211> LENGTH: 261 <212> TYPE: DNA <213> ORGANISM: Nicotiana tabacum <400> SEQUENCE: 11 gatgatagtt tatctttgag aaaggctcta atagtatgca gagtgattgc tggtagggtg     60 catagacctt tggaaaatgt tcaagaattg attggtcaat cagggtttga ttcattggct    120 ggaaaagtag gactctactc aaatattgaa gaactctatt tgctcaattc taaagctttg    180 cttccttgtt ttgtggtaat ctgtaaatca taaaaaatac aaggtgattg agccattctt    240 tcatgtaatt caattgaagt t                                              261 <210> SEQ ID NO 12 <211> LENGTH: 725 <212> TYPE: DNA <213> ORGANISM: Nicotiana tabacum <400> SEQUENCE: 12 acatggggat tcatacttta ctgcaatatt acaactttta ctagatccaa cttcaatttc     60 ttgattcact aatactctat atttcttgat tccttatctc cctcttctat ctctctctct    120 ctataaaaga aaaactctat tcattggcag ctagcttttg atctgtagag tttgtggctg    180 aagttaaacg aagatgagaa gaaactgtaa cttggagctc aggcttatgc ctccttcttt    240 ttctttttct cctaagaatt gcactacccc ttacttctca acggataggg aggataaaga    300 aagcacagaa gagaaacaac cacagcagct aacaatattt tacaatggaa aatttgtggt    360 ttctgatgct actgaacttc aggctaaagc aataatatat ctggcaagta gagaaatgga    420 ggagaaaaca aaaatccggt caccaatttc agaatcatca tcaccaattt cagagccttc    480 atcaccattt ttacaatctc cagcttctga tctttctatg aagagatctc tacaaaggtt    540 tctgcagaag agaaaaaata gaattcaagc aacttctcct tatcatcact agtttagttc    600 catttgtaca tatattttgt aatttgcggg gagaaattgg aaaattggat tagtaagcaa    660 aacactagtg tatcacttaa ttttacagtt tcggcaatgc aattttttca taaaagggtg    720 ggcgc                                                                725 <210> SEQ ID NO 13 <211> LENGTH: 1490 <212> TYPE: DNA <213> ORGANISM: Nicotiana tabacum <400> SEQUENCE: 13 atgtgggtac tatttccctc acattttcct ttcacaataa acaaacttcc gcctcaaagc     60 cgaaaaacca gagctctcag ctctattttc tcttgctatt ttcaacaaac tgttaacgat    120 ctcgtcagct atttccgaaa tcctgaagtt ggagctagtt ttaagtgaaa ataatggaga    180 gagattttat gggtttgact catcatgtga agcaagaagt cactgaagaa cctatagatc    240 cagcacctct gagaagttca gcaatgcagt ggtcattctc gaacaacatc tcgactcatc    300 ctcaatacct ctctttcaag ggtgctcaag aggataggcc aaaaactggt tttgattctc    360 ttgcatcaac tggattggtg actataacca caactgaagc tgtcgactcg agtcatcgat    420 catactctgg tgtcgggcag aaaaatatga tgcttgaaaa gcaaggtgga acacactaca    480 tgtcgacaac tttctctcct catcactatg atgcacacgc catgcatcga tctcatggtg    540 tcagagtgct cccagtttcc aacccagcaa atcagatttc tgtatcaatg actatgcctg    600 gtcataagtc ctttgtttct cctcttggac agaatccagt tgctagcccc atttcagctg    660 ttccaactaa cagcgctgtc gtgggcacaa ctgatttaag gggtgctccg aaaactcccc    720 caggtcctgc tcagttgacc atcttttatg ctggttccgt ctgcgtttat gataatgttt    780 caccagagaa ggctcaagct attatgttgc ttgctggaaa tgcaccacct gttacgccaa    840 gtgcaacatc tgctctatct ccagttcagg cgcccatacc taagtcctct tctgttgact    900 cttttgttgt aaatcagtcc cataacacaa cacctactct ccccagcccc atttctataa    960 catcccattg tggatctcaa tctgctggag tgtctagtaa tacaaatgga gtaactatta   1020 tcaaatcaat tggggtccta ccatctcctt ctaataaagc agaactttct aaattttcca   1080 gttccatagg atctgttcct gccacctttg ttcaatcagc tgtaccacag gcacgcaagg   1140 catcattggc tcggttcttg gagaagcgca aagaaagggt aataagtgca tcaccttacg   1200 tcagctgcaa gcaatcccca gaatgcagca ctcttggata tggaagcaga agtttcgcaa   1260 aagattcttt aggctctttt cctcccccat gtaatcaatt tggtcaagga gacgtgaaat   1320 gccaacagtg gcaaaataat gtagacacaa ggtgaagact gtaccagatt agattattaa   1380 agctaaattg gtggtcgttt tgacttcaat acttcagttc tctcttagat gcgatatatt   1440 attttaggtt gttttccttg taattgtgat cagagccttt tcatctgaaa              1490 <210> SEQ ID NO 14 <211> LENGTH: 1078 <212> TYPE: DNA <213> ORGANISM: Nicotiana tabacum <400> SEQUENCE: 14 gacttaaaaa ttgccttctt tttcatctca tccatagttt cttgaattct tgtttttggg     60 atttcaactt ctatttcagc ttctatgtct ataccattcg aacatgatta tataggttta    120 tcagaagctt ctttaatgga aagaaattct gataaaaata gtgatgttct taaccttaag    180 gagactgagc taagacttgg gttaccgggt actgaggaaa caaatacggg tcttaaccct    240 tcaaacaatt ttatatcaag aaccaaaagg ggtttttctg atgccattga tgcttctgga    300 aaatgggatt tgtccattaa ttgcagatca gaaactgatt ggagaaaaga agacttgtta    360 ttttccccca aaggaagtaa tggaagctca aagccaactc catcaattga aaatagtgct    420 cctcagactt caaaggcaca agtagtagga tggccaccaa ttagatcatt ccgcaaaaat    480 acactggcca ccaaaaagaa tgatgctgaa ggaaaatcag gttcaggttg cctttatgtg    540 aaagttagaa tggatggtgc tccatatttg agaaaggttg atatcaaaac ttacagcgac    600 tatggggagc tctcatcagc acttgaaaag atgttcagct gctttagtat tgggcagtgc    660 gccagcgatg gacttccggg gcaagaggaa cttagtgaaa gtcacttgat ggatcttctc    720 aatggttctg agtatgttct gacttatgaa gacaaagatg gtgattggat gcttgttggc    780 gatgttcctt gggagatgtt catagactca tgcaagagat tgcggatcat gaaaagctca    840 gaggcaattg ggctagctcc aagggctata cacaagtgca agaacaaaaa ctagtgactg    900 aaaaaccatt caatggtttc tatgtcgatg attatccttt ttctgctctc ttttgtatct    960 ggaattagac tagacgtgta gcattccctg aaaggaaaag cactggttta agaagatata   1020 accggtgata tccaagattt ttgtttagtg tttagtgttc cctacggaaa aaaagaaa     1078 <210> SEQ ID NO 15 <211> LENGTH: 621 <212> TYPE: DNA <213> ORGANISM: Nicotiana tabacum <400> SEQUENCE: 15 cagaggataa aactccccaa cccagatgct ctccccaaat ccctaaatcc aacgtcagtg     60 atttttgcta tagtttataa aattaccaag aacgtcgtta cacgaattca acgtctcaac    120 cccgatttga gacttgatcc tcacatacta atcttctgtg ctcgtgcacc tggagaagct    180 tcctctccac accaagctga tattcaacca atcaattttc catctgatgg tagtaacaat    240 caaggtcgag agtcctccaa ataggctatc agctcagcgg aaggttttgc tgcgctccat    300 ttgctccgga gttgcttatg tggtcaatat gattaggaca tgtactgatt agtatgtcgg    360 ggccgtgtcc cgacctttat gacatttatg tactcttaga ggtttgtaga catatgtcga    420 atacgtgaaa gattgtacgg ccttgtcggc ctatgttttg agtttataaa tgatcatgtt    480 ggcctattag gcccgtatgt cacatgtata tgatgatgta ataagaaaga tacgttacgt    540 tggtactcgg ttgagtaagg taccgggtgc ccgtcgtggc ccatcggttt gagtcgtgac    600 acttctctgc ctcaaattca a                                              621 <210> SEQ ID NO 16 <211> LENGTH: 496 <212> TYPE: DNA <213> ORGANISM: Nicotiana tabacum <400> SEQUENCE: 16 gcttttagaa ttgggattaa agagtttttt acgactagag agagagagaa gcagaagctg     60 aaggagaaga gaatatcgga agaaggatga tacaccggaa atggagtttg ctaacaggcc    120 ccgctgcaat tctcggcggt atcgtcggta ctatcgtcgt cgccaatttt atcttcgtcc    180 aaaatgaccc gttccttaag cccgatcgga agcaggagaa ggcaccttca aacaagtgag    240 aaatgcgtgt gattttctct ggtttggggt tttctgttgg tttgatttgt cactacatta    300 cggcccaata aactcaaatt ttgagcatta gcttgaatgt aggttttctt ttgttggctt    360 tctttctgta ctctttctct tcacagaata tgaaagtatg ctccaaacaa gagtcctagg    420 ttgggaactg gtcatctcct gtttcgtgac gctttattca ggttatgaat agaataaaat    480 gtggagatgc gacaaa                                                    496 <210> SEQ ID NO 17 <211> LENGTH: 546 <212> TYPE: DNA <213> ORGANISM: Nicotiana tabacum <400> SEQUENCE: 17 gtgagagacg gaaagttcaa tccaccagca cagagaacaa gagaaatccc taaatggcga     60 cggcgatgtt cagatctagt attcgctccg ccctccgcag cggcgctcct cgtgtaactc    120 cggcttccaa gagaaccttc tcttctcact catccgttga ggaagaggcc cgtgaagcct    180 ctaagtggga gaaaattact tatgttggaa tagtttcctg ctctattctt gctgcgattt    240 gtctgtcaaa gggtcaccct cactctgatg agcctcctgc ttactcatat ctgcacattc    300 gcaacaagga gtttccatgg ggtccagatg ggctttttga ggtcaagcac cactgaaact    360 gcgtggtttc tctgtgaagg cgttaaaata attcctgtcc atccgcgagg atgatcacat    420 ttgttgaatt ttcattagat gtctactttt ggttctttgc ttataagaaa cctttgcctt    480 ttctttgaca tatttccatc ttttgctgta tacttacaat gtgctttaaa gaataagaat    540 tcagga                                                               546 <210> SEQ ID NO 18 <211> LENGTH: 537 <212> TYPE: PRT <213> ORGANISM: Nicotiana tabacum <400> SEQUENCE: 18 Met Glu Val Ala Phe Arg Lys Ser Ile Asn Gly Gly Leu Val Lys Glu  1               5                   10                  15       Glu Lys Arg Asn Lys Leu Ala Tyr Gln Ser Ser Ser Asp Glu Glu Gly              20                  25                  30           Phe Val Glu Asp Ser Asn Val Leu Lys Val Gly Lys Glu Arg Glu Val          35                  40                  45               His Glu Asp Asp Asn Ser Lys Tyr Pro Gln Gln Glu Asp Ile Asp Ser      50                  55                  60                   Asp Lys Glu Asp Asp Gln Leu Gln Ser Val Lys Ala Asp Met Lys Glu  65                  70                  75                  80   Val Met Lys Glu Asn Gln Arg Leu Lys Met His Leu Asp Arg Ile Met                  85                  90                  95       Lys Asp Tyr Arg Asn Leu Gln Leu Gln Phe His Asp Ile Val Gln Arg              100                 105                 110          Asn Ala Glu Lys Ser Asn Ser Ile Ile Asp Thr Asp Arg His Asn Glu          115                 120                 125                   Cys Asn Glu Ala Glu Phe Val Ser Leu Ser Leu Gly Arg Ser Ser Ser      130                 135                 140                  Asp Thr Lys Lys Glu Glu Tyr Leu Ser Lys Ile Leu Ser Lys Asp Lys  145                 150                 155                 160  Ala Glu Glu Glu Asn Lys Gly Gly Leu Thr Leu Gly Leu Asp Cys Lys                  165                 170                 175      Phe Asp Leu Cys Val Lys Thr Thr Pro Thr Glu Phe Ser Thr Ala Asn              180                 185                 190          Leu Ser Glu Glu Asn Arg Ser Glu Glu Val Lys Asp Glu Asn Gly Glu          195                 200                 205              Thr Leu Pro Pro His Lys Ile Leu Lys Thr Met Arg Asn Gly Glu Asp      210                 215                 220                  Asp Thr Gln Pro Asn Pro Ser Lys Arg Ala Lys Val Ser Val Arg Val  225                 230                 235                 240  Arg Cys Asp Ala Pro Thr Met Asn Asp Gly Cys Gln Trp Arg Lys Tyr                  245                 250                 255      Gly Gln Lys Ile Ala Lys Gly Asn Pro Cys Pro Arg Ala Tyr Tyr Arg              260                 265                 270          Cys Thr Val Ala Pro Ser Cys Pro Val Arg Lys Gln Val Gln Arg Cys          275                 280                 285              Ile Glu Asp Met Ser Ile Leu Ile Thr Thr Tyr Glu Gly Thr His Asn      290                 295                 300                  His Pro Leu Ser Leu Ser Ala Thr Ser Met Ala Ser Thr Thr Ser Ala  305                 310                 315                 320  Ala Ala Ser Met Leu Leu Ser Gly Ser Ser Ser Ser Ser Glu Ser Gly                  325                 330                 335      Pro Asn Pro Pro Ala Thr Asp Ala Thr Asn Ile Asn Gly Leu Asn Phe              340                 345                 350          Tyr Leu Ser Asp Ser Ser Lys Pro Lys Pro Phe Tyr Leu Gln Asn Ser          355                 360                 365               Ser Ile Ser Ser Ser Ser Ser Pro Pro Thr Ile Thr Leu Asp Leu Thr      370                 375                 380                  Ser Ser Ser Phe Thr Ser Leu Phe Pro His His Asn Arg Met Ser Ser  385                 390                 395                 400  Asn Tyr Leu Pro Arg Tyr Asn Ser Ser Thr Asn Ile Leu Asn Phe Ser                  405                 410                 415      Ser Leu Glu Ser Asn Pro Leu Leu Pro Met Ser Trp Ser Asn Gly Ala              420                 425                 430          Tyr Asn Lys Asn Gln Glu Ile Ser Ser Leu Asn Phe Ala Arg Arg Pro          435                 440                 445              Gln Asp Ile Leu Phe Gln Ser Tyr Leu Gln Asn Asn Ile Ser Ala Lys      450                 455                 460                  Pro Thr Gln Ser Leu Leu Pro Gln Asp Thr Ile Ala Ala Ala Thr Lys  465                 470                 475                 480  Ala Ile Thr Ser Asp Pro Asn Phe Gln Ser Ala Leu Ala Val Ala Leu                  485                 490                 495      Ala Ser Ile Ile Gly Ser Gly Ser Gly Asn His Ala Gly Gly Ile Glu              500                 505                 510          Glu Lys Ser Gly Leu Asn Leu Lys Val Thr Glu Pro Phe Pro Val Leu          515                 520                 525              Cys Ser Phe Pro Ser Thr Ser Lys Lys      530                 535          <210> SEQ ID NO 19 <211> LENGTH: 605 <212> TYPE: PRT <213> ORGANISM: Nicotiana tabacum <400> SEQUENCE: 19 Met Gly Thr Val Asn Met Ser Trp Ser Asp Glu Asp Lys Ala Thr Val  1               5                   10                  15       Ala Ala Val Leu Gly Lys Glu Ala Phe Glu Tyr Leu Ile Ser Ser Ser              20                  25                  30           Val Ser Ala Glu Cys Ser Leu Met Ala Ile Gly Asn Asp Gln Asn Leu          35                  40                  45               Gln Asn Lys Leu Ser Asp Leu Val Glu Arg Pro Asn Ala Thr Asn Phe      50                  55                  60                   Ser Trp Asn Tyr Ala Ile Phe Trp Gln Ile Ser Arg Ser Lys Ser Gly  65                  70                  75                  80   Glu Leu Val Leu Gly Trp Gly Asp Gly Cys Cys Arg Glu Pro Arg Glu                  85                  90                  95       Gly Glu Glu Arg Glu Val Lys Ser Ile Phe Asn Leu Arg Leu Glu Asp              100                 105                 110          Glu Ala Pro Gln Arg Met Arg Lys Arg Val Leu Gln Lys Leu His Met          115                 120                 125              Leu Phe Gly Gly Thr Asp Glu Asp Asn Tyr Ala Ile Gly Leu Asp Arg      130                 135                 140                  Val Thr Asp Thr Glu Ile Phe Phe Leu Ala Ser Met Tyr Phe Ser Phe  145                 150                 155                 160  Pro Arg Gly Glu Gly Gly Pro Gly Lys Cys Phe Gly Ser Gly Lys His                  165                 170                 175      Leu Trp Leu Ser Asp Ala Leu Lys Ser Pro Leu Asp Tyr Cys Ala Arg              180                 185                 190          Ser Phe Leu Ala Lys Ser Ala Gly Met Gln Thr Ile Val Leu Ile Pro          195                 200                 205              Thr Asp Val Gly Val Val Glu Leu Gly Ser Val Arg Ser Ile Pro Glu      210                 215                 220                  Ser Leu Glu Leu Leu His Ser Ile Lys Ser Cys Phe Ser Ser Phe Leu  225                 230                 235                 240  Val Arg Ala Lys Gln Ala Ala Gly Leu Ala Val Val Thr Glu Lys Lys                  245                 250                 255      Asp Gly Asn Asn Ser Pro Phe Ser Ser Ser Ala Phe Ser Glu Arg Pro              260                 265                 270          Asp Gly Ile Pro Lys Ile Phe Gly His Asp Leu Asn Ser Gly Thr His          275                 280                 285              Phe Arg Glu Lys Leu Ala Val Arg Lys Ala Glu Glu Arg Pro Trp Asp      290                 295                 300                  Ile Tyr Gln Asn Gly Thr Arg Met Pro Phe Met Asn Gly Arg Thr Gly  305                 310                 315                 320  Leu His Ala Ala Ser Trp Ala Gln Phe Ser Asn Val Lys Pro Val Lys                  325                 330                 335      Pro Val Glu Leu Tyr Ser Pro Gln Thr Pro Pro Ala His Asn Leu Gln              340                 345                 350          Glu Leu Val Asn Gly Gly Arg Glu Glu Phe Arg Leu Asn Asn Phe Gln          355                 360                 365              His Gln Lys Pro Ala Arg Met Gln Ile Asp Phe Thr Gly Ala Thr Ser      370                 375                 380                  Arg Pro Ile Ile Ser Pro Ala His Thr Val Glu Ser Glu His Ser Asp  385                 390                 395                 400  Val Glu Ala Ser Cys Lys Glu Asp Cys Ala Gly Pro Val Asp Glu Lys                  405                 410                 415      Arg Pro Arg Lys Arg Gly Arg Lys Pro Ala Asn Gly Arg Glu Glu Pro              420                 425                 430          Leu Asn His Val Glu Ala Glu Arg Gln Arg Arg Glu Lys Leu Asn Gln          435                 440                 445              Arg Phe Tyr Ala Leu Arg Ala Val Val Pro Asn Ile Ser Lys Met Asp      450                 455                 460                  Lys Ala Ser Leu Leu Gly Asp Ala Ile Ala Tyr Ile Thr Glu Met Gln  465                 470                 475                 480  Lys Lys Leu Arg Asp Met Glu Ser Glu Arg Glu Leu Arg Leu Gly Ser                  485                 490                 495      Thr Ser Arg Asp Ala Met Ala Ala Glu Asp Ser Pro Asn Ser Glu Ile              500                 505                 510          Gln Ile Arg Gly Pro Asp Ile Asn Val Glu Ala Ala Asn Asp Glu Val          515                 520                 525              Ile Val Arg Val Ser Cys Pro Leu Glu Thr His Pro Ile Ser Arg Val      530                 535                 540                  Ile Gln Thr Phe Lys Asp Ala Gln Ile Asn Val Val Glu Ser Lys Leu  545                 550                 555                 560  Ser Ala Gly Asn Gly Thr Val Phe His Thr Phe Val Leu Lys Ser Ser                  565                 570                 575      Gly Ser Glu Gln Leu Thr Lys Glu Lys Leu Leu Ala Ala Phe Ser Ser              580                 585                 590          Glu Ser Asp Ser Leu Arg Gln Phe Ser Pro Val Gly Gln          595                 600                 605  <210> SEQ ID NO 20 <211> LENGTH: 305 <212> TYPE: PRT <213> ORGANISM: Nicotiana tabacum <400> SEQUENCE: 20 Met Gly Arg Pro Pro Cys Cys Asp Lys Ile Gly Val Lys Lys Gly Pro  1               5                   10                  15       Trp Thr Pro Glu Glu Asp Ile Met Leu Val Ser Tyr Val Gln Glu His              20                  25                  30           Gly Pro Gly Asn Trp Arg Ala Val Pro Thr Asn Thr Gly Leu Arg Arg          35                  40                  45               Cys Ser Lys Ser Cys Arg Leu Arg Trp Thr Asn Tyr Leu Arg Pro Gly      50                  55                  60                   Ile Lys Arg Gly Ser Phe Thr Asp Gln Glu Glu Lys Met Ile Ile Gln  65                  70                  75                  80   Leu Gln Ala Leu Leu Gly Asn Lys Trp Ala Ala Ile Ala Ser Tyr Leu                  85                  90                  95       Pro Glu Arg Thr Asp Asn Asp Val Lys Asn Tyr Trp Asn Thr His Leu              100                 105                 110          Lys Lys Lys Leu Lys Lys Leu Glu Ser Ser Asp Leu Tyr Ser Lys Asp          115                 120                 125              Gly Ser Cys Leu Ser Pro Ser Asn Ser Thr Ser Arg Gly Gln Trp Glu      130                 135                 140                  Arg Thr Leu Gln Thr Asp Ile Asn Thr Ala Lys Gln Ala Leu Gln Asn  145                 150                 155                 160  Ala Leu Ser Leu Asp Lys Ser Ser Pro Ile Pro Glu Tyr Thr Thr Thr                  165                 170                 175      Asp Val Lys Pro Ile Asn Leu Gly Cys Tyr Ser Tyr Ile Lys Gln Glu              180                 185                 190          Gly Lys Val Ser Thr Ser Thr Tyr Ala Ser Ser Ala Glu Asn Ile Ala          195                 200                 205              Lys Leu Leu Lys Gln Trp Thr Arg Ser Asp Ser Thr Asn Ile Ser Glu      210                 215                 220                  Gln Ser Lys Ala Ser Ser Ser Thr Gln Leu Ser Ser Asn Asn Asn Ala  225                 230                 235                 240  Thr Thr Glu Glu Phe Glu Ser Leu Ser Ser Phe Asp Ser Phe Glu Gln                  245                 250                 255      Ser Asn Ser Asp Gln Phe Ser Gln Ser Leu Thr Leu Glu Ala Gly Lys              260                 265                 270          Leu His Cys Glu Ile Ser Lys Arg Glu Val Asp Asp Gln Val Pro Leu          275                 280                 285              Ser Val Met Leu Glu Ser Trp Leu Phe Asp Glu Asn Asp Asp Leu Leu      290                 295                 300                  Ile  305  <210> SEQ ID NO 21 <211> LENGTH: 327 <212> TYPE: PRT <213> ORGANISM: Nicotiana tabacum <400> SEQUENCE: 21 Met Glu Ser Gln Trp Gln Glu Asn Ser Leu Ser Asp Leu Lys Met Leu  1               5                   10                  15       Ile Lys Glu Leu Asn Cys Gly Gln Glu Phe Thr His Lys Leu Arg Asp              20                  25                  30           Val Ile Lys Gln Ser Leu Val Asn Gly Asp Met Asn Met Leu Ala Glu          35                  40                  45               Asn Leu Val Gly Gln Ile Met Gly Ser Phe Cys Lys Thr Leu Ser Ile      50                  55                  60                   Leu Asn Thr Ser Asn Ser Asn Glu Asp Ser Gln Ile Pro Met Val Ala  65                  70                  75                  80   Val Phe Pro Cys Pro Lys Asp Gly Arg Thr Ser Pro Glu Asp Ser Thr                  85                  90                  95       Gly Ser Cys Lys Lys Ser Ser Ala Lys Asp Arg Ile Gly Cys Asn Lys              100                 105                 110          Lys Arg Lys Ile Ser Ala Lys Thr Val Lys Glu Thr Ser Thr Leu Ala          115                 120                 125              Asp Asp Gly His Val Trp Arg Lys Tyr Gly Gln Lys Gln Ile Leu Asp      130                 135                 140                  Ala Pro Tyr Pro Arg His Tyr Tyr Arg Cys Thr Asn Lys Phe Asp Gln  145                 150                 155                 160  Gly Cys Glu Ala Ile Lys Gln Val Gln Arg Ile Gln Asp Asn Pro Pro                  165                 170                 175      Gln Phe Arg Thr Ile Tyr Gln Gly His His Thr Cys Thr Thr Tyr Pro              180                 185                 190          Thr Ala Ser Gln Ile Leu Leu Asp Ser Ser Thr Asp Tyr Glu Asn Ser          195                 200                 205              Ser Ile Leu Leu Ser Phe Asn Thr Lys Asp Asn His Tyr Tyr His Pro      210                 215                 220                  Tyr Asn Phe Pro Thr Phe Phe Ser Thr Lys Lys Glu Thr Lys Glu Glu  225                 230                 235                 240  Asn Ser Pro Ser Phe Phe Tyr Pro Asn Asn Asn Gln Asn Gln Ile Ser                  245                 250                 255      Thr Ser Asp Tyr Ile Leu Pro Ala Asn Asp Tyr Trp Thr Pro Ala Thr              260                 265                 270          Glu Thr Ser Gly Asn Val Met Ala Thr Ala Leu Ser Ser Ala Ser Asp          275                 280                 285              Asn Val Asp Tyr Ile Ser Ser Glu Ser Val Thr Ser Thr His Asn Leu      290                 295                 300                  Glu Met Glu Met Glu Met Glu Met Glu Met Met Ala Gly Ile Asp Phe  305                 310                 315                 320  Asp Asp Leu Pro Phe Glu Phe                  325          <210> SEQ ID NO 22 <211> LENGTH: 726 <212> TYPE: PRT <213> ORGANISM: Nicotiana tabacum <400> SEQUENCE: 22 Met Asp Ala Ala Asn Leu Val Met Lys Ser Ser Leu Phe Ser Lys Ser  1               5                   10                  15       Pro Cys Pro Leu Phe Ser Ser Lys Leu Ile Pro Arg Ala Pro Pro Ser              20                  25                  30           Val Phe Thr Leu Pro Ser Thr Phe Arg Pro Leu Val Lys Cys Ile Gln          35                  40                  45               Ala Ser Phe Pro Pro Asn Pro Asp Ser Lys Lys Pro Ser Asn Asn Ser      50                  55                  60                   Thr Phe Thr Cys Ser Ala Val Thr Ser Phe Pro Ser Gln Gln Ser Gln  65                  70                  75                  80   Pro His Ala Pro Ser Asp Ala Lys Leu Gln Leu Leu Ile Ser Glu Phe                  85                  90                  95       Gln Ser Leu Val Glu Pro Met Asp Arg Val Lys Arg Leu Leu His Tyr              100                 105                 110          Ser Thr Leu Leu Pro Pro Met Asp Ala Ser Phe Lys Thr Pro Glu Asn          115                 120                 125              Arg Val Pro Gly Cys Thr Thr Gln Val Trp Leu Asn Val Ser Phe Asp      130                 135                 140                  Glu Ala Glu Asn Arg Met Lys Phe Leu Ala Asp Ser Asp Ser Glu Ile  145                 150                 155                 160  Thr Lys Gly Phe Cys Ala Cys Leu Val Ser Leu Leu Asp Gly Ala Thr                  165                 170                 175      Pro Asp Glu Val Leu Ala Leu Lys Thr Glu Asp Leu Asn Ala Leu Asn              180                 185                 190          Val Ala Gly Leu Asn Gly Lys Gly Ser Ala Ser Arg Ala Asn Thr Trp          195                 200                 205              His Asn Val Leu Val Ser Met Gln Lys Arg Thr Arg Ala Leu Val Ala      210                 215                 220                  Glu Arg Glu Gly Arg Pro Arg Gly Glu Leu Phe Pro Ser Leu Val Ile  225                 230                 235                 240  Thr Ala Asp Gly Ile Gln Pro Gln Gly Ser Tyr Ala Glu Ala Gln Ala                  245                 250                 255      Arg Phe Leu Phe Pro Asp Glu Ser Arg Val Gln Lys Leu Ala Asn Leu              260                 265                 270          Leu Lys Glu Lys Lys Ile Gly Val Val Ala His Phe Tyr Met Asp Pro          275                 280                 285              Glu Val Gln Gly Val Leu Thr Ala Ala Gln Lys Leu Trp Pro His Ile      290                 295                 300                  His Ile Ser Asp Ser Leu Val Met Ala Asp Lys Ala Val Ser Met Ala  305                 310                 315                 320  Lys Ala Gly Cys Glu Tyr Ile Ser Val Leu Gly Val Asp Phe Met Ser                  325                 330                 335      Glu Asn Val Arg Ala Ile Leu Asp Leu Ala Gly Phe Pro Glu Val Gly              340                 345                 350          Val Tyr Arg Met Ser Asp Glu Arg Ile Gly Cys Ser Leu Ala Asp Ala          355                 360                 365              Ala Ala Ser Pro Ala Tyr Leu Asp Tyr Leu Lys Thr Ala Ser Thr Ser      370                 375                 380                  Ser Pro Ser Leu His Val Val Tyr Ile Asn Thr Ser Leu Glu Thr Lys  385                 390                 395                 400  Ala Tyr Ser His Glu Leu Val Pro Thr Ile Thr Cys Thr Ser Ser Asn                  405                 410                 415      Val Val Gln Thr Ile Leu Gln Ala Phe Ala Glu Val Pro Asp Leu Glu              420                 425                 430          Val Leu Tyr Gly Pro Asp Thr Tyr Met Gly Ser Asn Ile Ala Glu Leu          435                 440                 445              Phe Thr Gln Met Ser Thr Met Thr Asp Glu Glu Ile Ser Ala Ile His      450                 455                 460                  Pro Leu His Asn Arg Ile Ser Ile Lys Ser Leu Leu Pro Arg Leu His  465                 470                 475                 480  Tyr Phe Gln Asp Gly Thr Cys Ile Val His His Leu Phe Gly His Glu                  485                 490                 495      Val Val Glu Lys Ile Asn Glu Met Tyr Gly Asp Ala Phe Leu Thr Ala              500                 505                 510          His Phe Glu Val Pro Gly Glu Met Phe Ser Leu Ala Met Glu Ala Lys          515                 520                 525              Lys Arg Gly Met Gly Val Val Gly Ser Thr Ser Asn Ile Leu Asp Phe      530                 535                 540                  Ile Lys Glu Arg Val Glu Glu Ser Leu Asn Arg Asn Val Asp Glu His  545                 550                 555                 560  Leu Gln Phe Val Leu Gly Thr Glu Ser Gly Met Ile Thr Ala Ile Val                  565                 570                 575      Ala Ala Val Gly Lys Leu Leu Gly Ser Ala Asp Ser Ser Ser Gly Gly              580                 585                 590          Ala Lys Val Ser Val Glu Ile Val Phe Pro Val Ser Ser Glu Ser Val          595                 600                 605              Thr Arg Thr Ser Thr Gly Ser Pro Leu Asp Gln Asn Lys Val Asn Ile      610                 615                 620                  Ile Pro Gly Val Ala Ser Gly Glu Gly Cys Ser Leu His Gly Gly Cys  625                 630                 635                 640  Ala Ser Cys Pro Tyr Met Lys Met Asn Ser Leu Ser Ser Leu Leu Lys                  645                 650                 655      Val Cys Gln Ser Leu Pro His Gly Lys Ala Glu Leu Ser Ala Tyr Glu              660                 665                 670          Ala Gly Arg Phe Ser Leu Arg Thr Pro Lys Gly Lys Gln Ile Ala Asp          675                 680                 685              Val Gly Cys Glu Pro Val Leu His Met Arg His Phe Gln Ala Thr Lys      690                 695                 700                  Arg Leu Pro Glu Gln Leu Ile Asn Gln Ile Leu Gln Pro Arg Asp Asn  705                 710                 715                 720  Gly Arg Ser Ser Ser Ala                  725      <210> SEQ ID NO 23 <211> LENGTH: 721 <212> TYPE: PRT <213> ORGANISM: Nicotiana tabacum <400> SEQUENCE: 23 Met Asp Ala Ala Asn Leu Val Met Lys Ser Ser Met Phe Ser Lys Ser  1               5                   10                  15       Pro Cys Pro Val Phe Gly Ser Lys Leu Ile Pro Arg Ala Pro Pro Ser              20                  25                  30           Val Phe Thr Leu Pro Ser Thr Phe Arg Pro Leu Val Lys Cys Ile Gln          35                  40                  45               Ala Ser Phe Pro Gln Asn Pro Asp Ser Lys Ile Pro Ser Asn Asn Ser      50                  55                  60                   Thr Phe Thr Cys Ser Ala Val Thr Ser Phe Pro Ser Gln Gln Ser Gln  65                  70                  75                  80   Pro His Ala Thr Ser Asp Ala Lys Leu Gln Leu Leu Ile Ser Glu Phe                  85                  90                  95       Gln Ser Leu Val Glu Pro Met Asp Arg Val Lys Arg Leu Leu His Tyr              100                 105                 110          Ser Thr Leu Ile Pro Ser Met Asp Ala Ser Leu Lys Thr Pro Glu Asn          115                 120                 125              Arg Val Leu Gly Cys Thr Thr Gln Val Trp Leu His Val Ser Phe Asp      130                 135                 140                  Glu Ala Glu Asn Arg Met Lys Phe Val Ala Asp Ser Asp Ser Asp Ile  145                 150                 155                 160  Thr Lys Gly Phe Cys Ala Cys Leu Val Ser Leu Leu Asp Gly Ala Thr                  165                 170                 175      Pro Asp Glu Val Leu Ala Leu Lys Thr Glu Asp Leu Asn Ala Leu Asn              180                 185                 190          Val Ala Gly Leu Asn Gly Lys Gly Ser Ala Ser Arg Ala Asn Thr Trp          195                 200                 205              His Asn Val Leu Val Ser Met Gln Lys Arg Thr Arg Ala Leu Val Ala      210                 215                 220                  Glu Arg Glu Gly Arg Pro Arg Asn Glu Leu Phe Pro Ser Leu Val Ile  225                 230                 235                 240  Thr Ala Asp Gly Ile Gln Pro Gln Gly Ser Tyr Ala Glu Ala Gln Ala                  245                 250                 255      Arg Phe Leu Phe Pro Asp Glu Ser Arg Val Gln Glu Leu Ala Ser Leu              260                 265                 270          Leu Lys Glu Lys Lys Ile Gly Val Val Ala His Phe Tyr Met Asp Pro          275                 280                 285              Glu Val Gln Gly Val Leu Thr Ala Ala Gln Lys Leu Trp Pro His Ile      290                 295                 300                  His Ile Ser Asp Ser Leu Val Met Ala Asp Lys Ala Val Ser Met Ala  305                 310                 315                 320  Lys Ala Gly Cys Glu Tyr Ile Ser Val Leu Gly Val Asp Phe Met Ser                  325                 330                 335      Glu Asn Val Arg Ala Ile Leu Asp Leu Ala Gly Phe Pro Glu Val Gly              340                 345                 350          Val Tyr Arg Met Ser Asp Glu Arg Ile Gly Cys Ser Leu Ala Asp Ala          355                 360                 365              Ala Ala Ser Pro Ala Tyr Leu Asp Tyr Leu Lys Thr Ala Ser Thr Ser      370                 375                 380                  Ser Pro Ser Leu His Val Val Tyr Ile Asn Thr Ser Leu Glu Thr Lys  385                 390                 395                 400  Ala Tyr Ser His Glu Leu Val Pro Thr Ile Thr Cys Thr Ser Ser Asn                  405                 410                 415      Val Val Gln Thr Ile Leu Gln Ala Phe Ala Glu Val Pro Asp Leu Glu              420                 425                 430          Val Leu Tyr Gly Pro Asp Thr Tyr Met Gly Ser Asn Ile Ala Glu Leu          435                 440                 445              Phe Thr Gln Met Ser Thr Met Thr Asp Glu Glu Ile Ser Glu Ile His      450                 455                 460                  Pro Leu His Asn Arg Ser Ser Ile Lys Ser Leu Leu Pro Arg Leu His  465                 470                 475                 480  Tyr Phe Gln Asp Gly Thr Cys Ile Val His His Leu Phe Gly His Glu                  485                 490                 495      Val Val Glu Asn Ile Asn Glu Met Tyr Gly Asp Ala Phe Leu Thr Ala              500                 505                 510          His Phe Glu Val Pro Gly Glu Met Phe Ser Leu Ala Met Glu Ala Lys          515                 520                 525              Lys Arg Gly Met Gly Val Val Gly Ser Thr Ser Asn Ile Leu Asp Phe      530                 535                 540                  Ile Lys Glu Arg Val Glu Glu Ala Leu Asn Arg Asn Val Asp Glu His  545                 550                 555                 560  Leu Gln Phe Val Leu Gly Thr Glu Ser Gly Met Ile Thr Ala Ile Val                  565                 570                 575      Ala Ala Val Gly Lys Leu Leu Gly Ser Ala Asp Thr Ser Ser Gly Gly              580                 585                 590          Ala Lys Val Ser Val Glu Ile Val Phe Pro Val Ser Ser Glu Ser Val          595                 600                 605              Thr Arg Thr Ser Thr Gly Ser Ser Leu Asp Gln Asn Lys Val Asn Ile      610                 615                 620                  Ile Pro Gly Val Ala Ser Gly Glu Gly Cys Ser Leu His Gly Gly Cys  625                 630                 635                 640  Ala Ser Cys Pro Tyr Met Lys Met Asn Ser Leu Ser Ser Leu Leu Arg                  645                 650                 655      Val Cys Gln Ser Leu Pro His Gly Lys Ala Glu Leu Ser Ala Tyr Glu              660                 665                 670          Ala Gly Arg Phe Ser Leu Gln Thr Pro Asn Gly Lys Gln Ile Ala Asp          675                 680                 685              Val Gly Cys Glu Pro Val Leu His Met Arg His Phe Gln Ala Thr Lys      690                 695                 700                  Arg Leu Pro Glu Gln Leu Ile Asn Gln Ile Leu Gln Arg Ser Ser Ser  705                 710                 715                 720  Ala  <210> SEQ ID NO 24 <211> LENGTH: 290 <212> TYPE: PRT <213> ORGANISM: Nicotiana tabacum <400> SEQUENCE: 24 Met Ala Leu Pro Gln Glu Asn Cys Thr Thr Leu Asp Leu Ile Arg Gln  1               5                   10                  15       His Leu Leu Asp Asp Asn Val Phe Met Glu His Tyr Cys Pro Gln Pro              20                  25                  30           Ile Leu Tyr Ser Gln Ser Ser Ser Ser Ser Glu Ser Leu Asn Ser Ile          35                  40                  45               Ala Ser Glu Leu Asn Asn Asp Thr Phe Ser Phe Glu Pro Thr Leu Asn      50                  55                  60                   Tyr Ala Asp Thr Ala Gln Ser Ser Asn Leu Asp Ile Ser Thr Phe Phe  65                  70                  75                  80   Asn Asn Ser Lys Thr Glu Phe Asp Cys Phe Glu Phe Glu Thr Lys Pro                  85                  90                  95       Asn Val Leu Ala Ala Arg Ile Ser Pro Asn Ser Pro Lys Gln Thr Ser              100                 105                 110          Phe Lys Glu Arg Lys Pro Ser Leu Asn Ile Ala Ile Pro Leu Lys His          115                 120                 125              Gln Glu Val Val Gln Lys Val Glu Lys Ser Asn Glu Ser Glu Lys Lys      130                 135                 140                  His Tyr Arg Gly Val Arg Gln Arg Pro Trp Gly Lys Phe Ala Ala Glu  145                 150                 155                 160  Ile Arg Asp Pro Asn Arg Lys Gly Thr Arg Val Trp Leu Gly Thr Phe                  165                 170                 175      Asp Thr Ala Leu Glu Ala Ala Lys Ala Tyr Asp Arg Ala Ala Phe Glu              180                 185                 190          Leu Arg Gly Ser Lys Ala Ile Val Asn Phe Pro Leu Glu Val Ala Asn          195                 200                 205              Phe Lys Gln Glu Phe Asn Asn Glu Ile Arg Pro Leu Val Asn Ser Ser      210                 215                 220                  Arg Lys Arg Val Arg Glu Thr Val Asn Glu Glu Gln Leu Val Ile Asn  225                 230                 235                 240  Lys Glu Met Lys Ile Glu Glu Glu Arg Val Pro Thr Ala Pro Leu Thr                  245                 250                 255      Pro Ser Ile Trp Ser Ala Ile Trp Asp Ser Gly Asp Gly Lys Gly Ile              260                 265                 270          Phe Glu Val Pro Pro Leu Ser Pro His Met Ala Tyr Ser Gln Leu Val          275                 280                 285              Met Ile      290  <210> SEQ ID NO 25 <211> LENGTH: 276 <212> TYPE: PRT <213> ORGANISM: Nicotiana tabacum <400> SEQUENCE: 25 Met Ala Ser Pro Gln Glu Asn Cys Thr Thr Leu Asp Leu Ile Arg Gln  1               5                   10                  15       His Leu Phe Asp Asp Ala Ala Phe Met Glu Tyr Tyr Cys Ser Glu Pro              20                  25                  30           Thr Thr Leu Tyr Ser Gln Asn Ser Ser Ser Ser Glu Ser Leu Asp Gln          35                  40                  45               Ser Phe Ser Phe Glu Pro Thr Leu Asn Tyr Ala Asp Thr Ala Gln Ser      50                  55                  60                   Ser Ser Phe Glu Ile Ser Ser Phe Phe Asp Asn Ser Lys Thr Glu Phe  65                  70                  75                  80   Asp Cys Ser Glu Leu Glu Thr Ile Gln Lys Gln Ser Leu Asn Ser Arg                  85                  90                  95       Lys Gln Thr Ser Phe Lys Glu Arg Lys Pro Ser Leu Asn Ile Ala Ile              100                 105                 110          Pro Val Lys Gln Gln Lys Val Glu Val Val Pro Arg Gly Lys Lys His          115                 120                 125              Tyr Arg Gly Val Arg Gln Arg Pro Trp Gly Lys Phe Ala Ala Glu Ile      130                 135                 140                  Arg Asp Pro Asn Arg Lys Gly Thr Arg Val Trp Leu Gly Thr Phe Asp  145                 150                 155                 160  Thr Ala Leu Glu Ala Ala Lys Ala Tyr Asp Arg Ala Ala Phe Lys Leu                  165                 170                 175      Arg Gly Asn Lys Ala Ile Val Asn Phe Pro Leu Glu Val Ala Asn Phe              180                 185                 190          Lys Gln Glu Tyr Asn Asn Glu Ile Pro Gln Ser Ala Asn Ser Gly Arg          195                 200                 205              Lys Arg Val Arg Glu Thr Glu Asn Glu Glu Gln Leu Val Ile Asn Lys      210                 215                 220                  Glu Met Lys Ile Glu Glu Glu Arg Val Pro Thr Thr Pro Leu Thr Pro  225                 230                 235                 240  Ser Ser Trp Ser Ala Ile Trp Asp Ser Gly Asp Gly Lys Gly Ile Phe                  245                 250                 255      Glu Met Pro Leu Leu Ser Pro Leu Ser Pro His Leu Pro Tyr Ser Gln              260                 265                 270          Leu Val Ile Ile          275      <210> SEQ ID NO 26 <211> LENGTH: 277 <212> TYPE: PRT <213> ORGANISM: Nicotiana tabacum <400> SEQUENCE: 26 Met Ala Ser Pro Gln Glu Asn Cys Thr Leu Asp Leu Ile Arg Gln His  1               5                   10                  15       Leu Phe Asp Asp Asp Ala Phe Met Glu Cys Tyr Cys Ser Glu Pro Thr              20                  25                  30           Thr Leu Asp Ser Gln Asn Ser Ser Ser Ser Glu Ser Leu Asp Gln Ser          35                  40                  45               Phe Ser Phe Glu Pro Thr Leu Asn Tyr Ala Asp Thr Ala Gln Ser Ser      50                  55                  60                   Ser Phe Glu Ile Ser Ser Phe Phe Asp Asn Ser Lys Thr Glu Phe Asp  65                  70                  75                  80   Cys Phe Glu Leu Glu Thr Ile Gln Lys Gln Ser Leu Asn Ser Arg Lys                  85                  90                  95       Gln Thr Ser Phe Lys Glu Arg Lys Pro Ser Leu Asn Ile Ala Ile Pro              100                 105                 110          Val Lys Leu Gln Lys Val Glu Val Val Pro Ser Glu Lys Lys His Tyr          115                 120                 125              Arg Gly Val Arg Gln Arg Pro Trp Gly Lys Phe Ala Ala Glu Ile Arg      130                 135                 140                  Asp Pro Asn Arg Lys Gly Thr Arg Val Trp Leu Gly Thr Phe Asp Thr  145                 150                 155                 160  Ala Ile Glu Ala Ala Lys Ala Tyr Asp Arg Ala Ala Phe Lys Leu Arg                  165                 170                 175      Gly Ser Lys Ala Ile Val Asn Phe Pro Leu Glu Val Ala Asn Phe Lys              180                 185                 190          Gln Glu Tyr Asn Asn Glu Ile Pro Gln Ser Ala Asn Ser Gly Arg Lys          195                 200                 205              Arg Val Arg Gly Thr Glu Asn Glu Glu Gln Leu Val Ile Asn Lys Glu      210                 215                 220                  Met Lys Arg Glu Glu Glu Arg Val Pro Thr Ala Ala Ala Pro Leu Thr  225                 230                 235                 240  Pro Ser Ser Trp Ser Ala Ile Trp Asp Ser Gly Asp Gly Lys Gly Ile                  245                 250                 255      Phe Glu Val Pro Pro Leu Ser Pro Leu Ser Pro His Ile Gly Tyr Ser              260                 265                 270          Gln Val Val Met Ile          275          <210> SEQ ID NO 27 <211> LENGTH: 70 <212> TYPE: PRT <213> ORGANISM: Nicotiana tabacum <400> SEQUENCE: 27 Asp Asp Ser Leu Ser Leu Arg Lys Ala Leu Ile Val Cys Arg Val Ile  1               5                   10                  15       Ala Gly Arg Val His Arg Pro Leu Glu Asn Val Gln Glu Leu Ile Gly              20                  25                  30           Gln Ser Gly Phe Asp Ser Leu Ala Gly Lys Val Gly Leu Tyr Ser Asn          35                  40                  45               Ile Glu Glu Leu Tyr Leu Leu Asn Ser Lys Ala Leu Leu Pro Cys Phe      50                  55                  60                   Val Val Ile Cys Lys Ser  65                  70   <210> SEQ ID NO 28 <211> LENGTH: 132 <212> TYPE: PRT <213> ORGANISM: Nicotiana tabacum <400> SEQUENCE: 28 Met Arg Arg Asn Cys Asn Leu Glu Leu Arg Leu Met Pro Pro Ser Phe  1               5                   10                  15       Ser Phe Ser Pro Lys Asn Cys Thr Thr Pro Tyr Phe Ser Thr Asp Arg              20                  25                  30           Glu Asp Lys Glu Ser Thr Glu Glu Lys Gln Pro Gln Gln Leu Thr Ile          35                  40                  45               Phe Tyr Asn Gly Lys Phe Val Val Ser Asp Ala Thr Glu Leu Gln Ala      50                  55                  60                   Lys Ala Ile Ile Tyr Leu Ala Ser Arg Glu Met Glu Glu Lys Thr Lys  65                  70                  75                  80   Ile Arg Ser Pro Ile Ser Glu Ser Ser Ser Pro Ile Ser Glu Pro Ser                  85                  90                  95       Ser Pro Phe Leu Gln Ser Pro Ala Ser Asp Leu Ser Met Lys Arg Ser              100                 105                 110          Leu Gln Arg Phe Leu Gln Lys Arg Lys Asn Arg Ile Gln Ala Thr Ser          115                 120                 125              Pro Tyr His His      130          <210> SEQ ID NO 29 <211> LENGTH: 393 <212> TYPE: PRT <213> ORGANISM: Nicotiana tabacum <400> SEQUENCE: 29 Met Glu Arg Asp Phe Met Gly Leu Thr His His Val Lys Gln Glu Val  1               5                   10                  15       Thr Glu Glu Pro Ile Asp Pro Ala Pro Leu Arg Ser Ser Ala Met Gln              20                  25                  30           Trp Ser Phe Ser Asn Asn Ile Ser Thr His Pro Gln Tyr Leu Ser Phe          35                  40                  45               Lys Gly Ala Gln Glu Asp Arg Pro Lys Thr Gly Phe Asp Ser Leu Ala      50                  55                  60                   Ser Thr Gly Leu Val Thr Ile Thr Thr Thr Glu Ala Val Asp Ser Ser  65                  70                  75                  80   His Arg Ser Tyr Ser Gly Val Gly Gln Lys Asn Met Met Leu Glu Lys                  85                  90                  95       Gln Gly Gly Thr His Tyr Met Ser Thr Thr Phe Ser Pro His His Tyr              100                 105                 110          Asp Ala His Ala Met His Arg Ser His Gly Val Arg Val Leu Pro Val          115                 120                 125              Ser Asn Pro Ala Asn Gln Ile Ser Val Ser Met Thr Met Pro Gly His      130                 135                 140                  Lys Ser Phe Val Ser Pro Leu Gly Gln Asn Pro Val Ala Ser Pro Ile  145                 150                 155                 160  Ser Ala Val Pro Thr Asn Ser Ala Val Val Gly Thr Thr Asp Leu Arg                  165                 170                 175      Gly Ala Pro Lys Thr Pro Pro Gly Pro Ala Gln Leu Thr Ile Phe Tyr              180                 185                 190          Ala Gly Ser Val Cys Val Tyr Asp Asn Val Ser Pro Glu Lys Ala Gln          195                 200                 205              Ala Ile Met Leu Leu Ala Gly Asn Ala Pro Pro Val Thr Pro Ser Ala      210                 215                 220                  Thr Ser Ala Leu Ser Pro Val Gln Ala Pro Ile Pro Lys Ser Ser Ser  225                 230                 235                 240  Val Asp Ser Phe Val Val Asn Gln Ser His Asn Thr Thr Pro Thr Leu                  245                 250                 255      Pro Ser Pro Ile Ser Ile Thr Ser His Cys Gly Ser Gln Ser Ala Gly              260                 265                 270          Val Ser Ser Asn Thr Asn Gly Val Thr Ile Ile Lys Ser Ile Gly Val          275                 280                 285              Leu Pro Ser Pro Ser Asn Lys Ala Glu Leu Ser Lys Phe Ser Ser Ser      290                 295                 300                  Ile Gly Ser Val Pro Ala Thr Phe Val Gln Ser Ala Val Pro Gln Ala  305                 310                 315                 320  Arg Lys Ala Ser Leu Ala Arg Phe Leu Glu Lys Arg Lys Glu Arg Val                  325                 330                 335      Ile Ser Ala Ser Pro Tyr Val Ser Cys Lys Gln Ser Pro Glu Cys Ser              340                 345                 350          Thr Leu Gly Tyr Gly Ser Arg Ser Phe Ala Lys Asp Ser Leu Gly Ser          355                 360                 365              Phe Pro Pro Pro Cys Asn Gln Phe Gly Gln Gly Asp Val Lys Cys Gln      370                 375                 380                  Gln Trp Gln Asn Asn Val Asp Thr Arg  385                 390              <210> SEQ ID NO 30 <211> LENGTH: 269 <212> TYPE: PRT <213> ORGANISM: Nicotiana tabacum <400> SEQUENCE: 30 Met Ser Ile Pro Phe Glu His Asp Tyr Ile Gly Leu Ser Glu Ala Ser  1               5                   10                  15       Leu Met Glu Arg Asn Ser Asp Lys Asn Ser Asp Val Leu Asn Leu Lys              20                  25                  30           Glu Thr Glu Leu Arg Leu Gly Leu Pro Gly Thr Glu Glu Thr Asn Thr          35                  40                  45               Gly Leu Asn Pro Ser Asn Asn Phe Ile Ser Arg Thr Lys Arg Gly Phe      50                  55                  60                   Ser Asp Ala Ile Asp Ala Ser Gly Lys Trp Asp Leu Ser Ile Asn Cys  65                  70                  75                  80   Arg Ser Glu Thr Asp Trp Arg Lys Glu Asp Leu Leu Phe Ser Pro Lys                  85                  90                  95       Gly Ser Asn Gly Ser Ser Lys Pro Thr Pro Ser Ile Glu Asn Ser Ala              100                 105                 110          Pro Gln Thr Ser Lys Ala Gln Val Val Gly Trp Pro Pro Ile Arg Ser          115                 120                 125              Phe Arg Lys Asn Thr Leu Ala Thr Lys Lys Asn Asp Ala Glu Gly Lys      130                 135                 140                  Ser Gly Ser Gly Cys Leu Tyr Val Lys Val Arg Met Asp Gly Ala Pro  145                 150                 155                 160  Tyr Leu Arg Lys Val Asp Ile Lys Thr Tyr Ser Asp Tyr Gly Glu Leu                  165                 170                 175      Ser Ser Ala Leu Glu Lys Met Phe Ser Cys Phe Ser Ile Gly Gln Cys              180                 185                 190          Ala Ser Asp Gly Leu Pro Gly Gln Glu Glu Leu Ser Glu Ser His Leu          195                 200                 205              Met Asp Leu Leu Asn Gly Ser Glu Tyr Val Leu Thr Tyr Glu Asp Lys      210                 215                 220                  Asp Gly Asp Trp Met Leu Val Gly Asp Val Pro Trp Glu Met Phe Ile  225                 230                 235                 240  Asp Ser Cys Lys Arg Leu Arg Ile Met Lys Ser Ser Glu Ala Ile Gly                  245                 250                 255      Leu Ala Pro Arg Ala Ile His Lys Cys Lys Asn Lys Asn              260                 265                  <210> SEQ ID NO 31 <211> LENGTH: 50 <212> TYPE: PRT <213> ORGANISM: Nicotiana tabacum <400> SEQUENCE: 31 Met Ile His Arg Lys Trp Ser Leu Leu Thr Gly Pro Ala Ala Ile Leu  1               5                   10                  15       Gly Gly Ile Val Gly Thr Ile Val Val Ala Asn Phe Ile Phe Val Gln              20                  25                  30           Asn Asp Pro Phe Leu Lys Pro Asp Arg Lys Gln Glu Lys Ala Pro Ser          35                  40                  45               Asn Lys      50   <210> SEQ ID NO 32 <211> LENGTH: 100 <212> TYPE: PRT <213> ORGANISM: Nicotiana tabacum <400> SEQUENCE: 32 Met Ala Thr Ala Met Phe Arg Ser Ser Ile Arg Ser Ala Leu Arg Ser  1               5                   10                  15       Gly Ala Pro Arg Val Thr Pro Ala Ser Lys Arg Thr Phe Ser Ser His              20                  25                  30           Ser Ser Val Glu Glu Glu Ala Arg Glu Ala Ser Lys Trp Glu Lys Ile          35                  40                  45               Thr Tyr Val Gly Ile Val Ser Cys Ser Ile Leu Ala Ala Ile Cys Leu      50                  55                  60                   Ser Lys Gly His Pro His Ser Asp Glu Pro Pro Ala Tyr Ser Tyr Leu  65                  70                  75                  80   His Ile Arg Asn Lys Glu Phe Pro Trp Gly Pro Asp Gly Leu Phe Glu                  85                  90                  95       Val Lys His His              100  <210> SEQ ID NO 33 <211> LENGTH: 90 <212> TYPE: DNA <213> ORGANISM: Nicotiana tabacum <400> SEQUENCE: 33 taaggttaaa tcttttttta tcataatact catcaaatct aagagacaca gagctcatta     60 atagcccgtt tggccaagct gcaaaaatca                                      90 <210> SEQ ID NO 34 <211> LENGTH: 72 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE:  <223> OTHER INFORMATION: Synthetic DNA <400> SEQUENCE: 34 actaataatt gcaccgagac aaacactaat aattgcaccg agacaaacac taataattgc     60 accgagacaa ac                                                         72 <210> SEQ ID NO 35 <211> LENGTH: 28 <212> TYPE: DNA <213> ORGANISM: Nicotiana tabacum <400> SEQUENCE: 35 caccacaaga tacaattgca gctgctac                                        28 <210> SEQ ID NO 36 <211> LENGTH: 26 <212> TYPE: DNA <213> ORGANISM: Nicotiana tabacum <400> SEQUENCE: 36 ggctaaagca atgacttcag taagcg                                          26 <210> SEQ ID NO 37 <211> LENGTH: 26 <212> TYPE: DNA <213> ORGANISM: Nicotiana tabacum <400> SEQUENCE: 37 caccattgct tacataactg agatgc                                          26 <210> SEQ ID NO 38 <211> LENGTH: 30 <212> TYPE: DNA <213> ORGANISM: Nicotiana tabacum <400> SEQUENCE: 38 acgatatgat tcttcactac actttatgcc                                      30 <210> SEQ ID NO 39 <211> LENGTH: 28 <212> TYPE: DNA <213> ORGANISM: Nicotiana tabacum <400> SEQUENCE: 39 caccgcatca agtgctgaaa acatagcc                                        28 <210> SEQ ID NO 40 <211> LENGTH: 29 <212> TYPE: DNA <213> ORGANISM: Nicotiana tabacum <400> SEQUENCE: 40 cactaatgtt aaaacagtca tacctggcc                                       29 <210> SEQ ID NO 41 <211> LENGTH: 30 <212> TYPE: DNA <213> ORGANISM: Nicotiana tabacum <400> SEQUENCE: 41 caccattatt accatcctta taattttccc                                      30 <210> SEQ ID NO 42 <211> LENGTH: 29 <212> TYPE: DNA <213> ORGANISM: Nicotiana tabacum <400> SEQUENCE: 42 gaacttatcc tgaatctacc tatactccc                                       29 <210> SEQ ID NO 43 <211> LENGTH: 26 <212> TYPE: DNA <213> ORGANISM: Nicotiana tabacum <400> SEQUENCE: 43 caccgagcaa tgattcaagt atgggg                                          26 <210> SEQ ID NO 44 <211> LENGTH: 26 <212> TYPE: DNA <213> ORGANISM: Nicotiana tabacum <400> SEQUENCE: 44 cgatgtctac tacacagaga attgcc                                          26 <210> SEQ ID NO 45 <211> LENGTH: 29 <212> TYPE: DNA <213> ORGANISM: Nicotiana tabacum <400> SEQUENCE: 45 caccatcgtc ggaatttcaa tttgctacc                                       29 <210> SEQ ID NO 46 <211> LENGTH: 28 <212> TYPE: DNA <213> ORGANISM: Nicotiana tabacum <400> SEQUENCE: 46 attgttgaga agggaaggaa gtcacagc                                        28 <210> SEQ ID NO 47 <211> LENGTH: 26 <212> TYPE: DNA <213> ORGANISM: Nicotiana tabacum <400> SEQUENCE: 47 caccatcttg cctaccgcca ttttcc                                          26 <210> SEQ ID NO 48 <211> LENGTH: 28 <212> TYPE: DNA <213> ORGANISM: Nicotiana tabacum <400> SEQUENCE: 48 tgtatgcatt taacgagggg tctaaagg                                        28 <210> SEQ ID NO 49 <211> LENGTH: 28 <212> TYPE: DNA <213> ORGANISM: Nicotiana tabacum <400> SEQUENCE: 49 caccaagaat ttaataatga gattcggc                                        28 <210> SEQ ID NO 50 <211> LENGTH: 27 <212> TYPE: DNA <213> ORGANISM: Nicotiana tabacum <400> SEQUENCE: 50 atcgaacaaa ttgttaaact cactgcg                                         27 <210> SEQ ID NO 51 <211> LENGTH: 29 <212> TYPE: DNA <213> ORGANISM: Nicotiana tabacum <400> SEQUENCE: 51 caccaagttc gcagcagaaa ttcgtgacc                                       29 <210> SEQ ID NO 52 <211> LENGTH: 28 <212> TYPE: DNA <213> ORGANISM: Nicotiana tabacum <400> SEQUENCE: 52 tacacatctt ctattgagtc ctaatccc                                        28 <210> SEQ ID NO 53 <211> LENGTH: 26 <212> TYPE: DNA <213> ORGANISM: Nicotiana tabacum <400> SEQUENCE: 53 tataataatg agattccaca gtcggc                                          26 <210> SEQ ID NO 54 <211> LENGTH: 31 <212> TYPE: DNA <213> ORGANISM: Nicotiana tabacum <400> SEQUENCE: 54 aataaatacg taggttttag taggtatatg c                                    31 <210> SEQ ID NO 55 <211> LENGTH: 30 <212> TYPE: DNA <213> ORGANISM: Nicotiana tabacum <400> SEQUENCE: 55 caccgatgat agtttatctt tgagaaaggc                                      30 <210> SEQ ID NO 56 <211> LENGTH: 30 <212> TYPE: DNA <213> ORGANISM: Nicotiana tabacum <400> SEQUENCE: 56 aacttcaatt gaattacatg aaagaatggc                                      30 <210> SEQ ID NO 57 <211> LENGTH: 30 <212> TYPE: DNA <213> ORGANISM: Nicotiana tabacum <400> SEQUENCE: 57 caccgaagat gagaagaaac tgtaacttgg                                      30 <210> SEQ ID NO 58 <211> LENGTH: 29 <212> TYPE: DNA <213> ORGANISM: Nicotiana tabacum <400> SEQUENCE: 58 ctggagattg taaaaatggt gatgaaggc                                       29 <210> SEQ ID NO 59 <211> LENGTH: 27 <212> TYPE: DNA <213> ORGANISM: Nicotiana tabacum <400> SEQUENCE: 59 cacccataac acaacaccta ctctccc                                         27 <210> SEQ ID NO 60 <211> LENGTH: 30 <212> TYPE: DNA <213> ORGANISM: Nicotiana tabacum <400> SEQUENCE: 60 tattgaagtc aaaacgacca ccaatttagc                                      30 <210> SEQ ID NO 61 <211> LENGTH: 30 <212> TYPE: DNA <213> ORGANISM: Nicotiana tabacum <400> SEQUENCE: 61 caccaaaggt tgatatcaaa acttacagcg                                      30 <210> SEQ ID NO 62 <211> LENGTH: 29 <212> TYPE: DNA <213> ORGANISM: Nicotiana tabacum <400> SEQUENCE: 62 cttcttaaac cagtgctttt cctttcagg                                       29 <210> SEQ ID NO 63 <211> LENGTH: 35 <212> TYPE: DNA <213> ORGANISM: Nicotiana tabacum <400> SEQUENCE: 63 caccgctata gtttataaaa ttaccaagaa cgtcg                                35 <210> SEQ ID NO 64 <211> LENGTH: 29 <212> TYPE: DNA <213> ORGANISM: Nicotiana tabacum <400> SEQUENCE: 64 tacatcatca tatacatgtg acatacggg                                       29 <210> SEQ ID NO 65 <211> LENGTH: 31 <212> TYPE: DNA <213> ORGANISM: Nicotiana tabacum <400> SEQUENCE: 65 caccagaagc tgaaggagaa gagaatatcg g                                    31 <210> SEQ ID NO 66 <211> LENGTH: 26 <212> TYPE: DNA <213> ORGANISM: Nicotiana tabacum <400> SEQUENCE: 66 aaacaggaga tgaccagttc ccaacc                                          26 <210> SEQ ID NO 67 <211> LENGTH: 28 <212> TYPE: DNA <213> ORGANISM: Nicotiana tabacum <400> SEQUENCE: 67 caccaagaga aatccctaaa tggcgacg                                        28 <210> SEQ ID NO 68 <211> LENGTH: 30 <212> TYPE: DNA <213> ORGANISM: Nicotiana tabacum <400> SEQUENCE: 68 agcacattgt aagtatacag caaaagatgg                                      30 <210> SEQ ID NO 69 <211> LENGTH: 24 <212> TYPE: DNA <213> ORGANISM: Escherichia coli <400> SEQUENCE: 69 cacctacggc aaagtgtggg tcaa                                            24 <210> SEQ ID NO 70 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Escherichia coli <400> SEQUENCE: 70 tgtctggctt ttggctgtga                                                 20 <210> SEQ ID NO 71 <211> LENGTH: 431 <212> TYPE: DNA <213> ORGANISM: Nicotiana tabacum <400> SEQUENCE: 71 accacaagat acaattgcag ctgctacaaa agcaataaca tccgacccaa attttcaatc     60 tgcattggct gttgctcttg catctatcat tggctcaggc agcggaaatc atgcaggtgg    120 tattgaagaa aaatctggtc taaatttgaa ggttaccgaa ccatttccag ttctttgcag    180 cttcccatct acctcaaaga aataatatat ccaattaact gttcttcaaa tttttctgaa    240 taaatcgact tctacggcaa atagacaggc tgctagtaac tttcgcttgc tgaagtaaga    300 aactaattgc ggcgttaatt aatcagatgt aatatttttt ttatgatttg gaggtacgat    360 gtccaaagtg tagatatttt agtttgataa aactaattga cacttcgctt actgaagtca    420 ttgctttagc c                                                         431 <210> SEQ ID NO 72 <211> LENGTH: 460 <212> TYPE: DNA <213> ORGANISM: Nicotiana tabacum <400> SEQUENCE: 72 ccattgctta cataactgag atgcagaaaa aactaagaga catggaatcc gagagggagc     60 tgagattagg aagcacttca agggatgcaa tggctgcaga agacagcccg aattcagaga    120 ttcaaatccg tggacccgac atcaacgtag aagctgccaa tgatgaagtc attgtaaggg    180 tgagttgtcc tctggaaacc catccaatat caagagtcat ccaaacattc aaagatgcac    240 agatcaatgt tgttgaatca aaactttctg ccgggaatgg aactgtattt cacacatttg    300 tactcaagtc tagtggatct gaacagctga caaaggaaaa gttgctggct gcattttcca    360 gcgaatcaga ctcgctgagg caattttcac cggtagggca ataacagttt tatgttttat    420 gtagttgcta ggcataaagt gtagtgaaga atcatatcgt                          460 <210> SEQ ID NO 73 <211> LENGTH: 471 <212> TYPE: DNA <213> ORGANISM: Nicotiana tabacum <400> SEQUENCE: 73 cgcatcaagt gctgaaaaca tagccaaatt gcttaaacaa tggaccagaa gtgattcaac     60 aaacatttct gagcaatcga aagcttcatc aagtactcaa ctctcaagta ataacaatgc    120 caccaccgag gaatttgagt cactttccag tttcgattca tttgaacagt caaattcaga    180 tcaattttca cagagtttga cacttgaggc tggtaaatta cactgtgaaa ttagtaaaag    240 agaagtggat gatcaagtac ccttgtcagt aatgctggag agttggcttt ttgatgaaaa    300 tgacgatttg ctaatttaga aggaattttt ttgcttttcc atttggggat tctatttgtt    360 gcattatgtt tttgtttctt accccaagta ctagaatttt acctaggtat ggatgtgaca    420 tccacattct tttttttttt tgggccaggt atgactgttt taacattagt g             471 <210> SEQ ID NO 74 <211> LENGTH: 383 <212> TYPE: DNA <213> ORGANISM: Nicotiana tabacum <400> SEQUENCE: 74 cattattacc atccttataa ttttcccaca tttttttcaa caaaaaaaga aactaaagag     60 gaaaactccc caagtttctt ctaccctaat aacaaccaaa accaaatatc aacttccgac    120 tatattcttc cggccaatga ttattggact ccggcaactg aaacctccgg caatgttatg    180 gcgacggcgt tatcgtcggc gtctgataat gtggattaca tctcatctga atcagttact    240 agcactcaca atttggagat ggagatggag atggagatgg agatgatggc gggaattgac    300 tttgacgatt tgccttttga attttaaggg tagatttttc tctcatattt ttttgggagt    360 ataggtagat tcaggataag ttc                                            383 <210> SEQ ID NO 75 <211> LENGTH: 372 <212> TYPE: DNA <213> ORGANISM: Nicotiana tabacum <400> SEQUENCE: 75 cgagcaatga ttcaagtatg ggggagtttg atgaatataa aatattcata tattatatac     60 ttaaaaatat actattttaa ataaagtatt tatataatat ttcgattctc tgtattttct    120 aacaatattt tgcaggagat aagaatgcta ttaattaagc aagaaaatga aagaatcaag    180 aagctcgtaa cggattcact ccataatgca agaagatcac gacgcatctt cttcatgacg    240 tatcttcctc gagatacatc ttcctcaaga catattctcc tcaagatgca tcttcctcac    300 ttgagatcac aacacttcaa gaagaaatgc acgtctataa atagaaggca attctctgtg    360 tagtagacat cg                                                        372 <210> SEQ ID NO 76 <211> LENGTH: 482 <212> TYPE: DNA <213> ORGANISM: Nicotiana tabacum <400> SEQUENCE: 76 ccatcgtcgg aatttcaatt tgctaccatt aatttgcaag gccctcctcc tcccgttccc     60 tttgtcctct cctctctctt ctgcacatcc aaatccaact tccctaccgc cattttccgc    120 acttcgataa ctcgttaacc cctcagtctc taatttcttc ctcaccccaa aaaaaaaaaa    180 actttcattt ctctgtcttc tttccaaact tttttcttcc tcccctgctt acacacaaga    240 atctgtgatg gatgccgcaa atttagtcat gaaatcttcc ttgttttcga aatccccatg    300 tccccttttt agttctaaac tcattcctag agcaccaccc tctgtcttta ctctgccttc    360 tacctttaga cccctcgtta aatgcataca agcttcattc ccaccaaacc ctgattccaa    420 aaaaccctca aacaattcaa cctttacgtg ttcagctgtg acttccttcc cttctcaaca    480 at                                                                   482 <210> SEQ ID NO 77 <211> LENGTH: 306 <212> TYPE: DNA <213> ORGANISM: Nicotiana tabacum <400> SEQUENCE: 77 ccatcttgcc taccgccatt ttccgcactt cgagaactcg ttaacccctc actctccaat     60 ttcgtcctca cccaaaaaaa aaaaaaaaaa aaccttgtca gttctctgtc ttcttttcaa    120 actcttttct tctttctcct ctgcttaaac acaagaatct gttatggacg ccgcaaattt    180 agtcatgaaa tcttccatgt tttcgaaatc cccatgtccc gtttttggtt ctaaactcat    240 tcctagagca ccaccctctg tctttactct gccttctacc tttagacccc tcgttaaatg    300 cataca                                                               306 <210> SEQ ID NO 78 <211> LENGTH: 486 <212> TYPE: DNA <213> ORGANISM: Nicotiana tabacum <400> SEQUENCE: 78 aagaatttaa taatgagatt cggccattgg tgaactcaag caggaaaagg gtgagagaaa     60 cagtgaatga ggagcaacta gttatcaata aggaaatgaa aatagaagaa gaaagagtcc    120 cgacggctcc attaacgccg tcaatttggt cggcaatttg ggacagtgga gatgggaagg    180 gtatttttga agtgccgcca ttatctccac atatggccta ttctcagctt gtcatgatat    240 aatcaataat ggataaggag tatataattt gggatgttag tatttggaag atgatgaata    300 tataaatatg cacctgacta tgaagaaagt ctgaggtgaa atcaagaatt aagatgagat    360 tcaataggaa gatgtagaac aataaaatag tccatggatg tgtctttggg tctttaatct    420 tttctgattt tattgattta gcgttatttc atgtaaatac gcagtgagtt taacaatttg    480 ttcgat                                                               486 <210> SEQ ID NO 79 <211> LENGTH: 515 <212> TYPE: DNA <213> ORGANISM: Nicotiana tabacum <400> SEQUENCE: 79 caagttcgca gcagaaattc gtgacccgaa ccgaaagggg actcgggttt ggttaggaac     60 ctttgacact gccttagagg cggccaaggc atatgacagg gcagcgttta aacttagagg    120 aaacaaagca atagtgaatt tccctctcga agttgcaaac tttaagcaag aatataataa    180 tgagattcca cagtcagcta actcaggccg gaaaagggtg agagaaacag agaatgagga    240 gcaactcgtt atcaataagg aaatgaaaat agaagaagaa agagtcccta cgactccatt    300 aacgccgtca agttggtcgg cgatttggga cagtggagat gggaagggta tatttgagat    360 gccgctgctt tccccattgt ctccacattt gccttattct cagcttgtca ttatataatc    420 aaaaggacac cggtatatat acatatgcac ctgaccgtaa agaaagtctg aggtgattcc    480 ctgaattggg attaggactc aatagaagat gtgta                               515 <210> SEQ ID NO 80 <211> LENGTH: 567 <212> TYPE: DNA <213> ORGANISM: Escherichia coli <400> SEQUENCE: 80 tataataatg agattccaca gtcggctaac tcaggccgga aaagggtgag aggaacagag     60 aatgaggagc aattagttat caataaggaa atgaaaagag aagaagaaag agtccctact    120 gcggcggctc cattaacgcc gtcaagttgg tcggcgattt gggacagcgg agacggaaaa    180 ggaatttttg aggtgccgcc tctttcccca ttgtctccac atatagggta ttctcaggtt    240 gtgatgatat gatcagataa ggaacggcaa cgtatataga ttgtggtgtt agtatttagt    300 agatgaagga taaatattgc acctgactgt aaaaagtctg tggtgattaa tttctcagcc    360 aaaaaaagaa atatggggga aggtgggggt agctacggga attagtatgg tgataataaa    420 gattggtgtc tggtctcctc cttaagtctt ttgattaaat tttattgttt atgtaaaaac    480 gtcagtcaga gatctgtttg attgttttat atattcatat ctatgaaact atgaaagcat    540 atacctacta aaacctacgt atttatt                                        567 <210> SEQ ID NO 81 <211> LENGTH: 261 <212> TYPE: DNA <213> ORGANISM: Nicotiana tabacum <400> SEQUENCE: 81 gatgatagtt tatctttgag aaaggctcta atagtatgca gagtgattgc tggtagggtg     60 catagacctt tggaaaatgt tcaagaattg attggtcaat cagggtttga ttcattggct    120 ggaaaagtag gactctactc aaatattgaa gaactctatt tgctcaattc taaagctttg    180 cttccttgtt ttgtggtaat ctgtaaatca taaaaaatac aaggtgattg agccattctt    240 tcatgtaatt caattgaagt t                                              261 <210> SEQ ID NO 82 <211> LENGTH: 314 <212> TYPE: DNA <213> ORGANISM: Nicotiana tabacum <400> SEQUENCE: 82 gaagatgaga agaaactgta acttggagct caggcttatg cctccttctt tttctttttc     60 tcctaagaat tgcactaccc cttacttctc aacggatagg gaggataaag aaagcacaga    120 agagaaacaa ccacagcagc taacaatatt ttacaatgga aaatttgtgg tttctgatgc    180 tactgaactt caggctaaag caataatata tctggcaagt agagaaatgg aggagaaaac    240 aaaaatccgg tcaccaattt cagaatcatc atcaccaatt tcagagcctt catcaccatt    300 tttacaatct ccag                                                      314 <210> SEQ ID NO 83 <211> LENGTH: 493 <212> TYPE: DNA <213> ORGANISM: Nicotiana tabacum <400> SEQUENCE: 83 cccataacac aacacctact ctccccagcc ccatttctat aacatcccat tgtggatctc     60 aatctgctgg agtgtctagt aatacaaatg gagtaactat tatcaaatca attggggtcc    120 taccatctcc ttctaataaa gcagaacttt ctaaattttc cagttccata ggatctgttc    180 ctgccacctt tgttcaatca gctgtaccac aggcacgcaa ggcatcattg gctcggttct    240 tggagaagcg caaagaaagg gtaataagtg catcacctta cgtcagctgc aagcaatccc    300 cagaatgcag cactcttgga tatggaagca gaagtttcgc aaaagattct ttaggctctt    360 ttcctccccc atgtaatcaa tttggtcaag gagacgtgaa atgccaacag tggcaaaata    420 atgtagacac aaggtgaaga ctgtaccaga ttagattatt aaagctaaat tggtggtcgt    480 tttgacttca ata                                                       493 <210> SEQ ID NO 84 <211> LENGTH: 443 <212> TYPE: DNA <213> ORGANISM: Nicotiana tabacum <400> SEQUENCE: 84 aaaggttgat atcaaaactt acagcgacta tggggagctc tcatcagcac ttgaaaagat     60 gttcagctgc tttagtattg ggcagtgcgc cagcgatgga cttccggggc aagaggaact    120 tagtgaaagt cacttgatgg atcttctcaa tggttctgag tatgttctga cttatgaaga    180 caaagatggt gattggatgc ttgttggcga tgttccttgg gagatgttca tagactcatg    240 caagagattg cggatcatga aaagctcaga ggcaattggg ctagctccaa gggctataca    300 caagtgcaag aacaaaaact agtgactgaa aaaccattca atggtttcta tgtcgatgat    360 tatccttttt ctgctctctt ttgtatctgg aattagacta gacgtgtagc attccctgaa    420 aggaaaagca ctggtttaag aag                                            443 <210> SEQ ID NO 85 <211> LENGTH: 454 <212> TYPE: DNA <213> ORGANISM: Nicotiana tabacum <400> SEQUENCE: 85 gctatagttt ataaaattac caagaacgtc gttacacgaa ttcaacgtct caaccccgat     60 ttgagacttg atcctcacat actaatcttc tgtgctcgtg cacctggaga agcttcctct    120 ccacaccaag ctgatattca accaatcaat tttccatctg atggtagtaa caatcaaggt    180 cgagagtcct ccaaataggc tatcagctca gcggaaggtt ttgctgcgct ccatttgctc    240 cggagttgct tatgtggtca atatgattag gacatgtact gattagtatg tcggggccgt    300 gtcccgacct ttatgacatt tatgtactct tagaggtttg tagacatatg tcgaatacgt    360 gaaagattgt acggccttgt cggcctatgt tttgagttta taaatgatca tgttggccta    420 ttaggcccgt atgtcacatg tatatgatga tgta                                454 <210> SEQ ID NO 86 <211> LENGTH: 393 <212> TYPE: DNA <213> ORGANISM: Nicotiana tabacum <400> SEQUENCE: 86 cagaagctga aggagaagag aatatcggaa gaaggatgat acaccggaaa tggagtttgc     60 taacaggccc cgctgcaatt ctcggcggta tcgtcggtac tatcgtcgtc gccaatttta    120 tcttcgtcca aaatgacccg ttccttaagc ccgatcggaa gcaggagaag gcaccttcaa    180 acaagtgaga aatgcgtgtg attttctctg gtttggggtt ttctgttggt ttgatttgtc    240 actacattac ggcccaataa actcaaattt tgagcattag cttgaatgta ggttttcttt    300 tgttggcttt ctttctgtac tctttctctt cacagaatat gaaagtatgc tccaaacaag    360 agtcctaggt tgggaactgg tcatctcctg ttt                                 393 <210> SEQ ID NO 87 <211> LENGTH: 488 <212> TYPE: DNA <213> ORGANISM: Nicotiana tabacum <400> SEQUENCE: 87 caagagaaat ccctaaatgg cgacggcgat gttcagatct agtattcgct ccgccctccg     60 cagcggcgct cctcgtgtaa ctccggcttc caagagaacc ttctcttctc actcatccgt    120 tgaggaagag gcccgtgaag cctctaagtg ggagaaaatt acttatgttg gaatagtttc    180 ctgctctatt cttgctgcga tttgtctgtc aaagggtcac cctcactctg atgagcctcc    240 tgcttactca tatctgcaca ttcgcaacaa ggagtttcca tggggtccag atgggctttt    300 tgaggtcaag caccactgaa actgcgtggt ttctctgtga aggcgttaaa ataattcctg    360 tccatccgcg aggatgatca catttgttga attttcatta gatgtctact tttggttctt    420 tgcttataag aaacctttgc cttttctttg acatatttcc atcttttgct gtatacttac    480 aatgtgct                                                             488 <210> SEQ ID NO 88 <211> LENGTH: 501 <212> TYPE: DNA <213> ORGANISM: Nicotiana tabacum <400> SEQUENCE: 88 tacggcaaag tgtgggtcaa taatcaggaa gtgatggagc atcagggcgg ctatacgcca     60 tttgaagccg atgtcacgcc gtatgttatt gccgggaaaa gtgtacgtat caccgtttgt    120 gtgaacaacg aactgaactg gcagactatc ccgccgggaa tggtgattac cgacgaaaac    180 ggcaagaaaa agcagtctta cttccatgat ttctttaact atgccggaat ccatcgcagc    240 gtaatgctct acaccacgcc gaacacctgg gtggacgata tcaccgtggt gacgcatgtc    300 gcgcaagact gtaaccacgc gtctgttgac tggcaggtgg tggccaatgg tgatgtcagc    360 gttgaactgc gtgatgcgga tcaacaggtg gttgcaactg gacaaggcac tagcgggact    420 ttgcaagtgg tgaatccgca cctctggcaa ccgggtgaag gttatctcta tgaactgtgc    480 gtcacagcca aaagccagac a                                              501 <210> SEQ ID NO 89 <211> LENGTH: 25 <212> TYPE: DNA <213> ORGANISM: Nicotiana tabacum <400> SEQUENCE: 89 ggattcccgg gattttgaat tcttg                                           25 <210> SEQ ID NO 90 <211> LENGTH: 29 <212> TYPE: DNA <213> ORGANISM: Nicotiana tabacum <400> SEQUENCE: 90 atcgaacaaa ttgttaaact cactgcgta                                       29 <210> SEQ ID NO 91 <211> LENGTH: 26 <212> TYPE: DNA <213> ORGANISM: Nicotiana tabacum <400> SEQUENCE: 91 ctttccctcg ttttattagc agatca                                          26 <210> SEQ ID NO 92 <211> LENGTH: 30 <212> TYPE: DNA <213> ORGANISM: Nicotiana tabacum <400> SEQUENCE: 92 ctatttacaa gaattaacgc ttaatcaatg                                      30 <210> SEQ ID NO 93 <211> LENGTH: 24 <212> TYPE: DNA <213> ORGANISM: Nicotiana tabacum <400> SEQUENCE: 93 actaataatt gcaccgagac aaac                                            24 <210> SEQ ID NO 94 <211> LENGTH: 9 <212> TYPE: PRT <213> ORGANISM: Arabidopsis thaliana <400> SEQUENCE: 94 Thr Glu Leu Arg Leu Gly Leu Pro Gly  1               5                    <210> SEQ ID NO 95 <211> LENGTH: 9 <212> TYPE: PRT <213> ORGANISM: Arabidopsis thaliana <400> SEQUENCE: 95 Thr Asp Leu Arg Leu Gly Leu Ser Phe  1               5                    <210> SEQ ID NO 96 <211> LENGTH: 8 <212> TYPE: PRT <213> ORGANISM: Arabidopsis thaliana <400> SEQUENCE: 96 Glu Leu Glu Leu Gly Leu Gly Leu  1               5                <210> SEQ ID NO 97 <211> LENGTH: 8 <212> TYPE: PRT <213> ORGANISM: Arabidopsis thaliana <400> SEQUENCE: 97 Glu Leu Gly Leu Thr Leu Ser Leu  1               5                <210> SEQ ID NO 98 <211> LENGTH: 8 <212> TYPE: PRT <213> ORGANISM: Arabidopsis thaliana <400> SEQUENCE: 98 Glu Leu Asp Leu Gly Leu Ser Leu  1               5                <210> SEQ ID NO 99 <211> LENGTH: 8 <212> TYPE: PRT <213> ORGANISM: Arabidopsis thaliana <400> SEQUENCE: 99 Asp Leu Gly Leu Ser Leu Arg Thr  1               5                <210> SEQ ID NO 100 <211> LENGTH: 8 <212> TYPE: PRT <213> ORGANISM: Arabidopsis thaliana <400> SEQUENCE: 100 Asn Leu Ser Leu Ser Leu Thr Phe  1               5                <210> SEQ ID NO 101 <211> LENGTH: 7 <212> TYPE: PRT <213> ORGANISM: Arabidopsis thaliana <400> SEQUENCE: 101 Lys Lys Leu Glu Leu Arg Leu  1               5            <210> SEQ ID NO 102 <211> LENGTH: 9 <212> TYPE: PRT <213> ORGANISM: Nicotiana tabacum <400> SEQUENCE: 102 Ile Asp Leu Asp Leu Asn Leu Ala Pro  1               5                    <210> SEQ ID NO 103 <211> LENGTH: 9 <212> TYPE: PRT <213> ORGANISM: Arabidopsis thaliana <400> SEQUENCE: 103 Leu Asp Leu Asp Leu Asn Leu Pro Pro  1               5                    <210> SEQ ID NO 104 <211> LENGTH: 9 <212> TYPE: PRT <213> ORGANISM: Arabidopsis thaliana <400> SEQUENCE: 104 Leu Asp Leu Asp Leu Asn Leu Ala Pro  1               5                    <210> SEQ ID NO 105 <211> LENGTH: 8 <212> TYPE: PRT <213> ORGANISM: Oryza sativa <400> SEQUENCE: 105 Phe Asp Leu Asp Leu Asn Arg Pro  1               5                <210> SEQ ID NO 106 <211> LENGTH: 9 <212> TYPE: PRT <213> ORGANISM: Arabidopsis thaliana <400> SEQUENCE: 106 Phe Gln Phe Asp Leu Asn Phe Pro Pro  1               5                    <210> SEQ ID NO 107 <211> LENGTH: 7 <212> TYPE: PRT <213> ORGANISM: Arabidopsis thaliana <400> SEQUENCE: 107 Leu Asp Leu Asn Ala Ser Pro  1               5            <210> SEQ ID NO 108 <211> LENGTH: 9 <212> TYPE: PRT <213> ORGANISM: Arabidopsis thaliana <400> SEQUENCE: 108 Leu Asp Leu Asp Leu Asn Phe Pro Pro  1               5                    <210> SEQ ID NO 109 <211> LENGTH: 7 <212> TYPE: PRT <213> ORGANISM: Arabidopsis thaliana <400> SEQUENCE: 109 Phe Asp Leu Asn Ile Pro Pro  1               5            <210> SEQ ID NO 110 <211> LENGTH: 7 <212> TYPE: PRT <213> ORGANISM: Arabidopsis thaliana <400> SEQUENCE: 110 Leu Asp Leu Asn Leu Thr Pro  1               5            <210> SEQ ID NO 111 <211> LENGTH: 6 <212> TYPE: PRT <213> ORGANISM: Arabidopsis thaliana <400> SEQUENCE: 111 Ile Asp Leu Asn Leu Pro  1               5        <210> SEQ ID NO 112 <211> LENGTH: 7 <212> TYPE: PRT <213> ORGANISM: Catharanthus roseus <400> SEQUENCE: 112 Leu Asp Leu Asn Leu Thr Pro  1               5            <210> SEQ ID NO 113 <211> LENGTH: 7 <212> TYPE: PRT <213> ORGANISM: Catharanthus roseus <400> SEQUENCE: 113 Phe Asp Leu Asn Leu Pro Ala  1               5            <210> SEQ ID NO 114 <211> LENGTH: 28 <212> TYPE: DNA <213> ORGANISM: Nicotiana tabacum <400> SEQUENCE: 114 cacctacgac atggaagtgg ctttcaga                                        28 <210> SEQ ID NO 115 <211> LENGTH: 25 <212> TYPE: DNA <213> ORGANISM: Nicotiana tabacum <400> SEQUENCE: 115 gccttatctt tgctcaagat tttgg                                           25 <210> SEQ ID NO 116 <211> LENGTH: 25 <212> TYPE: DNA <213> ORGANISM: Nicotiana tabacum <400> SEQUENCE: 116 cacctgacta tgaagaaagt ctgag                                           25 <210> SEQ ID NO 117 <211> LENGTH: 33 <212> TYPE: DNA <213> ORGANISM: Nicotiana tabacum <400> SEQUENCE: 117 ggctttaatt gaataacttc ataaaatgaa tcg                                  33 <210> SEQ ID NO 118 <211> LENGTH: 25 <212> TYPE: DNA <213> ORGANISM: Nicotiana tabacum <400> SEQUENCE: 118 caccattgtc tccacatttg cctta                                           25 <210> SEQ ID NO 119 <211> LENGTH: 28 <212> TYPE: DNA <213> ORGANISM: Nicotiana tabacum <400> SEQUENCE: 119 gaaaagaatt caagactcaa agacaccc                                        28 <210> SEQ ID NO 120 <211> LENGTH: 24 <212> TYPE: DNA <213> ORGANISM: Nicotiana tabacum <400> SEQUENCE: 120 cacctcaacg gctaccagaa tggc                                            24 <210> SEQ ID NO 121 <211> LENGTH: 29 <212> TYPE: DNA <213> ORGANISM: Nicotiana tabacum <400> SEQUENCE: 121 ccaccattct ctgtatgttg aattgctcc                                       29 <210> SEQ ID NO 122 <211> LENGTH: 492 <212> TYPE: DNA <213> ORGANISM: Nicotiana tabacum <400> SEQUENCE: 122 cacctacgac atggaagtgg ctttcagaaa atctattaat ggaggcttag tcaaagagga     60 gaagaggaac aaattagctt atcaatccag ttctgatgag gagggttttg ttgaagacag    120 taatgttctt aaggtcggga aggaaagaga agtccatgag gacgataatt cgaagtatcc    180 tcagcaagag gatatcgaca gtgacaagga ggacgatcag ctacaatcag tcaaagctga    240 tatgaaagag gtaatgaaag aaaatcagag gctgaagatg cacttggatc gaattatgaa    300 ggattatcgg aaccttcagc tgcaatttca cgacattgtt caaagaaatg ctgaaaaatc    360 caatagtatt attgatactg atcggcataa tgaatgtaac gaagctgaat ttgtctccct    420 tagcttagga agatcttcaa gcgacactaa aaaagaagag tacttatcca aaatcttgag    480 caaagataag gc                                                        492 <210> SEQ ID NO 123 <211> LENGTH: 205 <212> TYPE: DNA <213> ORGANISM: Nicotiana tabacum <400> SEQUENCE: 123 cacctgacta tgaagaaagt ctgaggtgaa atcaagaatt aagatgagat tcaataggaa     60 gatgtagaac aataaaatag tccatggatg tgtctttggg tctttaatct tttctgattt    120 tattgattta gcgttatttc atgtaaatac gcagtgagtt taacaatttg ttcgattcat    180 tttatgaagt tattcaatta aagcc                                          205 <210> SEQ ID NO 124 <211> LENGTH: 178 <212> TYPE: DNA <213> ORGANISM: Nicotiana tabacum <400> SEQUENCE: 124 caccattgtc tccacatttg ccttattctc agcttgtcat tatataatca aaaggacacc     60 ggtatatata catatgcacc tgaccgtaaa gaaagtctga ggtgattccc tgaattggga    120 ttaggactca atagaagatg tgtagaagag gggtgtcttt gagtcttgaa ttcttttc      178 <210> SEQ ID NO 125 <211> LENGTH: 341 <212> TYPE: DNA <213> ORGANISM: Nicotiana tabacum <400> SEQUENCE: 125 cacctcaacg gctaccagaa tggcacttcc aaacaccaaa acgggcacca gaatggcact     60 ttcgaacatc ggaacggcca ccagaatggg acatccgaac aacagaacgg gacaatcagc    120 catgacaatg gcaacgagct actgggaagc tccgactcta ttaagcctgg ctggttttca    180 gagtttagcg cattatggcc aggtgaagca ttctcactta aggttgagaa gttactattc    240 caggggaagt ctgattacca agatgtcatg ctctttgagt cagcaactta tgggaaggtt    300 ctgactttgg atggagcaat tcaacataca gagaatggtg g                        341 <210> SEQ ID NO 126 <211> LENGTH: 37 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE:  <223> OTHER INFORMATION: Synthetic primer <400> SEQUENCE: 126 gcgattaatg gaagtcatat ctaccaacac aaatggc                              37 <210> SEQ ID NO 127 <211> LENGTH: 35 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE:  <223> OTHER INFORMATION: Synthetic primer <400> SEQUENCE: 127 cgtggtcgac ttaagactcg atcatacttc tggcg                                35 <210> SEQ ID NO 128 <211> LENGTH: 1145 <212> TYPE: DNA <213> ORGANISM: Nicotiana tabacum <400> SEQUENCE: 128 gcgattaatg gaagtcatat ctaccaacac aaatggctct accatcttca agaatggtgc     60 cattcccatg aacggccacc aaaatggcac ttctgaacac ctcaacggct accagaatgg    120 cacttccaaa caccaaaacg ggcaccagaa tggcactttc gaacatcgga acggccacca    180 gaatgggaca tccgaacaac agaacgggac aatcagccat gacaatggca acgagctact    240 gggaagctcc gactctatta agcctggctg gttttcagag tttagcgcat tatggccagg    300 tgaagcattc tcacttaagg ttgagaagtt actattccag gggaagtctg attaccaaga    360 tgtcatgctc tttgagtcag caacttatgg gaaggttctg actttggatg gagcaattca    420 acatacagag aatggtggat ttccatacac tgaaatgatt gttcatctac cacttggttc    480 catcccaaac ccaaaaaagg ttttgatcat cggcggagga attggtttta cattattcga    540 aatgcttcgt tatccttcaa tcgaaaaaat tgacattgtt gagatcgatg acgtggtagt    600 tgatgtatcc agaaaatttt tcccttatct ggcagctaat tttaacgatc ctcgtgtaac    660 cctagttctc ggagatggag ctgcatttgt aaaggctgca caagcgggat attatgatgc    720 tattatagtg gactcttctg atcccattgg tccagcaaaa gatttgtttg agaggccatt    780 ctttgaggca gtagccaaag cccttaggcc aggaggagtt gtatgcacac aggctgaaag    840 catttggctt catatgcata ttattaagca aatcattgct aactgtcgtc aagtctttaa    900 gggttctgtc aactatgctt ggacaaccgt tccaacatat cccaccggtg tgatcggtta    960 tatgctctgc tctactgaag ggccagaagt tgacttcaag aatccagtaa atccaattga   1020 caaagagaca actcaagtca agtccaaatt aggacctctc aagttctaca actctgatat   1080 tcacaaagca gcattcattt taccatcttt cgccagaagt atgatcgagt cttaagtcga   1140 ccacg                                                               1145 <210> SEQ ID NO 129 <211> LENGTH: 24 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE:  <223> OTHER INFORMATION: Synthetic primer <400> SEQUENCE: 129 ggatccgtga tggatgccgc aaat                                            24 <210> SEQ ID NO 130 <211> LENGTH: 27 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE:  <223> OTHER INFORMATION: Synthetic primer <400> SEQUENCE: 130 ggtaccttaa gcagagcttg atcgtcc                                         27 <210> SEQ ID NO 131 <211> LENGTH: 24 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE:  <223> OTHER INFORMATION: Synthetic primer <400> SEQUENCE: 131 ggatccgtta tggacgccgc aaat                                            24 <210> SEQ ID NO 132 <211> LENGTH: 27 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE:  <223> OTHER INFORMATION: Synthetic primer <400> SEQUENCE: 132 ggtaccttaa gcggagcttg atcgttg                                         27 

1. An isolated polynucleotide set forth in any one of the following (a), (b), and (c), the isolated polynucleotide having a function of regulating a content of a plant metabolite: (a) a polynucleotide consisting of the base sequence of any one of SEQ ID NO: 1 to 10 and 12 to 16; (b) a polynucleotide consisting of a base sequence in which one or several bases are deleted, inserted, substituted or added in the base sequence of any one of SEQ ID NO: 1 to 10 and 12 to 16; and (c) a polynucleotide that hybridizes, under a stringent condition, to a polynucleotide consisting of a complementary sequence of the polynucleotide (a).
 2. An isolated polynucleotide encoding a polypeptide set forth in any one of the following (d) and (e), the polypeptide having a function of regulating a content of a plant metabolite: (d) a polypeptide consisting of the amino acid sequence of any one of SEQ ID NO: 18 to 26 and 28 to 31; and (e) a polypeptide consisting of an amino acid sequence in which one or several amino acids are deleted, inserted, substituted or added in the amino acid sequence of any one of SEQ ID NO: 18 to 26 and 28 to
 31. 3. An isolated polypeptide set forth in any one of the following (d) and (e), the isolated polypeptide having a function of regulating a content of a plant metabolite: (d) a polypeptide consisting of the amino acid sequence of any one of SEQ ID NO: 18 to 26 and 28 to 31; and (e) a polypeptide consisting of an amino acid sequence in which one or several amino acids are deleted, inserted, substituted or added in the amino acid sequence of any one of SEQ ID NO: 18 to 26 and 28 to
 31. 4. A vector comprising the isolated polynucleotide as set forth in claim
 1. 5. A vector allowing production of a transformed plant whose content of a plant metabolite is regulated, the vector comprising a polynucleotide that is a part of the isolated polynucleotide as set forth claim
 1. 6. A method for producing a transformed plant whose content of a plant metabolite is regulated, the method comprising the step of transforming a plant cell by using the vector as set forth in claim
 4. 7. A transformed plant whose content of a plant metabolite is regulated, the transformed plant being produced by using the vector as set forth in claim
 4. 8. A tobacco product produced by using a plant body of the transformed plant as set forth in claim 7, the transformed plant being Nicotiana tabacum or Nicotiana rustica.
 9. A vector comprising the isolated polynucleotide as set forth in claim
 2. 10. A vector allowing production of a transformed plant whose content of a plant metabolite is regulated, the vector comprising a polynucleotide that is a part of the isolated polynucleotide as set forth claim
 2. 11. A method for producing a transformed plant whose c ontent of a plant metabolite is regulated, the method com prising the step of transforming a plant cell by using the vector as set forth in claim
 5. 12. A method for producing a transformed plant whose c ontent of a plant metabolite is regulated, the method com prising the step of transforming a plant cell by using the vector as set forth in claim
 9. 13. A method for producing a transformed plant whose c ontent of a plant metabolite is regulated, the method com prising the step of transforming a plant cell by using the vector as set forth in claim
 10. 14. A transformed plant whose content of a plant metabolite is regulated, the transformed plant being produced by using the vector as set forth in claim
 5. 15. A transformed plant whose content of a plant metabolite is regulated, the transformed plant being produced by using the vector as set forth in claim
 9. 16. A transformed plant whose content of a plant metabolite is regulated, the transformed plant being produced by using the vector as set forth in claim
 10. 17. A tobacco product produced by using a plant body of the transformed plant as set forth in claim 14, the transformed plant being Nicotiana tabacum or Nicotiana rustica.
 18. A tobacco product produced by using a plant body of the transformed plant as set forth in claim 15, the transformed plant being Nicotiana tabacum or Nicotiana rustica.
 19. A tobacco product produced by using a plant body of the transformed plant as set forth in claim 16, the transformed plant being Nicotiana tabacum or Nicotiana rustica. 